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The sulfur containing histidine derivative ergothioneine is a ubiquitous natural product. Research on 
its biosynthesis and degradation can elucidate the complex biological and molecular function of this 
small molecular weight compound. The biosynthesis of ergothioneine is well established, yet little is 
known about its degradation. The first step of ergothioneine degradation is catalyzed by the enzyme 
ergothionase, which will be the focus of this thesis. 
Ergothionase catalyzes the 1,2-elimination of trimethylamine from ergothioneine to yield thiourocanic 
acid. In this work, kinetic and structural investigations elucidate the mechanism of ergothionase. Based 
on the identification of catalytic residues, we are able to portray ergothionase producing organisms 
and found that they are mainly gut bacteria. This finding is in particular interesting because 
ergothioneine as food-additive is generally regarded as safe, whereas the ergothionase-mediated 
degrading of ergothioneine yields to trimethylamine, which is toxic.   
Furthermore, we characterized two unknown lyases. One of these new lyases employs a similar 
mechanism as ergothionase but uses an oxidized substrate derivative. Whereas, the other new lyase 
catalyzes the elimination of trimethylamine from trimethylhistidine (TMH) and has distinctive 
differences in the active site compared to ergothionase. The function and position of the catalytic acid 
in the active site of TMH-lyase suggest a mechanistic variation of the thought to be well-known 4-
methylideneimidazol-5-one (MIO) dependent aromatic amino acid lyases: maybe the posttranslational 
formed MIO-moiety does not only serve as electron sink but also as catalytic acid. 
Studies on the phylogeny of ergothionase, TMH-lyase, aromatic amino acid lyase and the 
aspartase/fumarase superfamily propose that ergothionase has evolved prior to the aromatic amino 
acid lyases. The long evolutionary history of ergothionase underscores ergothioneine as ancient 
molecule. However, it is questioning that on the one hand an aromatic amino acid lyase represents the 
first step of the ubiquitous histidine degradation pathway, whereas on the other hand histidine builds 
the basis for ergothioneine biosynthesis. This finding might suggest the presence of an unknown 
alternative histidine degradation pathway.  
In addition, we have not only studied the degradation but also the biosynthesis of ergothioneine. 
Thereby, we focused on the regulation of EgtD, the methyltransferase of ergothioneine biosynthesis, 
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PknD    Protein kinase D 
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SDS   Sodium dodecyl sulfate 
SmEgtD  EgtD from Mycobacterium smegmatis 
STPK   Serine/Threonine protein kinase 
TAL   Tyrosine ammonia-lyase 
TbEgtD   EgtD from Mycobacterium tuberculosis 
TdETL   Ergothioneine trimethylamine-lyase from Treponema denticola 
TMH   Trimethylhistidine 







More than 3 billion years ago, a single primordial cell embodied the origin for all organisms on earth.[1] 
Ever since, duplication and divergence of ancestral genes led to the evolution of novel enzymes. The 
variety of enzymes allowed organisms to adapt rapidly to changes in their environment. Accordingly, 
the enzymatic repertoire expanded all along and constituted the chemical basis of life. The progressive 
modification of enzymatic reactions led to a great diversity of functionality, structural folds and 
mechanisms. This diversity will be described in detail in the next section on the example of ammonia-
lyase. The numerous solutions that Nature found to catalyze carbon-nitrogen bond cleavage 
underscore the fundamental role that these lyases play in biology.  
 
1.1 Diversity of Ammonia-Lyases 
Ammonia-lyases are functionally related enzymes that catalyze the reversible cleavage of carbon-
nitrogen bonds.[2] The numerical classification scheme for enzymes categorizes ammonia-lyases as EC 
4.3.1.X. While ammonia-lyases are functionally related proteins, many members of this enzyme class 
are structurally unrelated (Figure 1). Even structurally related lyases may not be mechanistically 
related, as will be highlighted throughout this thesis. Functionally related enzymes are expected to 
employ a common mechanism for catalysis, yet the deceptively simple deamination reaction catalyzed 
by the ammonia-lyases proceeds with an immense diversity of mechanisms.[3] The extensive 
mechanistic diversity observed for the relatively straightforward deamination reaction is remarkable. 






Figure 1. Diversity of quaternary structures (A – C), protein fold (D – G), and cofactors (H – K) of ammonia-lyases. A: dimer of 
diaminopropionate ammonia-lyase (PDB: 4D9K). B: tetramer of aspartase (PDB: 1JSW). C: hexamer of β-alanyl-CoA ammonia-
lyase (PDB: 4MZQ). D: TIM-barrel fold of a subunit of methylaspartase (PDB: 1KKO). E: Rossmann fold of a subunit of ornithine 
cyclodeaminase (PDB: 1U7H). F: helix bundle of a subunit of histidine ammonia-lyase (PDB: 1B8F). G: functional subunit of 
ethanolamine ammonia-lyase (PDB: 3ABO). H: Cofactor NAD+ of cyclodeaminase. I: adenosylcobalamine of ethanolamine 
ammonia-lyase. J: pyridoxal 5’-phophate of diaminopropionate ammonia-lyase. K: 4-methylideneimidazol-5-one of aromatic 





1.1.1 Aspartase/Fumarase Superfamily 
The most common ammonia-lyases are part of the aspartase/fumarase superfamily. The 
aspartase/fumarase superfamily represents a class of C-N/ C-O lyases with a common reaction 
mechanism and a characteristic tertiary fold and quaternary structure.[4] The sequence identity within 
superfamily members is low (15%), however their members share three highly conserved regions in 
their amino acid sequence.[5] The best studied members of the superfamily besides aspartase (EC 
4.3.1.1) and fumarase (EC 4.2.1.2) are argininosuccinate lyase with δ-crystallin (EC 4.3.2.1) and 
adenylosuccinat lyase (EC 4.3.2.2). In the following, we will focus on the highly specific enzymes 
aspartase and fumarase. 
Aspartases catalyze the reversible deamination of L-aspartic acid to fumarate (Figure 2).[6] Considering 
the physiological function, aspartase plays an important role in microbial nitrogen metabolism. The 
amino acid degradation enzyme is involved in controlling the nitrogen flux of the organism.[7] 
Fumarases catalyze the reversible dehydration of L-malate to form fumarate (Figure 2). The fumarase 
family can be classified into two types: the class-I and class-II fumarases.[8] Class-I fumarases are iron-
dependent dimeric proteins, whereas class-II members are part of the aspartase/fumarase 
superfamily. Here, we will focus on class-II fumaraes. Fumarases are ubiquitous proteins that are 
conserved from prokaryotes to humans and play an important part in the tricarboxylic acid cycle.[9] The 
tricarboxylic acid cycle is the major energy-yielding metabolic pathway for all aerobic organisms. The 
ubiquity of this pathway and the importance of the protein fumarase within this pathway shows that 
fumarases might be the common ancestor of lyases and thus play a crucial role in evolution. 
 
Figure 2. Reversible deamination of L-aspartic acid to fumarate catalyzed by aspartate ammonia-lyases (top) and reversible 
dehydration of L-malate to fumarate catalyzed by fumarase (below). 
 
Both aspartase and fumarase catalyze the reversible anti-1,2-addition-elimination reaction in a 
common mechanism, which has been elucidated based on crystallographic and kinetic studies.[4] The 





domains (Figure 1).[10,11] Each protein possesses four identical active sites located at the interface of 
three subunits. Based on pH-rate profiles, an acid-base dependent E1cb mechanism was suggested 
(Figure 3).[12] A general base mediates the removal of the pro-R proton from the β-position of the 
substrate L-malate (in the case of fumarase) or L-aspartic acid (in the case of aspartase). Abstraction 
of the β-proton is facilitated by binding-induced distortion of the geometry of the substrate to 
resemble a sp2 hybridization.[13] The catalytic base that performs this abstraction is located on a highly 
flexible loop that undergoes conformational changes upon substrate binding and catalysis.[14] It was 
suggested that an oxyanion species on a serine residue acts as a base. After proton abstraction, the 
resulting carbanion is stabilized as aci-carboxylate; the transition state analogue 2-amino-3-nitro-
propionate is a potent inhibitor, which  provided strong evidence for formation of the carbanion 
intermediate.[15] The substrate itself can function as electron-sink and a conserved lysine residue 
stabilizes the aci-carboxylate-like formation.[13] Subsequent ketonization of the carboxylate-
intermediate implements cleavage of the C-O bond (in the case of fumarase) or the C-N bond (in the 
case of aspartase). In aspartase a significant isotope effect was observed with 15N-substituted 
substrate, corroborating that cleavage of the C-N bond is the rate-determining step in this enzyme.[16] 
This cleavage of the C-N bond, or C-O bond in fumarases, can be facilitated by the presence of a 
catalytic acid that donates a proton to the leaving group. In aspartase, a histidine residue within the 
active site has been suspected to be the catalytic acid,[11] however this residue is not fully conserved 
in all aspartases.[17] Thus, it remains questionable whether the leaving group in aspartase is the 
ammonium ion or free ammonia.[18] In contrast, in fumarases the catalytic acid histidine, which forms 
a charge relay with a conserved glutamate residue, is essential to generate the H2O leaving group.[4,19] 
 
Figure 3. Proposed mechanism of aspartase. The requirement of the catalytic acid is not fully elucidated yet. 
 
1.1.2 Methylaspartate Ammonia-Lyase 
In contrast to the aspartase/fumarase superfamily, the methylaspartate ammonia-lyase requires a 
divalent cation for their activity. Methylaspartate ammonia-lyase (EC 4.3.1.2) catalyzes the reversible 





was first detected in 1959 in the anaerobic bacterium Clostridium tetanomorphum.[20] This enzyme is 
part of the mesaconate pathway for anaerobic glutamate degradation to yield acetyl-coenzyme A 
(acetyl-CoA).[21] Methylaspartate ammonia-lyase was also found to be important in haloarchaea.[22] 
Accordingly, a new biosynthetic pathway to oxidize acetyl-CoA to glyoxylate was proposed with 
methylaspartate ammonia-lyase appearing to be a key enzyme in this pathway. 
 
Figure 4. Reaction catalyzed by 3-methylaspartate ammonia-lyase (MAL). Reversible deamination of (2S,3S)-threo-3-
methyylaspartate to mesaconic acid. 
 
Methylaspartate ammonia-lyase was first purified and characterized in 1992 and was suggested to 
represent a new class of enzyme without any convincing homology to any other lyases known at this 
point.[23] The solved crystal structures and kinetic studies revealed that the structural and mechanistic 
features resembles the enolase superfamily.[24,25] Methylaspartate ammonia-lyase is a homo-dimeric 
protein with a characteristic TIM barrel fold and β-strands wrapping around the barrel (Figure 1). This 
is a significant structural difference to the aspartase/fumarase superfamily. Furthermore, Mg2+ and K+ 
cations are crucial for methylaspartase activity.[23]  
The β-proton of the substrate is abstracted by a catalytic base (Figure 5). Considering the catalytic base, 
it is important to mention that methylaspartate ammonia-lyase is not diastereoselective; not only the 
anti-deamination, but also the syn-deamination is catalyzed.[26] Hence, there are two different residues 
acting as catalytic base.[27] A lysine residue acts as catalytic base for the major anti-elimination reaction, 
whereas a histidine residue acts as a base for the minor syn-elimination. If this histidine residue is 
mutated to alanine, the enzyme gets diastereoselective.[27] After proton abstraction, the resulting ene-
diolate is stabilized by the divalent Mg2+ cation (Figure 5).[24,25] Mg2+ assisted binding of the aci-
carboxylate intermediate causes a lower pKa of the β-proton. Finally, the enolate intermediate 
collapses and ammonia is released to form the product mesaconate. 
 





1.1.3 Aminoacyl-CoA Ammonia-Lyase 
Aminoacyl-CoA ammonia-lyase is not dependent on divalent cations. Instead, this enzyme requires the 
electron-withdrawing capacity of the thioester linkage of substrates that are conjugated to CoA. 
The enzyme β-alanyl-CoA ammonia-lyase (EC 4.3.1.6) catalyzes the reversible deamination reaction of 
β-alanine-CoA to yield acrylyl-CoA and ammonia (Figure 6).[28] Degradation of β-alanine by activation 
of the CoA-thioester and subsequent deamination was found in the anaerobic bacterium 
Clostridium propionicum. There are two genes to express β-alanyl-CoA ammonia-lyase; one is 
constitutively expressed to obtain low basal activity, whereas the other is induced at high β-alanine 
concentrations.[29] The excessive protein production plays a secondary role in binding acrylyl-CoA, and 
thus avoids the toxicity of this strong nucleophilic compound. 
 
Figure 6. Reaction catalyzed by β-alanyl-CoA ammonia-lyase. Reversible deamination of β-alanine-CoA to acrylyl-CoA. 
 
The protein β-alanyl-CoA ammonia-lyase consists of five stranded anti-parallel β-sheets and a long α-
helix, a so-called “hot-dog fold”.[30] The active site is located at the interface of two subunits. Three of 
these functional dimers are combined to give a homo-hexamer (Figure 1). Interestingly, the protein 
structure does not show similarities to other lyases that catalyze similar reactions, yet the protein 
entails high structural similarity to acyl-CoA thioesterase. The crystal structure of β-alanyl-CoA 
ammonia-lyase revealed a tyrosine residue as the likely proton acceptor of the α-methylene proton 
(Figure 7). Acidity of the proton is increased through the electron withdrawing of the thioester linkage. 
The resulting enolate is stabilized by the dipole of the α-helix that facilitates the initial proton 
abstraction. After the retro-Michael elimination the ammonia is protonated by a side-chain threonine 
residue. However, further experiments are required to provide further evidence for this proposed 
mechanism.[30] 
 
Figure 7. Proposed mechanism of β-alanyl-CoA ammonia-lyase. 
O

















The enzyme 3-aminobutyryl-CoA ammonia-lyase (EC 4.3.1.14), first identified in Clostridium 
subterminale, catalyzes the reversible deamination of 3-aminobutyryl-CoA to produce crotonyl-CoA 
and ammonia (Figure 8).[31] 3-Aminobutyryl-CoA ammonia-lyase is part of lysine fermentation to 
acetate, butyrate and ammonia in anaerobic bacteria. Based on the discovery of 3-aminobutyryl-CoA 
ammonia-lyase in Brevibacterium, it is postulated that this enzyme is similar to β-alanyl-CoA ammonia-
lyase.[32] However, no mechanistic studies have been reported yet.  
 
Figure 8. Reaction catalyzed by 3-aminobutyryl-CoA ammonia-lyase. Reversible deamination of 3-aminobutyryl-CoA to 
crotonyl-CoA. 
 
1.1.4 Hydroxy Amino Acid Dehydratase/Deaminase 
In contrast to the other presented lyases, the members of the hydroxy amino acid 
dehydratase/deaminase family are pyridoxal 5’-phophate (PLP) dependent enzymes.[5] One 
representative of the hydroxy amino acid dehydratase/deaminase family is the enzyme 
diaminopropionate ammonia-lyase (EC 4.3.1.15) which catalyzes the α,β-elimination reaction of both 
L- and D-diaminoproionate to form pyruvate and ammonia (Figure 9).[33] Other representative enzymes 
catalyzing the dehydratase/deaminase reaction through a similar PLP-dependent mechanism are D- 
(EC 4.3.1.18), and L-serine ammonia-lyase (EC 4.3.1.17), L-threonine ammonia-lyase (EC 4.3.1.19), D-
glucosaminate ammonia-lyase (EC 4.3.1.9), threo-3-hydroxy-L-aspartate ammonia-lyase (EC 4.3.1.16), 
erythro-3-hydroxy-L-aspartate ammonia-lyase (EC 4.3.1.20), threo-3-hydroxy-D-aspartate ammonia-
lyase (EC 4.3.1.27), carbamoyl-serine ammonia-lyase (EC 3.4.1.13).[2,5] 
 
Figure 9. Reaction catalyzed by diaminopropionate ammonia-lyase. Diaminopropionate is degraded via aminoacrylate to give 
pyruvate. 
 
Diaminopropionate ammonia-lyase is the first PLP dependent enzyme found to catalyze the 
elimination of an amino group at the β-position of the substrate.[33] Most substrates of the other 





position.[5] Therefore, it is more convenient to name this family as  dehydratase/deaminase, instead of 
lyase. The diaminopropionate degrading enzyme is prokaryotic and has not been reported to exist in 
eukaryotes.[34] Beside conversion of both the D- and L- isoform of diaminopropionate, the enzyme 
possesses a narrow substrate specificity.[34,35]  
The crystal structure of diaminopropionate ammonia-lyase of Escherichia coli revealed a dimeric 
protein with one active site in each of the two protomers (Figure 1).[36] Each protomer consists of a 
large and a small domain with a β-sheet core surrounded by α-helices. PLP is bound at the interface 
between the large and the small domain through a lysine residue that anchors the PLP as a Schiff-base 
using its ε-amino group. Upon substrate binding, the neutral α-amino group of diaminopropionate 
forms the external aldimine with PLP while the lysine residue is released (Figure 10). For the proceeding 
step, two different residues are suggested as base for each enantiomer: the lysine residue acts as 
catalytic base for the L-isoform of the substrate, whereas an aspartate residue acts as catalytic base 
for the D-enantiomer. Abstraction of the α-proton of the substrate leads to the release of the β-amino 
group. Formation of the PLP-aminoacrylate intermediate is then followed by the approach of the lysine 
residue towards C4 of PLP, whereby aminoacrylate is released. Finally, aminoacrylate undergoes a 
spontaneous, non-enzymatic hydrolysis to form pyruvate and ammonia.  
 
Figure 10. Proposed mechanism of diaminopropionate ammonia-lyase.  
 
The crystal structure of diaminopropionate ammonia-lyase from E. coli revealed a disulfide bond close 
to the active site, which is suggested to be important for stabilizing a channel that regulates the entry 





typhimurium diaminopropionate ammonia-lyase.[37] In contrast, the structure of the lyase of 
S. typhimurium possesses a phosphate ion in the active site at a position corresponding to the 
aminoacrylate intermediate. Therefore, it is proposed that monovalent metal ions enhance the 
catalytic rate of S. typhimurium diaminopropionate ammonia-lyase by chelating the phosphate ion.  
In prokaryotes, diaminopropionate interferes with enzymes involved in amino acid metabolism, 
causing growth inhibition.[38] Thus, degradation of diaminopropionate via diaminopropionate 
ammonia-lyase is highly important to prevent its toxicity.  
 
1.1.5 Ethanolamine Ammonia-Lyase 
The only ammonia-lyase that utilizes a hydrogen radical abstraction mechanism is responsible for the 
fermentation of ethanolamine.[39][40] The first enzyme of the ethanolamine degradative pathway of 
bacteria is ethanolamine ammonia-lyase (EC 4.3.1.7), which reversibly converts ethanolamine into 
acetaldehyde and ammonia (Figure 11). Catalysis involving hydrogen radical abstraction is unusual and 
completely unrelated to other ammonia-lyases mechanisms and requires the cofactor 
adenosylcobalamine (AdoCbl) (Figure 1). This naturally occurring organo-metallic compound contains 
a unique Co-C bond and represents a classical cofactor for enzymatic radical reactions.[41] 
 
Figure 11. Reaction catalyzed by ethanolamine ammonia-lyase. Ethanolamine is converted to give acetaldehyde and 
ammonia. 
 
The crystal structure of ethanolamine ammonia-lyase of Escherichia coli revealed that the enzyme is a 
hexamer and each of the six functional subunits comprises a α- and β-subunit and AdoCbl cofactor 
(Figure 1).[42] The α-subunit is folded into a TIM-barrel structure and the β-subunit partially covers the 
AdoCbl that is bound in the interface of both subunits. The tight interaction through hydrogen bonds 
and van der Waals contacts between enzyme and the cobalamin-binding site and the adenine ring-
binding site causes tensile forces that lead to an enzyme-induced homolysis of the Co-C bond. This 
results in cob(II)alamin and a 5’-deoxyadenosyl radical (Figure 12). The 5’-deoxyadenosyl radical 
removes a hydrogen atom from the C2 position of the substrate and thus generates the initial substrate 
radical.[43] This is followed by migration of the amine from the C1 to the C2 position of the substrate. 
The resulting hemiaminal radical abstracts a hydrogen atom of the 5’-deoxyadenosyl radical. Finally, 





The products leave the active site of the enzyme through displacement by water molecules.[42] 
However, it is not known if the substrate binds as neutral or protonated form, which might also change 
during the reaction. 
 
Figure 12. Proposed mechanism of ethanolamine ammonia-lyase. 
 
The presented ethanolamine ammonia-lyase is the first enzyme of the degradative pathway of 
ethanolamine.[39] The acetaldehyde produced by the lyase is further used for acetyl-CoA formation, 
which is utilized in many metabolic processes.[44] The ethanolamine catabolism is used by a variety of 
bacteria in the intestine of mammals. Phosphatidylethanolamine is a phospholipid in the gut which is 
important for proper gut functioning. The bacterial breakdown of phosphatidylethanolamine might 
cause disease linked to disrupting gut functions.[44] 
 
1.1.6 Amino Acid Cyclodeaminase 
Amino acid cyclodeaminases are NAD+ dependent, which is a unique feature among the family of 
lyases.[3] L-Ornithine cyclodeaminase (EC 4.3.1.12) is the first identified amino acid cyclodeaminase.[45] 
This enzyme produces L-proline and ammonia (Figure 13). Another cyclodeaminase, namely L-lysine 
cyclodeaminase (EC 4.3.1.28), forms L-pipecolic acid was only found in 1998 (Figure 13).[46] Both 
cyclodeaminases resemble oxidoreductases, however the overall reaction consists of both a reduction 
and oxidation. Thus, the whole process is redox neutral and the cofactor NAD+ is recycled to its original 
oxidation state through the reaction cycle. Therefore, the classification as lyase, rather than 






Figure 13. Reaction catalyzed by ornithine cyclodeaminase (top) and lysine cyclodeaminase (below). 
 
The crystal structure of ornithine cyclodeaminase of Pseudomonas putida comprises a homodimeric 
fold of two functional subunits.[47] Each subunit possesses a cofactor binding domain and a substrate 
binding domain. The substrate binding site consists of a 14 stranded β-barrel after oligomerization. 
The cofactor binding domain is located in a Rossmann fold with six parallel β-strands and helices as 
crossover elements (Figure 1). Thus, two NAD+ molecules are bound within the dimer. 
The first investigation into the mechanism for ornithine cyclodeaminase proposed a deamination of 
the α-amino group of lysine prior to cyclization and finally reduction to form proline.[48] However, 
based on the crystal structure an alternative mechanism is now favored (Figure 14).[47] Goodman et al. 
proposed a hydride transfer from the C2 position of the substrate to NAD+ supported by an active site 
aspartate residue. This dehydrogenation results in formation of an imine intermediate. Subsequently, 
the δ-amine gets deprotonated and attacks the C2 position, leading to the ring closure and formation 
of the α-amino proline intermediate. Finally, elimination of ammonia is followed by hydride transfer 






Figure 14. Proposed mechanism of ornithine cyclodeaminase. 
 
Lysine cyclodeaminase shows strong sequence homology to ornithine cyclodeaminase.[49] In vitro 
characterization of lysine cyclodeaminase with isotopically labeled substrate showed the loss of the α-
amine throughout the reaction. Based on the crystal structure of lysine cyclodeaminase of 
Streptomyces pristinaespiralis it is presumed that both cyclodeaminases act by a similar mechanism.[50] 
 
1.1.7 Aromatic Amino Acid Ammonia-Lyase 
Aromatic amino acid ammonia-lyases catalyze the reversible elimination of ammonia from the amino 
acids histidine (histidine ammonia-lyase, HAL, EC 4.3.1.3), tyrosine (tyrosine ammonia-lyase, TAL, EC 
4.3.1.23) or phenylalanine (phenylalanine ammonia-lyase, PAL, EC 4.3.1.24) to form the corresponding 
α-β unsaturated acids (Figure 15).[51] So far, the existence of a tryptophan ammonia-lyase has not been 
confirmed.[52] The PAL-mediated reaction occurs mainly in plants and fungi, whereas in animals and 
most bacteria phenylalanine reacts via a PLP-dependent transaminase reaction to the corresponding 
2-keto acid phenylpyruvate.[53] PAL activity serves a biosynthetic purpose as it represents the first step 
in the phenylpropanoid pathway. Thereby, the α-β unsaturated cinnamic acid is the precursor for lignin 
and flavonoid biosynthesis. Similar to PAL activity, TAL activity and the corresponding product p-
coumaric acid is involved in the phenylpropanoid pathway. HAL activity gives urocanate, a component 
that protects the skin from UV radiation.[54] The involvement of HAL in the histidine degradation 






Figure 15. Reaction catalyzed by histidine ammonia-lyase, HAL (top), tyrosine ammonia-lyase, TAL (middle), phenylalanine 
ammonia-lyase, PAL (below). 
 
The overall structure of HAL, PAL and TAL is a homo-tetramer composed of multiple parallel α-helices 
(Figure 1).[55–57] The enzymes possess four identical active sites, each built of residues from three 
different subunits.  
In order to catalyze the elimination reaction, aromatic amino acid ammonia-lyases have to abstract 
the non-acidic proton at the β-position of the substrate (pKa 40)[58], while the hydrogen at the α-amino 
group must remain untouched to maintain leaving-group abilities.[59] To manage this challenge, these 
enzymes possess a highly conserved structural feature. Early studies suggested the presence of an 
electrophilic dehydroalanine within the active site that acts as a Michael-acceptor.[60] However, the 
first crystal structure of HAL from Pseudomonas putida revealed the presence of the five-membered 
heterocycle 4-methylideneimidazol-5-one (MIO).[57] The MIO-moiety is formed posttranslational and 
autocatalytically by cyclization and double dehydration of the active site tripeptide Ala-Ser-Gly (Figure 
16). In some cases, alanine is replaced by threonine, serine or cysteine residues.[59,61] The tripeptide is 
highly conserved among the class of aromatic amino acid ammonia-lyases and is essential for their 
activity. 
 






Two reaction mechanisms for these MIO-dependent enzymes have been suggested: a Friedel-Craft-
type mechanism[62] and a MIO-adduct mechanism[63]. 
The Friedel-Craft type mechanism suggests addition of the aromatic side chain of the substrate to the 
electrophilic alkene of the MIO-group (Figure 17).[64] In this mechanistic proposal the main function of 
the MIO-group is acidification of the β-protons through electrophilic activation in their close vicinity.  
 
Figure 17. Proposed Friedel-Craft type mechanism of aromatic amino acid ammonia-lyase. 
 
The MIO-adduct mechanism relies on the formation of a covalent adduct between the amino group of 
the substrate and the exocyclic alkene of the MIO-group (Figure 18).[51,63] It is proposed that the 
formation of a secondary ammonium ion increases its leaving-group abilities.[63,65] A highly conserved 
tyrosine residue, which is located on a flexible loop covering the active site, acts as essential enzymatic 
base and abstracts the β-proton of the substrate.[66]The resulting carbanion intermediate can be 
stabilized by the dipole of the α-helices that point with their positive end towards the active site.[55] 
Upon loss of the MIO-NH2 leaving group, the product is released.  
 
Figure 18. Proposed MIO-adduct mechanism of aromatic amino acid ammonia-lyase. 
 
Nowadays, the MIO-adduct mechanism is generally preferred: The structure of a TAL variant with 





the ligand to the methylidene carbon of the MIO-moeity of the enzyme.[56] Additionally, docking 
studies of a PAL structure and theoretical studies with HAL further supports the MIO-adduct 
mechanism.[67][68] Detailed conseredations of the crystal structures of related aminomutases also 
favored this mechanistic pathway.[66,69] Molecular mechanistic calculations rouled out the Friedel-Craft 
type mechanism due to the high energy of the reaction intermediates.[70] However, the difficulty of 
deprotonating a benzylic methylene proton is not fully resolved by the MIO-adduct mechanism.[51]  
 
1.2 Application in Biocatalysis of Ammonia-Lyases 
The described mechanistic and structural diversity of ammonia-lyases provides opportunities for their 
use in a variety of different applications. Particularly, the formation of chiral amino acids from olefinic 
acids and ammonia is very difficult to accomplish non-enzymatically. Some ammonia-lyases are of high 
value for industrial application as will be outlined in the following. 
Aspartase. The earliest success for industrial application of an ammonia-lyase was achieved by 
aspartase. The high specificity and activity of the enzyme was useful for the industrial preparation of 
L-aspartic acid.[71] The enantiopure compound is required for the synthesis of artificial dipeptide 
sweeteners and as a building block for pharmaceuticals.[72] Aspartase can further be used for 
enantioselective synthesis of labeled L-aspartic acid. However, due to the high specificity of aspartase 
and the complex flexibility of the loop covering the active site, the synthesis of substituted aspartic 
acid derivatives remains difficult.[73] Molecular engineering of aspartase is needed to shape the active 
site in order to accommodate different substrates.[74] On the contrary, the narrow substrate range of 
aspartase can be advantageous for multi-enzymatic cascades.[75] Aspartase can be added to reaction 
cascades with ammonia as byproduct. The enzyme utilizes ammonia to catalyze its reaction, and thus 
can shift the equilibria of the reaction cascade towards the product site.  
Methylaspartate ammonia-lyase. In contrast to aspartase, methylaspartate ammonia-lyase does not 
undergo large conformational changes upon substrate binding resulting in a broad substrate 
tolerance.[76] That makes the enzyme in particular interesting as a biocatalyst for generating building 
blocks for chemical synthesis. The high activity of methylaspartate ammonia-lyase on non-natural 
substrates has long  been established.[77] However, only the finding of a diastereoselective 
methylaspartase mutant paved the way for further investigations into the asymmetric synthesis of 3-
substituted aspartic acid derivatives.[27] Redesigning of the active site of methylaspartase extended the 
range of accessible aspartic acid derivatives.[78] Two distinct single-point mutations exhibit a wide 





Aminoacyl-CoA ammonia-lyase. In theory, usage of aminoacyl-CoA ammonia-lyase might be useful for 
the production of small β-amino acids since the enzyme tolerates different substrate derivatives.[29] 
However, application for large scale production is unlikely due to the difficulty to access CoA 
derivatives as substrates.[5] 
Diaminopropionate ammonia-lyase. The enzyme diaminopropionate ammonia-lyase is responsible 
for degradation of the toxic compound diaminopropionate.[33] The seeds of the drought resistant 
legume Lathyrus sativus contain 2,3-dioxalyl diaminopropionate, which leads to toxicity when large 
quantities are consumed.[79] Engineering transgenic plants that overexpress diaminopropionate 
ammonia-lyase might reduce the content of toxine in seeds. However, this engineering idea has not 
been realized so far and there is no other known application to date. 
Ethanolamine ammonia-lyase. To date, no alternative substrates for this enzyme has been found. 
Additionally, the usage of the cofactor AdoCbl further complicates the usage of this enzyme; thus, 
possible applications remain limited.[5] 
Amino acid cyclodeaminases. Both ornithine and lysine cyclodeaminase are highly enantioselective 
and efficient enzymes and therefore interesting as biocatalysts for the industrial production of L-
proline and L-pipecolic acid.[47][50] An engineered strain of E. coli achieved an efficient fermentative 
overproduction of L-pipecolic acid from glucose.[80] In addition, a directed evolution approach opened 
ways to broaden the substrate specificity of lysine cyclodeaminase to catalyze cyclodeamination of 
alternative molecules.[81] The resulting derivatives of substituted pipecolic acid are interesting 
precursor molecules for the pharmaceutical industry. A great benefit for industrial applications is that 
NAD+ is reconverted throughout the reaction. Therefore, there is no need to continually supply the 
cofactor during synthesis.  
Aromatic amino acid ammonia-lyase. The reversibility of the deamination/amination reaction of 
aromatic amino acid ammonia-lyases enables the production of enantiopure L-amino acids from the 
inexpensive aryl acrylic acid substrates.[5] A high concentration of ammonia can shift the equilibrium 
of the reaction to favor amination. The first industrial application of PAL was patented 1976 for L-
phenylalanine production. Beside direct production of the L-enantiomer, aromatic amino acid 
ammonia-lyase can also be used for enantiopure synthesis of the D-enantiomer.[82,83] After chemical 
racemic amination, the enzyme selectively deaminates the L-product, and thus only the D-product 
remains. Immobilization of arylalanine ammonia-lyase further improved enzyme stability and catalytic 
efficiency, which is advantageous for industrial biocatalysis application.[84] The broad substrate 
tolerance known today for PAL provides access to a sustainable synthesis of non-natural amino acid 





was found with increased activity for p-bromo cinnamic acid, that enables a broad spectrum of further 
chemical reactions, which is of great interest for the chemical industry.[85] One example for an 
application of green chemistry is the chemoenzymatic cascade to produce S-2-indolinecarboxylic acid, 
a precursor of the antihypertensive indolapril.[86] Thereby, PAL-mediated amination of a cinnamic acid 
derivative is followed by cupper catalyzed cyclization, without the usage of an organic solvent. A 
completely different application of TAL and PAL is the introduction of the phenylpropanoid pathway 
into Saccharomyces cerevisiae for in vivo production of secondary metabolites.[87] Since 2017, 
pegylated PAL is a FDA-approved enzyme substitution therapy for the treatment of phenylketonuria, 
a genetic inborn disorder, leading to accumulation of phenylalanine.[88] 
 
1.3 Histidine Degradation 
The aromatic amino acid ammonia-lyase HAL presents the first step in the histidine degradation 
pathway. Degradation of histidine results in glutamate, ammonia and a one-carbon compound, either 
formamide or formate (Figure 19).[89] Genes for proteins participating in the histidine utilization 
pathway are encoded in the hut operon. The hut-system is a ubiquitous and highly conserved pathway.  
The degradation of most amino acids starts with the conversion to the corresponding keto-acids 
catalyzed by a PLP-dependent transaminase. In contrast, the first step in histidine degradation is non-
oxidative elimination of the α-amino group catalyzed by HAL. As outlined in section 1.1.7, HAL contains 
the posttranslational formed electrophilic MIO-moiety, which is crucial for activity. HAL is a highly 
conserved protein, with bacterial and mammalian representatives sharing >40% sequence identity, 
indicating that HAL is presumably the oldest MIO-containing lyase.[90] In the second step of the hut-
pathway, the α-β unsaturated product urocanate is hydrated by the NAD+ dependent urocanase 
(Figure 19).[91,92] In this reaction, NAD+ serves as electrophile that gets attacked by the imidazole of the 
substrate. After addition of water to the covalent adduct, the product hydroxy-imidazolepropionate 
tautomerizes to generate imidazolonepropionate. Subsequently, the third step of the hut-pathway is 
ring cleavage by a hydrolase to form S-formiminoglutamate (Figure 19). Even if imidazolonepropionate 
is unstable, the enzymatic cleavage is essential in order to use histidine as carbon source.[93] 
Furthermore, it has been shown that hydrolase-deficiency leads to poisoning, indicating that 
regulation of the hut-pathway is essential.[94]  
These first three steps of the histidine utilization pathway are similar for all genera, whereas the 
following removal of the formimino-group follows three different pathways (Figure 19).[89] One 





in enteric bacteria in which formamide is excreted as the waste product. The other pathway (B), mainly 
occurring in Pseudomonas, possesses two enzymes. First, a zinc-dependent deiminase catalyzed 
reaction to yield formylglutamate and ammonia, followed by hydrolysis to formate and glutamate.[60] 
Thus, the second pathway gives a second molecule of ammonia from each molecule of histidine. In 
mammals (C), the formimino-group is transferred to tetrahydrofolate (FH4).[53] 
 
Figure 19. Histidine degradation pathway. The first three steps are universal. A occurs mainly in enteric bacteria, B occurs 
mainly in Pseudomonas and C occurs in mammals.  
 
Due to the high energy cost of histidine synthesis, tight regulation of its degradation is essential.[89] 
Therefore, induction of the hut-system should be avoided if the available amount of histidine is needed 
for protein synthesis. The expression for the genes of the hut-operon is in most organisms induced by 
urocanate, the product of the HAL reaction.[95] Regulation of gene expression by the first pathway 
intermediate guarantees that the hut-system is only activated when enough histidine is available to 
lead to an accumulation of urocanate. As histidine can serve as a carbon and ammonia source, hut 
expression is repressed if a better carbon source such as glucose or an excess of ammonia is 
available.[96] In contrast, nitrogen limitation activates hut expression.[97] 
The strong conservation of the involved enzymes, the genetic clustering of the hut-operon and its 
ubiquity among different organisms suggests that the presented histidine degradation pathway has a 







Ergothioneine is a trimethylated thiourea derivative of histidine (Figure 20). In 1909, the small 
molecular weight thiol was isolated from the ergot fungus.[98] At physiological conditions, the thione-
thiol tautomere exists predominantly in its thione form, which helps to prevent autooxidation.[99]  
 
Figure 20. Tautomerization of ergothioneine. 
 
The redox potential of ergothioneine, -60 mV, is comparable high.[100] Other small molecular weight 
thiols such as glutathione or mycothiole possess redox potentials of -200 to -320 mV (SHE).[101] It has 
been shown that ergothioneine is an effective scavenger for reactive oxidative species in vitro.[102,103] 
There are numerous in vitro studies about the excellent antioxidant properties of ergothioneine, 
however solid in vivo studies are rare.[104] Strictly anaerobic organisms are able to biosynthesize 
ergothioneine, indicating that the function of ergothioneine is likely not limited to antioxidative 
properties.[105] This finding was further indispensable as it shows that emergence of ergothioneine 
might predate the rise of atmospheric oxygen 2.4 billion years ago. The coupling of ergothioneine to 
mycothiol has been reported to play an important role in the biosynthesis of the antibiotic 
lincomycin.[106] Furthermore, several bacterial species have been found to live on ergothioneine as 
their sole source of nitrogen.[107] These bacterial species are able to degrade ergothioneine to 
thiourocanic acid and trimethylamine. The enzyme ergothionase that catalyzes the degradation 
reaction will be the focus of this thesis. 
A wide range of living organisms like microorganisms, fungi, plants, animals and even the human body 
contain levels of ergothioneine.[108] However, only certain bacteria and fungi are able to biosynthesize 
ergothioneine.[109,110] For humans, dietary goods like mushrooms or beans are the major ergothioneine 
source.[111] A specific transporter (OCTN-1) is responsible for ergothioneine uptake in the cells.[112] The 
presence of the specific ergothioneine transporter implies that ergothioneine must have a useful 
function in mammals. Animals with OCTN-1 knockout are more susceptible for oxidative stress,[113] 
furthermore, the octn-1 gene is associated with rheumatoid arthritis,[114] and Crohns disease.[115] 
Ergothioneine is stated to be a potential treatment for diseases like neurodegenerative disease, 
cardiovascular disease, diabetes or cancer.[116] In the case of tissue injury, it has been hypothesized 





that ergothioneine can even be considered as a vitamin.[117] However, health benefits of the 
consumption of large amounts of ergothioneine are questionable, as will become apparent throughout 
this thesis.  
We can conclude that the exact physiological role of ergothioneine is not completely understood yet. 
However, the ubiquity of ergothioneine among all kingdoms of life suggests an important function. 
Investigation of the degradation of ergothioneine and investigation on the regulatory mechanism of 
ergothioneine biosynthesis can contribute to gain a deeper understanding of this unique compound. 
 
1.4.1 Biosynthesis of Ergothioneine 
The biosynthesis of ergothioneine has been subject to research for over half a century. In 1956, 
Genghof et al. showed the synthesis of ergothioneine in fungi for the first time.[110] Later, ergothioneine 
biosynthesis was shown in cell-free extracts from Neurospora crassa.[118–120] In 2010, the discovery of 
a five-gene cluster in mycobacteria, called egtABCDE, paved the way for the biochemical 
understanding of ergothioneine biosynthesis.[121] The first step in the biosynthesis of ergothioneine is 
trimethylation of the -amino group of histidine (Figure 21). All three SAM-dependent methylation 
reactions are catalyzed by one enzyme, namely EgtD. EgtA is a ligase responsible for adenosine 
triphosphate (ATP)-dependent dipeptide formation of cysteine and glutamate to produce γ-glutamyl 
cysteine. Subsequently, TMH and γ-glutamyl cysteine are substrates for the iron-dependent sulfoxide 
synthase EgtB. The glutamyl moiety is cleaved off by EgtC and finally the pyridoxal-phosphate 
dependent β-lyase EgtE forms the product ergothioneine. Identification of the biosynthetic gene 
cluster in Mycobacterium smegmatis provides the basis for the discovery of alternative biosynthetic 
pathways of this unique compound.  
 

















































This five-gene pathway appears to be limited to the phylum of actinobacteria.[122] However, it was 
shown that other bacteria like Burkholderia spp. or Chloracidobacterium thermophilum are also able 
to synthesize ergothioneine.[123,124] The main difference is that EgtB does not utilize γ-glutamyl cysteine 
as shown before. Instead, EgtB uses cysteine as sulfur donor for the oxygen dependent C-S bond 
formation at the C2-position of TMH (Figure 22). Therefore, EgtA and EgtC are not required here, 
shortening ergothioneine synthesis to a three step process in these organisms. 
 
Figure 22. Ergothioneine biosynthetic pathway in bacteria like Burkholderia spp. or Chloracidobacterium thermophilum. 
 
Fungal ergothioneine biosynthesis also utilises cysteine as the sulfur donor.[125] The fungus Neurospora 
crassa possesses a fusion of EgtD-like and EgtB-like enzyme, called Egt-1, that combines trimethylation 
of histidine and subsequent C-S bond formation with cysteine (Figure 23). The second enzyme of the 
biosynthetic pathway, Egt-2, is a PLP-dependent C-S lyase catalyzing the final step of ergothioneine 
biosynthesis. A similar two-step pathway has also been reported for the fission yeast 
Schizosaccharomyces pombe.[126] 
 
Figure 23. Ergothioneine biosynthetic pathway in fungi. 
 
In addition to these oxygen-dependent biosynthetic pathways, anaerobic ergothioneine biosynthesis 
has recently been found (Figure 24).[105] The anaerobic green sulfur bacterium Chlorobium limicola 
encodes for an EgtD-like SAM-dependent methyltransferase, EanA, which produces TMH from 





site cysteine in the persulfide state that acts as a nucleophile and attacks the C2-position of the 
imidazolium of TMH for anaerobic C-S bond formation.[127] 
 
Figure 24. Anaerobic ergothioneine biosynthetic pathway. 
 
Thorough structural and biochemical characterization of the enzymes involved in the three different 
routes for ergothioneine biosynthesis suggests that ergothioneine biosynthesis may have evolved 
several times independently throughout history.[128] The ubiquity of these enzymes underscores the 
physiological importance of this thiol-containing compound in Nature.[129] 
 
1.4.2 Degradation of Ergothioneine 
As described above, the molecular and biochemical description of ergothioneine biosynthesis led to 
substantial achievements. In contrast, little is known about ergothioneine degradation. The existence 
of the enzyme ergothionase has been reported to be responsible for cleavage of the trimethylamine 
group of ergothioneine, resulting in the unsaturated thiourocanic acid (Figure 25). In 1957, 
disappearance of ergothioneine and emergence of thiourocanic acid was first shown in Alcaligenes 
faecalis.[130] In the early 1960’s, ergothionase activity was demonstrated in cell-free experiments.[107,131] 
Identification of the gene coding for ergothionase allowed a first characterization of the recombinant 
produced and purified enzyme.[132] In this thesis, we describe extensive kinetic studies and the first 
structural characterization of an ergothionase, which provide a substantial insight into the enzymatic 
mechanism.[133] 
 
Figure 25. Proposed catabolism of ergothioneine. 
 
In the next step of the ergothioneine degradation pathway, the enzyme thiourocanate hydratase 





similarity of these first two steps in ergothioneine degradation to the histidine utilization pathway is 
striking, suggesting that the product 3-(5-oxo-2-thioxoimidazolidin-4-yl) propionic acid is also further 









2 Aim of this Thesis 
Ergothioneine is ubiquitous amongst Nature and appears to be an important molecule. The 
consumption of ergothioneine is generally regarded as safe, however, the molecular mechanism of 
action of this low-molecular weight thiol is not fully elucidated. One approach to understand its role in 
biology is to explore the biochemistry of its degradation. The goal of this thesis is to elucidate the 
mechanism of the ergothioneine degradation enzyme ergothionase. Identification of catalytic residues 
will then allow classification of ergothionase producing organisms. Furthermore, a previously unknown 
TMH-lyase will be characterized. The suggested mechanism of this lyase will shed new light on the 
mechanism of the well-known MIO-dependent aromatic amino acid lyases. Finally, the comparison of 
ergothionase and TMH-lyase to MIO-dependent lyases and the aspartase/fumarase superfamily will 








3 The Mechanism of Ergothionase 
Ergothionase (EC 4.3.1.) is a lyase responsible for the degradation of ergothioneine to thiourocanic 
acid and trimethylamine.[107] The enzyme cleaves both the β-C-H and the α-C-N bonds of the substrate 
resulting in the formation of the α-β unsaturated product thiourocanic acid and the leaving group 
trimethylamine (Figure 26). 
 
Figure 26. Reaction catalyzed by ergothionase. Ergothioneine is degraded to thiourocanic acid and trimethylamine. 
 
The enzymatic activity of ergothionase was first described in 1957, when Yanasugondha et al. found 
out that the organism Alcaligenes faecalis was able to uptake ergothioneine as a source of carbon and 
energy.[130] They cultured fourteen different strains of bacteria in the presence of ergothioneine. At 
various time points they tested the amount of ergothioneine and thiourocanic acid. In the presence of 
the gram-negative soil bacteria Alcaligenes faecalis they were able to follow disappearance of 
ergothioneine and at the same time accumulation of thiourocanic acid. Four years later Kelly et al. 
were able to show degradation of ergothioneine by cell-free enzyme preparations of A. faecalis.[131] In 
1962, Wolff showed ergothionase activity in a cell-free extract of Escherichia coli W.[107] Furthermore, 
he developed a spectrophotometric assay to follow the formation of thiourocanic acid at 311 nm.  
Muramatsu et al. presented the first detailed characterization of ergothionase in 2013.[132] They 
identified the gene encoding ergothionase by Edman degradation. With the sequence of ergothionase 
at hand, they were able to work with the purified enzyme of Burkholderia sp. HME13 yielded by 
recombinant protein production in Escherichia coli. One interesting finding was that ergothionase is 
not able to produce ergothioneine from a high concentration of thiourocanic acid (2.5 mM) and a four-
fold excess of trimethylamine. After a 12 h incubation, they could not detect any ergothioneine 
suggesting that the degradation reaction is irreversible. Muramatsu et al. also demonstrated that 
ergothionase from Burkholderia sp. HME13 loses its activity above 70 °C. This high stability could be 
advantageous when using ergothionase for the quantification of ergothioneine in blood or food 
samples as proposed by the authors.  
Ergothionase presents a novel enzyme type that shows relation to the aspartase/fumarase superfamily 
and to the aromatic amino acid ammonia-lyases. Whereas, the catalytic important MIO-moiety of the 




aromatic amino acid ammonia-lyases is not present in ergothionase. Furthermore, ergothionase is the 
first known enzyme that catalyzes the Hofmann elimination. As there is little known about 
ergothionase up to date, the aim of this chapter is to reveal the distinct mechanism of this enzyme. 
 
3.1 Selection of a Specific Enzyme for Kinetic and Structural Characterization 
Research on bacterial enzymes in the postgenomic era has the advantage that for any enzyme type 
there are a wide variety of homologs, which can be chosen for detailed characterization. Criteria for 
the selection of a specific protein for further analysis may include (I) the accessibility by recombinant 
production in E. coli, (II) the stability in vitro and (III) the activity and the propensity to crystalize. To 
identify an optimal candidate, we chose five sequences for further analysis, representing all putative 
ergothionase homologs.  
Ergothionase from Thermotalae metallivorans was not accessible by recombinant production in E. coli. 
In contrast, ergothionase from Streptococcus thermophilus was producible in yields up to 10 mg/L of 
culture, however the protein was not stable in vitro. Production of the ergothionase candidate from 
Synergistes jonesii had good yields (5 mg/L of culture) and the enzyme was stable, however activity on 
ergothioneine was low (<0.007 s-1).  
Only the ergothioneine trimethylamine lyases from Treponema denticola (TdETL) and Burkholderia 
pseudomallei (BpETL) allowed further studies. B. pseudomallei belongs to the phylum of β-
proteobacteria and occurs mainly in subtropical and tropical regions. It is a pathogen bacterium 
causing the disease melioidosis.[135] Interestingly, B. pseudomallei contains the genes encoding for EgtD 
and EgtB, proteins involved in ergothioneine biosynthesis.[123] This shows that the bacteria is also able 
to produce ergothioneine. A closer look into the sequence of BpETL revealed an N-terminal leader 
sequence (MQRFLTRSAIALALFAAVPAFA). The leader sequence contains 22, mainly hydrophobic, 
amino acids. The function of this leader sequence is to direct the way of the protein towards a channel 
in the plasma membrane. Hence, BpETL is an extracellular protein. After successful translocation of 
the protein, the signal peptide is cleaved and digested by proteases.[136] In summary, B. pseudomallei 
is able to both produce and degrade ergothioneine. However, due to the leader sequence of 
ergothionase, we assume that the degradation of ergothioneine occurs extracellularly, whereas 
ergothioneine production occurs intracellularly. Thus, B. pseudomallei strictly separates the 
production and degradation of ergothioneine.  




The gram-negative spirochete T. denticola is a pathogenic bacteria associated with parodontitis.[137] In 
contrast to B. pseudomallei, T. denticola degrades ergothioneine intracellular, but does not contain 
the genes for ergothioneine biosynthesis.  
Sequence alignments of BpETL and TdETL revealed 50% sequence similarity. Comparison of the 
catalytic parameters between BpETL and TdETL revealed that at their corresponding pH-optima 
ergothioneine turnover of TdETL is around 25-times faster than ergothioneine turnover of BpETL (Table 
1). Furthermore, the KM of BpETL increases around 5-times in comparison to TdETL. Due to the loss in 
catalytic efficiency of BpETL compared to TdETL, we decided to run further kinetic experiments with 
TdETL.  
Table 1. Observed kinetic parameters at the pH-optima of TdETL (pH 7.5) and BpETL (pH 6). 
  kcat [s-1]  KM [µM] kcat/KM [M-1s -1] 
TdETL  64 ± 3 45 ± 4 1.4 x 106 
BpETL  2.4 ± 0.1 240 ± 15 1.0 x 104 
 
 
3.2 Ergothionase Activity: Acid-Base Catalysis 
Acid-base catalysis is an important chemical process in biology. The concerted action of perfectly 
positioned functional groups acting as base and acid enables enzymes to catalyze even difficult 
elimination or addition reactions. In this regard, ergothionase is a remarkable enzyme because it is the 
first known enzyme that catalyzes the Hofmann elimination. In 1957, Yanasugondha et al. recognized 
a pH-dependence on the reactivity of ergothionase; the disappearance of ergothioneine was fast 
between pH 8 – 9 but negligible at pH 6.[130] However, they did not work with pure enzymes but on 
whole cell lysates, and therefore their observed pH-dependence is influenced by many variables. 
Nevertheless, Wolff also found ergothionase from E. coli showed maximum activity between 
pH 8.5 – 9.[107] Muramatsu et al. also reported that the maximum activity of ergothionase from 
B. pseudomallei HME13 was at pH 8.[132] Given the observation that activity of this enzyme has a 
narrow pH optimum at around neutral pH, the possibility raised that this enzyme requires base and 
acid for catalysis. To eluciate the role of the acid- and base-catalyzed steps, we initiated a more detailed 
mechanistic and structural investigation of TdETL.  
 




3.2.1 Activity of Ergothionase in Dependence of pH  
Based on the work of Wolff, we developed a spectrophotometric assay to follow ergothionase 
activity.[107] Strong absorbance of the unsaturated thiourocanic acid at 311 nm provided a convenient 
method to follow the enzymatic reaction (ε311, thiourocanic acid = 22500 M-1cm-1). The wavelength of 311 nm 
is specific for the product and no other contents of the assay showed absorbance at this specific 
wavelength. Thus, we could monitor product formation in a continuous reaction. With the knowledge 
of the extinction coefficient of the product and the concentration of used enzyme, we could calculate 
the reaction rate. The catalytic parameters presented in this thesis were determined using this assay. 
First, we examined the pH dependence of TdETL. For this purpose, we determined the Michaelis-
Menten parameters at a pH ranging from pH 5.5 up to pH 9.5. Both, kcat and kcat/KM showed a bell-
shaped pH-dependence (Figure 27). To determine the pKa values of these critical proton transfer 
equilibria, the point of inflection was calculated by fitting the obtained kcat and kcat/KM parameters to 
the following equation: y = kHA/ (1+10(pKa1-pH) + 10(pH-pKa2)).[138] The calculated pKa1 and pKa2 represent 
the pKa values of the corresponding acid and base, respectively.  
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Figure 27. pH-Dependent kcat and kcat/KM values of TdETL WT. pH dependent kinetic parameters were fitted to y = kHA/ 
(1+10(pKa1-pH) + 10(pH-pKa2)). 
 
For TdETL, the obtained pKa values for kcat were pKa1 = 6.6 ± 0.1 and pKa2 = 8.7 ± 0.1. In case of kcat/KM 
the obtained pKa values were pKa1 = 6.1 ± 0.2 or pKa2 = 9.3 ± 0.2. In general, pH activity profiles for 
enzymatic reactions can give insights about the protonation state of either the substrate or the amino 
acid side chain of the protein. In our case, the substrate ergothioneine has a quite acidic pKa of 1.3 due 
to the carboxylic acid, and the imidazole-H has a pKa value of 10.8.[139] As the identified pKa values for 
the catalyzed reaction are in between pH 6 – 9, we can assume that the pKa values obtained from the 
calculation above are not related to the substrate but rather emerge from the protein. Hence, the 




observed pH-dependent activity is set by pKa values of key ionizable groups within the active site of 
TdETL. This data suggests that certain protonation states of specific protein residues are important to 
provide the protons or charges needed in the catalytic mechanism of TdETL.  
One side chain residue of TdETL has a kinetic pKa = 6.6 ± 0.1. At pH levels below this pKa, the residue is 
protonated and the activity of the enzyme drops. We therefore propose that this residue functions as 
a catalytic base for the degradation reaction. At pH levels above pKa2 = 8.7 ± 0.1, the enzyme activity 
decreases again due to the deprotonation of another important residue. This active site group might 
be the catalytic acid.  
The observed pH-dependence suggests that TdETL catalysis follows an acid-base dependent 
mechanism (Figure 28). The base is responsible for the abstraction of the β-proton of the substrate. 
The nature of the acid-catalyzed step is less obvious. Further structural, mutational and kinetic studies 
will contribute to reveal the function of the acid catalysis in ergothionase and elucidate which residues 
act as the general acid and base. In the case of related MIO-dependent aromatic amino acid ammonia-
lyases, the need of an acid has never been investigated. For the enzyme fumarase a catalytic acid is 
essential to generate the leaving group H2O.[19] Whereas for aspartase the need of an acid has not been 
definitively elucidated and it remains questioning if the leaving group is free ammonia or the 
ammonium ion.[18]  
 
Figure 28. General proposed acid base dependent mechanism for the degradation of ergothioneine. 
 
3.2.2 Crystal Structure 
TdETL was crystallized and the structure was solved by Florian Leisinger. The crystal structures were 
solved in the apo-form (PDB: 6S7J, resolution 2.2 Å), covalently bound to the product thiourocanic acid 
and in complex with the substrate analogue desmethyl-ergothioneine sulfonic acid (PDB: 6S7Q, 
resolution 2.7 Å).[133] The obtained structures are the first known crystal structures of ergothionase. 
The structure is part of the protein domain family lyase_aromatic pfam00221. A high similarity (RMSD 
1.58 Å) to the structure of histidine ammonia-lyase from Pseudomonas putida (PpHAL, pdb: 1B8F)[57] 




was assessed. The overall structure of TdETL composes a basic α-helical homo-tetrameric structure 
(Figure 29). The α-helices are arranged in parallel.  
 
Figure 29. Crystal structure of the homo-tetramer of TdETL (pdb: 6S7Q) (left). The black box indicates the active site of subunit 
A that is shown in detail on the right. The ligand desmethyl ergothioneine sulfonic acid is depicted in wheat. 
 
The four active sites of the tetramer are located at the interfaces between the monomers. Each active 
site contains residues from three different subunits. The imidazole moiety of desmethyl ergothioneine 
sulfonic acid hydrogen bonds to His84 and Glu412 (Figure 29). Glu412 is coordinated to Lys384 that 
hydrogen bonds the sulfonic acid moiety of the ligand. The carboxylate of desmethyl-ergothioneine 
sulfonic acid approaches Asn311 and Arg281. The active site is covered by a loop that is positioned in 
a closed conformation in all structures. The native and the liganded structure do not show 
conformational changes upon substrate binding (Figure 30). A more detailed description of the crystal 
structure will be given in context with the kinetic data.  





Figure 30. Superimposed structure of TdETL in the apo form (raspberry, PDB: 6S7J) and in complex with desmethyl 
ergothioneine sulfonic acid (blue, PDB: 6S7Q). No conformational changes are observed upon substrate binding.  
 
3.2.3 Identification of Important Catalytic Residues: Activity of Mutants 
The observed pH-dependent activity profile reveals that ergothionase follows an acid-base dependent 
mechanism (section 3.2.1). One side chain residue of the protein functions as a general base to abstract 
the β-proton of the substrate, whereas another residue is responsible for leaving group protonation 
and therefore functions as a general acid.  
The closely related MIO-dependent lyases all contain a highly conserved tyrosine residue. In 2004, 
Ritter and Schulz found that their variant Y110F of phenylalanine ammonia-lyase of 
Petroselinum crispum (PcPAL) loses activity. However, they initially hypothesized that Tyr110 was not 
very important for catalysis, but suggested that the variant causes competitive inhibition with the 
substrate phenylalanine.[140] Later, the tyrosine residue was found to be the general base.[56,66,141] The 
function of this conserved tyrosine residue is the abstraction of the β-proton of the substrate. The 
sequence alignment suggests that the equivalent tyrosine residue is conserved in ergothionases 
(Figure 31). Therefore, we surmised that Tyr54 could be the catalytic base of TdETL.  
 
Figure 31. Abbreviated sequence alignment of the ergothionases TdETL and BpETL and the aromatic amino acid lyases 
Pseudomonas putida histidine ammonia-lyase (PpHAL), Rhodobacter sphaeroides tyrosine ammonia-lyase (RsTAL) and 
Petroselinum crispum phenylalanine ammonia-lyase (PcPAL). The catalytic important residues for ergothionase activity are 
highlighted in turquoise, the conserved amino acids forming the MIO-moiety are highlighted in pink. Counting is based on 
TdETL. 
        54   143    384      412 
TdETL  ...KPVYGLNR...SIG-EGDIT...GTIQKTFTM...GTI--EDHAS... 
BpETL  ...QQIYGLTV...SIG-EADIT...GAMEKPPTA...GGI--EDIAT... 
PpHAL  ...RTAYGINT...SVGASGDLA...MIAQVTAAA...ANQ--EDHVS... 
RsTAL  ...RHVYGLTT...TVGASGDLT...MGAQVTATA...-NAANQDVVS... 
PcPAL  ...TDSYGVTT...TITASGDLV...KGAEIAMAS...AEQHNQDVNS... 




Analysis of the structure of TdETL in complex with desmethyl-ergothioneine sulfonic acid showed that 
Tyr54 is located above the β-methylene group, well-positioned for abstraction of the pro-S proton of 
the substrate (Figure 29). In addition, the crystal structure of TdETL co-crystallized with thiourocanic 
acid showed that the β-carbon of the product was covalently attached to Tyr54 (Figure 32). These 
findings gave strong indication that Tyr54 might be the catalytic base of TdETL. 
 
Figure 32. Crystal structure of TdETL in complex with thiourocanic acid. The catalytic base Tyr54 is shown in blue, the 
covalently bound product thiourocanic acid is shown in wheat.  
 
In order to test our hypothesis, we mutated Tyr54 to Phe. Michaelis-Menten kinetics from the Y54F 
variant were determined at the previously observed pH-optima for TdETL (pH 7.5). This mutation 
caused a dramatic reduction in activity, the kcat dropped over 3000-times in comparison to the wild 
type enzyme (Table 2). The equivalent variant in PpHAL caused a 104 reduction in activity.[142] We 
therefore propose that Tyr54, in its phenolate ionization state, functions as a general base catalyst.  
Table 2. Observed kinetic parameters at pH 7.5 of TdETL WT and variants using ergothioneine as substrate.  
  kcat [s-1]  KM [µM] kcat/KM [M-1s -1] 
TdETL WT 64 ± 3 45 ± 4 1.4 x 106 
TdETL Y54F 0.02 ± 0.01 31 ± 5 6.5 x 102 
TdETL K64M 0.11 ± 0.01 1.0 ± 0.1 1.1 x 105 
TdETL E412Q 0.05 ± 0.01 210 ± 20 2.4 x 102 
TdETL K384M 0.02 ± 0.01 46 ± 4 5.0 x 102 
 
The pH-dependent activity profile showed that, besides the catalytic base, a catalytic acid is also 
needed for catalysis. A closer look into the crystal structure of TdETL revealed that Glu412 and Lys384 




were positioned as potential catalytic acids (Figure 29). Glu412 hydrogen bonds with an imidazole N-
H group of the substrate (2.7 Å distance). The structural conservation of Glu412 in PpHAL underscores 
the importance of this residue for imidazole N-H binding (Figure 33). In contrast, Tyr- or Phe-lyases do 
not contain a conserved glutamate at the analogous position.  
 
Figure 33. Superimposed structure of TdETL (blue, PDB:6S7J) and PpHAL (orange, PDB:1B8F). Tyr54, His84 and Glu412 
(counting based on TdETL) are structurally highly conserved, whereas Glu143 in TdETL is located on the position of MIO in 
PpHAL.  
 
Lys384 belongs to the third subunit of TdETL; in the homo-tetramer, this residue points in hydrogen 
bonding distance (3 Å) towards the sulfur group of the substrate (Figure 29).  
To further study the function of Glu412 and Lys384, both residues were mutated to E412Q and K384M, 
respectively. The K384M variant causes a decrease in kcat by 3000-times (Table 2). Based on the strong 
decrease in activity of that variant and based on the crystal structure, we suggest that the cationic 
lysine residue has a complementary charge on the sulfur group of the substrate. In order to bind to the 
active site, the substrate ergothioneine must attain a zwitterionic state with an anionic sulfur head-
group and a cationic imidazolium (Figure 34). The variant K384M lacks a positive charge and may 
therefore no longer bind the zwitterionic state of the substrate. This charge separation appears to be 
crucial for catalysis and will be discussed in detail in the context of substrate activation in section 3.3. 
The decrease in kcat by over 1000-times in the E412Q variant can be explained as Glu412 hydrogen 
bonds with N-H of the imidazolium of the substrate, and upon catalysis, Glu412 transfers a proton from 
Lys384 to the leaving group trimethyl amine (Table 2).  
The dramatic effects on kcat and catalytic efficiency of the presented variants Y54F, K384M and E412Q 
demonstrate that these three residues are absolutely essential for catalysis. 





Figure 34. Mechanistic proposal of ergothioneine degradation within the active site of TdETL.  
 
3.2.4 Function of Lys64 
Our previous investigation into the pH-dependent activity profile of TdETL WT revealed a bell-shaped 
pH-dependence. The observed pKa values are set by key ionizable groups within the active site of 
TdETL. The acidic limb of the activity profile reflects the deprotonation of the catalytic base Tyr54 
(pKa1WT = 6.6 ± 0.1) (Figure 27). A tyrosine residue without any interaction has a pKa of 10. Thus, the 
obtained pKa value is lower than expected. Therefore, the anionic form of Tyr54 might be stabilized by 
a neighboring residue. Lys64 is a possible residue for stabilization; this residue is located on a flexible 
loop covering the active site in neighborhood to the catalytic base Tyr54. The obtained crystal structure 
of TdETL co-crystallized with desmethyl-ergothioneine presents Lys64 in a conformation, rotated away 
from Tyr54 (8.7 Å distance between Tyr54 and Lys64) (Figure 35). However, another data-set with low 
ligand occupancy revealed a flexible Lys64 in close contact to Tyr54.[133]  
  
Figure 35. Crystal structure of TdETL in complex with desmethyl-ergothioneine sulfonic acid (pdb: 6S7Q). The catalytic base 
Tyr54 and Lys64 are colored in blue. Here, Lys64 is rotated away; thus, the distance between phenolate of Tyr54 and the ε-
amino group of Lys64 is only 8.7 Å. However, Lys64 can also be rotated, and thus allow coordination to Tyr54.  




In order to investigate into the influence of Lys64, we designed the K64M variant. At pH 7.5, the K64M 
variant causes a minor decrease in activity in comparison to Y54F, E412Q or K384M (Table 2). The 
hydrogen bond interaction with Lys64 could account for the depressed pKa of Tyr54 (Figure 36). To test 
this idea, we recorded a pH-dependent activity profile for the K64M variant.  
 
Figure 36. Interaction between Lys64 and the catalytic base Tyr54 within the active site of TdETL. 
 
In a similar experiment as run for the wild type enzyme, we obtained a bell-shaped pH-dependence 
for the mutant (Figure 37). However, the single point-mutation was found to cause a shift in the pH-
optimum of TdETL. In contrast to the wild type, the pKa1 of K64M was increased by 1.6 pH units 
(pKa1WT = 6.6 ± 0.1 vs. pKa1K64M = 8.2 ± 0.2). This effect is consistent with the postulated activating role 
of Lys64. 










 = 8.2 ± 0.2 
pK
a2






























 = 6.1 ± 0.2 
pK
a2
















Figure 37. pH-Dependent kcat and kcat/KM values of TdETL K64M. Obtained kinetic parameters were fitted to y = kHA/ (1+10(pKa1-
pH) + 10(pH-pKa2)). 
 
Interestingly, in the pH-dependent activity profile of K64M, not only pKa1 was is shifted, but also pKa2 
was elevated by 0.8 pH units (pKa2WT = 8.7 ± 0.1 vs. pKa2K64M = 9.5 ± 0.1). As pointed out earlier, pKa1 




reflects the catalytic base, whereas pKa2 reflects the catalytic acid of the reaction. Thus, it first seems 
surprising that the K64M variant influences the pKa2 value as well. However, we have to consider that 
the total activity of K64M had dropped. Therefore, the inflection point representing pKa2 dropped as 
well. This results in a shift of the observed pKa2 of K64M in comparison to the wild type. Nevertheless, 
this shift does not present any direct influence of K64M on pKa2. Anyway, the elevation of pKa1 is 
obviously higher (ΔpKa1 = 1.6 pH-units; ΔpKa2 = 0.8 pH-units).  
 
3.3 Substrate Activation 
Ground-state destabilization of a substrate, along with transition-state stabilization, is a major 
component in enzyme catalysis.[143] Ground-state destabilization is important for lowering the 
activation energy barrier, while converting substrate molecules to products. An example of ground-
state destabilization through substrate polarization can be seen in the enzyme uracil DNA 
deglycosylase, which polarizes its substrate in order to catalyze the C-N bond cleavage reaction (Figure 
38).[144] The substrate uracil is polarized by active site residues to the higher energy structure, similar 
to the enolate form when it is bound in the enzyme. This polarized substrate closely resembles the 
transition state structure, and thus facilitates bond-cleavage. Das et al. outlined the importance of 
tautomeric strain in raising the energy of substrates in enzymes.[144]  
 
Figure 38. Scheme of the active site of uracil DNA deglycosylase. The substrate gets polarized in order to facilitate C-N bond 
cleavage.[144] 
 
However, it is important to note that ground-state destabilization accelerates catalysis only under the 
condition that the energy needed to distort the reacting part of the substrate is compensated either 
by (I) strong attractive interactions with other parts of the substrate and the enzyme, or (II) by 
stabilization of the entire protein fold upon ligand binding. If this condition is not fulfilled, the 
destabilizing interactions simply decreases the concentration of the enzyme:substrate complex, which 
in turn reduces the overall reaction rate. Ergothionase fulfills this condition: substrate binding seems 




to be irreversible (as will be described in section 3.4.1), meaning that the binding of the substrate at a 
concentration higher than KM gets exergonic. 
One major challenge for the enzyme ergothionase is the abstraction of the non-acidic β-proton of 
ergothioneine. The β-proton of an amino-acid has a pKa of 40.[58] In order to allow the abstraction of 
the β-proton, the ground-state of ergothioneine must be destabilized, leading to an increase in acidity 
at the β-position.  
We propose that ergothionase binds the substrate ergothioneine in its polarized form (Figure 39). The 
resonance structure of ergothioneine places the positive charge in vicinity of the β-proton; the electron 
withdrawal facilitates C-H bond cleavage. 
 
Figure 39. Resonance structure of ergothioneine. 
 
We suggest that the stabilization of the imidazolium thiolate form of the substrate might be important 
in the catalysis of ergothionase. The crystal structure of TdETL with desmethyl-ergothioneine sulfonic 
acid gives closer insights how the protein stabilizes the substrate. However, we have to consider that 
the obtained crystal structure shows desmethyl-ergothioneine sulfonic acid and not the substrate 
ergothioneine itself. Nevertheless, we analyzed the catalytic behavior of desmethyl-ergothioneine and 
ergothioneine sulfonic acid (section 0 and 3.3.4), and thus we can assume that desmethyl-
ergothioneine sulfonic acid is a good model for ergothioneine. Both N-H protons of the imidazole 
moiety of the ligand can be stabilized by the active site residues Glu412 (2.7 Å distance) and His84 
(3.0 Å distance) (Figure 40). His84 itself forms a hydrogen bonded triad with Ser83 and Asn79; this 
allows His84 to be a hydrogen bond donor towards the substrate. The π-electrons of the carbon-sulfur 
bond of the substrate can be polarized to the sulfur residue. The resulting thiolate is stabilized by 
Lys384 (2.7 Å distance). Hence, a cationic charge, stabilized by Glu412 and His84, remains on the 
imidazole moiety (Figure 41). This cationic charge causes an increase in acidity of the β-methylene 
group, which accelerates base-assisted C-H cleavage. Thus, the zwitterionic state of the substrate, 
leading to the cationic charge on the imidazole moiety, is indispensable for catalysis. In agreement 
with our earlier observation that C-H cleavage is a key step in catalysis, we understand that the 















In the following subchapter, the hypothesis that ergothionase binds the substrate in a polarized form 
will be tested by investigations on substrate specificity of the wild type and the K384M variant in 
particular.  
 
Figure 40. Crystal structure of TdETL in complex with desmethyl-ergothioneine sulfonic acid (colored in wheat). The N-H 
protons of the imidazole moiety of desmethyl-ergothioneine sulfonic acid is coordinated to His84 and Glu412 (colored in 
blue). The sulfur moiety of desmethyl-ergothioneine sulfonic acid is coordinated to Lys384 (colored in blue). 
 
 
Figure 41. Ergothioneine binding within the active site of TdETL. His84, Lys384 and Glu412 stabilize the zwitterionic state of 
the substrate. Thus, acidity of the β-methylene proton is increased (represented in pink). 
 
3.3.1 Substrate Specificity 
Kinetic investigations using substrate-related compounds and not only the main substrate, can help to 
gain a better understanding of enzyme mechanisms and is giving an important interpretive merit, 
especially regarding substrate activation. While ergothioneine appears to be the main substrate for 























N,N,N-α-trimethylhistidine (TMH) was tested as substrate for TdETL. TMH was transformed to urocanic 
acid with a rate of 0.04 s-1 (Table 3). Besides TMH, S-methyl ergothioneine was also found to be a poor 
substrate (rate = 0.001 s-1). While both compounds seem structurally similar to ergothioneine, the 
activity of TdETL was still found to be strongly reduced (1600-fold in the case of TMH and 64000-fold 
in the case of S-methyl ergothioneine).  
Table 3. Observed activity of TdETL WT on different substrates in HEPES buffer at pH 7.5 using 2 mM substrate.  
 Ergothioneine TMH 
S-Methyl 
ergothioneine 
TdETL WT [s-1] 64 ± 3 0.04 ± 0.01 0.001 
 
The structural difference between ergothioneine and TMH is the absence of sulfur in TMH. During 
catalysis, the thiolate of ergothioneine is required for hydrogen bonding interaction to Lys384 (Figure 
41). This hydrogen bonding interaction stabilizes the charge separation of the substrate. As described 
earlier, this cationic imidazolium is important to increase the acidity of the methylene group. However, 
the compound TMH cannot be stabilized in the charge separated form due to the missing sulfur. The 
crucial zwitterionic state for activity cannot be attained and TMH does neither hydrogen bond to 
Lys384, nor to Glu412 (Figure 42). Therefore, β-methylene acidity of the substrate is not increased, 
leading to a loss in activity for TMH.  
 
Figure 42. TMH binding within the active site of TdETL. The enzyme does not stabilize a cationic charge on the imidazole 
moiety; thus, acidity of the β-methylene proton is not increased (represented in blue). 
 
S-Methyl ergothioneine was also not accepted as a substrate by TdETL (rate = 0.001 s-1). The structural 
difference of S-methyl ergothioneine to ergothioneine is the addition of a methyl group on the sulfur 




residue (Figure 43). The presence of this methyl group appears to have a strong effect on activity. Since 
ergothioneine sulfonic acid is an accepted substrate for ergothionase (as described below), it is unlikely 
that simple steric hindrance of the additional methyl group in S-methyl ergothioneine is the reason for 
the loss in activity. The activity loss can be explained as the crucial charge-separation of the thiolate 
and imidazolium is not possible for S-methyl ergothioneine. Thus, S-methyl ergothioneine binds with 
a neutral imidazole moiety and acidity of the β-methylene group is not increased. 
 
Figure 43. S-Methyl ergothioneine binding within the active site of TdETL. The enzyme does not stabilize a cationic charge on 
the imidazole moiety; thus, acidity of the β-methylene proton is not increased (represented in blue). 
 
We showed that the active site residue Lys384 is highly important for stabilizing the thiolate of the 
substrate ergothioneine. The compounds TMH and S-methyl ergothioneine do not hydrogen bond with 
Lys384, which explain their reduced reactivity. Therefore, it would be interesting to investigate the 
substrate specificity of the K384M variant. 
 
3.3.2 Substrate Specificity of the K384M Variant 
Lys384 is an important residue within the active site of TdETL. As described earlier, we propose that 
Lys384 hydrogen bonds with the thiolate form of ergothioneine, and thus is responsible for stabilizing 
the crucial zwitterionic state of the substrate. To test this hypothesis, we constructed the K384M 
variant.  
The K384M variant degrades ergothioneine around 3000-times slower than the wild type enzyme 
(Table 4). Furthermore, the variant shows only negligible turnover on ergothioneine sulfonic acid. 
Nevertheless, in contrast to the wild type, the activity of K384M for both TMH and S-methyl 




ergothioneine increases five-times and 90-times, respectively. Thus, the single mutation not only 
decreased the activity of ergothionase but also impacts substrate specificity. 








TdETL WT [s-1] 64 ± 3 17 ± 1 0.04 ± 0.01 0.001 
TdETL K384M [s-1] 0.02 ± 0.001 0.005 ± 0.002 0.2 ± 0.01 0.09 ± 0.001 
 
This effect is likely caused by the change in the active site environment. The K384M variant leads to 
the loss of a positively charged residue within the active site of the protein. In the case of S-methyl 
ergothioneine, the neutral S-methyl head-group does not interfere with the neutral methionine. The 
protonated imidazolium moiety of S-methyl ergothioneine can still be stabilized by Glu412, and thus 
S-methyl ergothioneine can bind in a cationic form (Figure 44). As we have mentioned earlier, the 
cationic imidazolium is crucial for activity, while increasing acidity of the β-methylene group.  
 
Figure 44. S-Methyl ergothioneine binding within the active site of the variant TdETL K384M. The enzyme is able to stabilize 
the crucial cationic imidazolium moiety; thus, acidity of the β-methylene proton is increased (represented in pink). 
 
The increase in activity of the K384M variant over the wild type for TMH can be explained in a similar 
fashion as for S-methyl ergothioneine (Figure 45). Due to the absence of a cationic residue within the 
active site of the variant, TMH can bind in the cationic imidazolium form stabilized by Glu412. 





Figure 45. TMH binding within the active site of the variant TdETL K384M. The enzyme is able to stabilize the crucial cationic 
imidazolium moiety; thus, acidity of the β-methylene proton is increased (represented in pink). 
 
The observed activity of the K384M variant supports the hypothesis of the crucial charge separation 
of the substrate during catalysis of TdETL. 
 
3.3.3 Ergothioneine Sulfonic Acid as Substrate 
Ergothioneine sulfonic acid was first identified as a stable oxidation product of ergothioneine.[145] 
Servillo et al. confirmed the formation of both ergothioneine sulfonic acid and TMH after reaction of 
ergothioneine with the superoxide anion in cell-free experiments. Two years later, ergothioneine 
sulfonic acid was found to emerge during ergothioneine oxidation in the presence of high-glucose 
oxidative stress in endothelial cells.[146] However, the fate of the stable compound ergothioneine 
sulfonic acid was stated to be unknown so far.[99] Interestingly, TdETL also accepts ergothioneine 
sulfonic acid in considerable efficiency with a kcat of 17 ± 1 s-1 and a catalytic efficiency (kcat/KM) of 
1.1 x 105 M-1s-1 (Table 5). It appears that the large anionic head group of ergothioneine sulfonic acid 
fits into the active site and does not disturb the protein. Furthermore, the compound is able to obtain 
a zwitterionic state comparable to ergothioneine (Figure 46). Thus, the overall neutral complex is a 
good substrate for TdETL. The crystal structure reveals that the anionic head group can interact with 
Lys384. The remaining cationic imidazolium moiety can interact with Glu412. As stated earlier, this 
positive charge is crucial for catalysis as it increases acidity of the β-methylene proton. 





Figure 46. Ergothioneine sulfonic acid binding within the active site of TdETL. His84, Lys384 and Glu412 stabilize the 
zwitterionic state of the substrate. Thus, acidity of the β-methylene proton is increased (represented in pink). 
 
The activities of the variants Y54F, E412Q and K384M, using ergothioneine sulfonic acid as substrate 
were as drastically decreased as observed for ergothioneine (Table 5).  
Table 5. Observed kinetic parameters at pH 7.5 of TdETL WT and variants using ergothioneine sulfonic acid as substrate.  
 kcat [s-1]  KM [µM] kcat/KM [M-1s -1] 
TdETL WT 17 ± 1 150 ± 20 1.1 x1 05  
TdETL Y54F 0.003 ± 0.002 150 ± 30 1.7 x 101 
TdETL E412Q 0.002 ± 0.001 4 ± 1 4.6 x 102 
TdETL K384M 0.005 ± 0.002 1900 ± 200 0.3 x 101 
 
Due to the absence of the catalytic base, the kcat value, using ergothioneine sulfonic acid as the 
substrate, decreases over 5000-times for the Y54F mutant in comparison to the wild type. In 
agreement with our observation for ergothioneine, the variants E412Q and K384M lose activity over 
three orders of magnitude for ergothioneine sulfonic acid. The increased catalytic efficiency of E412Q 
(kcat/KM = 4.6 x 102 M-1s-1) in contrast to the other variants, can be explained by the omitted repulsion 
of the anionic head group and Glu412. Lys384 and Glu412 are both important for activity: Lys384 acts 
as proton donor; Glu412 helps stabilizing the cationic imidazolium and is responsible for proton 
transfer to the leaving group trimethylamine. Based on these findings, we proposed that ergothioneine 
sulfonic acid reacts in a similar mechanism as ergothioneine. 
 




3.3.4 Impact of Desmethyl-Ergothioneine 
The crystal structure obtained with desmethyl-ergothioneine sulfonic acid showed that the 
desmethylated substrate derivative can bind to the active site of TdETL. Therefore, we investigated if 
desmethyl-ergothioneine sulfonic acid and desmethyl-ergothioneine are also substrates.  
The observed activity of the desmethylated substrate derivatives was in both cases reduced by over 
three orders of magnitude in comparison to ergothioneine and ergothioneine sulfonic acid (Table 6).  









TdETL WT [s-1] 64 ± 3 0.012 17 ± 1 0.0022 
 
The much lower reactivity of desmethylated compounds can be rationalized as follows: The elimination 
of ergothioneine or ergothioneine sulfonic acid produces neutral trimethylamine with a pKa only 
slightly above the physiological pH (pKa 9- 10). In contrast to ergothioneine and ergothioneine sulfonic 
acid, the desmethylated compounds likely bind to the active site with a neutral amino group because 
the corresponding pocket is largely apolar and provides no counter charge to stabilize the 
dimethylamino function in protonated form. Elimination of this leaving group would produce an 
anionic dimethylamine that is characterized by a much higher pKa. Clearly, dimethylamine is a poor 
leaving group.   
The observation that the desmethylated compounds are poor substrates highlights a second part of 
the substrate activation strategy of TdETL: binding of the trimethylammonium moiety in an apolar 
pocket destabilizes the leaving group.  
Additionally, we investigated in the inhibitory influence of desmethyl-ergothioneine. Given its low 
reactivity, desmethyl-ergothioneine acts essentially as a substrate competitive inhibitor. Michaelis-
Menten kinetics of TdETL inhibition by desmethyl-ergothioneine were run by measuring the apparent 
KM,ergothioneine in the presence of different concentrations (250, 500, 1000, 1500, 2000 µM) of desmethyl-
ergothioneine. The kcat remained unchanged upon addition of the inhibitor whereas the KM value 




The value of Ki for desmethyl-ergothioneine (250 ± 30 µM) should be taken with care because 
substrate binding of TdETL might be irreversible, as will be discussed in section 3.4.1. Therefore, it is 




possible that binding of desmethyl-ergothioneine might also be partially irreversible. Hence, the 
physical meaning of Ki is obscure.  
 
3.3.5 Analysis of the Substrate and Solvent Isotope Effect of kcat  
In general, three different mechanisms for elimination reactions can be distinguished, namely E1, E1cb 
and E2 (Figure 47). E1-elimination is a unimolecular reaction, whereby the reaction velocity depends 
only on the concentration of the substrate. The formation of the carbocation through cleavage of the 
leaving group is the rate-determining step. In the case of E1cb-elimination, a carbanion is formed prior 
to cleavage of the leaving group, which is stabilized by conjugation prior to leaving group departure. 
E2-elimination is a bimolecular reaction, dependent on the concentration of both substrate and base. 
Thereby, C-H abstraction and cleavage of the leaving group occurs in one concerted step. Furthermore, 
E2-elimination demands an antiperiplanar arrangement (180°) of the cleaved leaving group and the C-
H bond because it aligns the orbitals responsible for forming the π-bond. In organic chemistry, E1, E1cb 
and E2 mechanisms are distinguished by the different kinetic behavior. In the case of ergothionase the 
reaction certainly behaves as unimolecular reaction. Whereas the presented nomenclature 
distinguishes the sequence of the elementary steps, meaning that in an E1 reaction the trimethylamine 
leaves the substrate first under formation of a carbocation; in an E1cb elimination the C-H cleavage 
occurs first, whereas an E2 elimination describes a concerted reaction. 
 
Figure 47. Scheme of the different types of elimination reaction. 
 
In order to identify the rate-limiting step of ergothionase, we determined the substrate kinetic isotope 
effect (KIE) for TdETL activity. Isotope substituted substrates require more energy to reach the 
transition state for C-D bond cleavage. If this bond cleavage is involved in the rate-limiting step, the 
deuterium-labelled ergothioneine will react at a slower rate, presented by a KIE > 1. In order to 




produce deuterated ergothioneine, the ergothioneine biosynthetic enzyme EanB and the starting 
material TMH (D5, 98%; 15N3, 98%) were used (Figure 48).[105]  
 
Figure 48. Enzyme-based production of deuterated ergothioneine from deuterated TMH (D5, 98%; 15N3, 98%). 
 
We determined the KIE by following turnover of TdETL using ergothioneine or deuterated 
ergothioneine as the substrate. The ratio kH/kD indicated a KIE = 1.8 ± 0.2, suggesting that the cleavage 
of the β-C-H bond of the substrate is the rate-limiting step. 
The kinetic solvent isotope effect (KSIE) examines the effect of solvent deuterium substitution on 
reaction velocity. However, KSIE are often difficult to interpret. Unlike specific deuteration of the 
substrate, deuteration of the solvent is not a specific perturbation. The exchange of water with 
deuterium oxide changes the viscosity of the solvent and the pKa values of functional groups. This in 
turn can affect conformational preferences of the protein, its flexibility and the protonation equilibria 
in the active site. The following discussion of these effects should be viewed as a tentative explanation 
of the observed effects. In this discussion, effects that are smaller than 1.4-fold are not considered 
significant because of the associated experimental error and viscosity effects. Isotope effects larger 
than 1.4 indicate that proton transfer is taking place during the transition state of a rate-limiting step. 
In the absence of proton inventory experiments, we cannot exclude the possibility that the observed 
isotope effects are caused by multiple coupled proton transfers. 
For the elimination reaction of TdETL, we determined a KSIE = 1.7 ± 0.1. This comparatively large effect 
is consistent with the idea that proton transfer occurs during a rate-limiting step. Given the above 
indications that TdETL activity depends on acid catalysis, it is possible that the observed isotope effect 
is related to proton transfer from the enzyme to eliminated trimethylamine. Mechanistically, this 
proton transfer could occur either coupled with or subsequent to C-H cleavage. If both protons are 
moving during the same transition state, one would expect that substrate and solvent isotope effects 
would cumulate by multiplication. 
To test this idea, we measured both the KSIE using deuterated ergothioneine as substrate and the KIE 
in D2O (Table 7). In both cases, no distinct effect was observable (KIED2O = 1.3 ± 0.2; KSIEdeut.-ergothioneine 























deuterated substrate with deuterated solvent should produce a larger effect – if the two proton 
transfer events would be coupled. In contrast, our observations suggest that the two events are not 
coupled. Both energy barriers are independent and equal rate-limiting steps. The diminished effects 
observed in the combined substrate and solvent deuteration experiments suggest that the two 
deuterium-sensitive steps occur sequentially. 
Table 7. Observed substrate kinetic isotope effects (KIE) and kinetic solvent isotope effect (KSIE) at pH 7.5 of TdETL WT. 
 KIE (kcat) KSIE (kcat) 
H2O  1.8 ± 0.2 --- 
D2O 1.3 ± 0.2 --- 
Ergothioneine --- 1.7 ± 0.1 
Deut.-Ergothioneine --- 1.0 ± 0.2 
 
The nature of the step, which is slowed down by deuteration of the substrate, can be clearly attributed 
to C-H cleavage by Tyr54. The identity of the step that is sensitive to solvent deuteration is less clear. 
Based on the mechanistic proposal depicted in Figure 34 we can identify two possibilities:  
I) Solvent deuteration changes the proton distribution between the substrate and residues Glu412, 
Lys384 and His84. This distribution could reduce the positive charge on the mercaptoimidazole ring, 
which in turn would reduce the acidity of the scissile β-proton of the substrate. However, this effect 
would make C-H cleavage slower and result in a multiplicative substrate/solvent kinetic isotope effect. 
This is not what we observed.  
II) Alternatively, it is possible that protonation of the expelled trimethylamine by the Glu412-Lys384 
dyad is partially rate-limiting and therefore slows the overall reaction in D2O. This proton transfer could 
occur either coupled to C-H abstraction or afterwards. The observed coupled isotope effects would 
support the latter option. Indeed, inspection of the crystal structure showed that the position of 
Glu412 relative to the dimethylamino group of desmethyl ergothioneine sulfonic acid is not amenable 
to direct proton transfer because the side chain of Glu412 is not positioned in the same axis as the C-
N bond of the substrate. Therefore, protonation of the leaving group has to occur after C-N cleavage 
and realignment of trimethylamine to point its lone pair towards Glu412. The structure does not reveal 
any other acidic residue that could protonate trimethylamine instead. Based on this analysis, we 
propose that the solvent-sensitive step is the protonation of trimethylamine by the Glu412-Lys384 
dyad.  
 




Additionally, we investigated in the the KSIE of the variants Y54F, E412Q and K384M in order to 
examine if active site residues are involved in proton transfer (Table 8). As previously rationalized, the 
interpretation of the KSIE is only a tentative explanation.  
Table 8. Observed kinetic solvent isotope effect (KSIE) on kcat at pH 7.5 of TdETL WT and variants. 
 KSIE (kcat) 
TdETL WT 1.7 ± 0.1 
TdETL Y54F 1.3 ± 0.1 
TdETL E412Q 1.0 ± 0.1 
TdETL K384M 1.5 ± 0.1 
 
For all variants, we observed a reduced KSIE in contrast to the wild type enzyme. The variant E412Q 
reduced the effect to unity, which might indicate that Glu412 is most intimately involved in the proton 
transfer step that is reflected by the solvent isotope effect. Possibly, in the E412Q variant the leaving 
group trimethylamine is no longer protonated, hence, the KSIE vanishes completely. The variant 
K384M has a KSIE of 1.5 ± 0.1. We propose that Lys384 stabilizes the thiolate of the zwitterionic state 
of the substrate and that Lys384 is the proton donor for the catalytic acid dyad with Glu412, therefore 
the variant K384M has a reduced KSIE in comparison to the wild type. For the Y54F variant we do not 
observe a significant KSIE (KSIEY54F = 1.3 ± 0.1). Due to the absence of the catalytic base, which causes 
slow β-C-H cleavage of the substrate, we barely see reactivity of that variant. Because the rate-limiting 
C-H cleavage step is decreased drastically in Y54F, the second step of the mechanism, namely the 
protonation of the leaving group is hard to analyze. 
 
3.4 Irreversible Substrate Binding Mechanism 
The crystal structure of TdETL revealed that the active site is occluded by a loop region that contains 
the catalytic base Tyr54. Closely-related MIO-dependent ammonia-lyases possess an equivalent loop 
region. The crystal structure of PcPAL (PDB: 1W27) showed that the tyrosine residue is located in great 
distance of the active site (~17 Å) (Figure 49).[140] This observation was a first indication for a high 
flexibility of the tyrosine containing loop-region.[148] Indeed, numerous homologous lyases have been 
crystallized with the active site loop in disordered conformations (PDB: 1Y2M, 1T6J, 2NYN, 
2NYF).[55,56,149,150] Based on the first ordered PAL structure (PDB: 3CZO), it can be suggested that 
conformational switches of the loop region are responsible for controlling access to the active site and 
that the stability of the closed loop-conformation might influence catalytic efficiency.[67] Site-directed 
mutagenesis on a structurally-related aminomutase showed that the introduction of a glycine residue 




in the active site loop allowed greater loop flexibility, which caused an increase in lyase over mutase 
activity (PDB: 4V2R).[151] In the following subchapter, we will focus on the substrate binding mechanism 
of TdETL and investigate the role of the active site loop. 
 
Figure 49. Superimposed structure of PAL with open loop conformation from Petroselinum crispum (green, PDB: 1W27) and 
PAL with closed loop conformation from Anabaena variabilis (violet, PDB: 3CZO). The catalytic base tyrosine located on the 
loop and the MIO-moiety in the active site are depicted in stick presentation.  
 
3.4.1 Substrate Isotope Effect Reveals Partial Irreversible Substrate Binding 
As discussed earlier, TdETL displays a substrate isotope effect of KIE (kcat) = 1.8 ± 0.2 (section 0). We 
deduced that the cleavage of the C-H bond of the substrate is the rate-limiting step of catalysis. In the 
case of the deuterated substrate, the β-C-D bond requires more activation energy for cleavage and 
therefore, the turnover in saturated substrate conditions for the deuterated substrate is reduced in 
comparison to the non-deuterated substrate. However, we could only observe a KIE on kcat. There was 
no distinct KIE when the substrate concentration was not saturated: KIE (kcat/KM) = 1.2 ± 0.1 (Table 9). 
These findings revealed that C-H cleavage is only rate-limiting if the protein is saturated with substrate, 
whereas at low substrate concentrations, the formation of the enzyme:substrate complex is 
dominating. These results implicate that formation of the enzyme:substrate complex is partially 
irreversible, meaning that the forward reaction is more likely than the decay of the enzyme:substrate 
complex. Therefore, we did not observe a KIE on kcat/KM. If the formation of the enzyme:substrate 
complex becomes the rate-limiting step, we have to focus on the definition of the KM value for TdETL. 
Usually, the KM value is defined as a constant describing the substrate affinity of the enzyme:[147] 









In the case of TdETL, the forward reaction of the enzyme:substrate complex is more likely than 
substrate unbinding. This is represented by k2 > k-1. Thus, substrate binding becomes an almost 




In addition, we also determined the KIE of the Y54F variant. The kcat of Y54F is reduced three orders of 
magnitude in comparison to the wild type (section 3.2.3). However, we observed that substrate 
unbinding is slower than C-H cleavage, similar as shown for the wild type enzyme (KIE (kcat) = 2.0 ± 0.2 
KIE (kcat/KM) = 1.2 ± 0.1) (Table 9). 
Table 9. Observed substrate kinetic isotope effects (KIE) of TdETL WT and TdETL Y54F at pH 7.5 using ergothioneine as 
substrate. 
 KIE (kcat) KIE (kcat/ KM) 
TdETL WT 1.8 ± 0.2 1.2 ± 0.1 
TdETL Y54F 2.0 ± 0.2 1.2 ± 0.1 
 
The presented irreversible substrate binding might result from a closed conformation of the active site 
loop domain. Therefore, we aimed at rendering substrate binding reversible by introducing several 
mutations that may impact loop conformation. These results are described in the following section. 
 
  




3.4.2 Destabilization of the Closed Loop Formation 
The loop region that covers the active site of TdETL, consisting of residues 50-69, contains three 
conserved glycine residues (Gly55, Gly59, Gly61) (Figure 50).  
 
Figure 50. Crystal structure of TdETL in complex with desmethyl-ergothioneine sulfonic acid (colored in wheat) (PDB: 6S7Q). 
The loop, consisting of residues 50–69 covering the active site, is colored in dark blue. The catalytic base Tyr54 and Asn63 are 
depicted in stick representation. Cα of the three glycine residues, Gly55, Gly59 and Gly61, are shown as red spheres. 
 
These glycine residues are also conserved in MIO-dependent ammonia-lyases (Figure 51). Louie et al. 
suggested that conservation of the three glycine residues might facilitate the mobility of the active site 
loop in PAL.[56]  
 
Figure 51. Sequence alignment of the lid-loop of ergothionases TdETL and BpETL and the aromatic amino acid lyases 
Pseudomonas putida histidine ammonia-lyase (PpHAL), Rhodobacter sphaeroides tyrosine ammonia-lyase (RsTAL) and 
Petroselinum crispum phenylalanine ammonia-lyase (PcPAL). The conserved residues are highlighted in turquoise. Asn63 is 
only conserved in ergothionases (highlighted in violet). Counting based on TdETL. 
 
Since glycine has no side chain, this residue can adopt conformations that are not permissible for other 
amino acids. Thus, glycine residues often play the role of a hinge in non-canonical secondary protein 
    54      63 
TdETL  ...GKPVYGLNRGVGWNKDKEFD... 
BpETL  ...GQQIYGLTVGVGLNKDREMV... 
PpHAL  ...DRTAYGINTGFGLLASTRIA... 
RsTAL  ...ARHVYGLTTGFGPLANRLIS... 
PcPAL  ...GTDSYGVTTGFGATSHRRTK... 




structures.[152] In order to determine if conformational changes of the active site loop are essential for 
substrate binding in TdETL, we aimed to destabilize the closed loop formation by mutation of the 
glycine residues.  
Since Gly55 is directly adjacent to the catalytic base Tyr54, we did not further investigate in this 
residue. Kinetic investigations of the G61A variant revealed a 500-times decrease in kcat and catalytic 
efficiency compared to the wild type (Table 10). The crystal structure suggests that Gly61 makes van 
der Waals contacts with the substrate, which explains the decrease in activity.  
Table 10. Observed kinetic parameters at pH 7.5 of TdETL WT and variants using ergothioneine as substrate. 
  kcat [s-1]  KM [µM] kcat/KM [M-1s -1] 
TdETL WT 64 ± 3 45 ± 4 1.4 x 106 
TdETL G59V < 0.001 --- --- 
TdETL G59A 0.44 ± 0.01 34 ± 2 1.3 x 104 
TdETL G61A 0.11 ± 0.01 27 ± 4 4.0 x 103 
 
Gly59 is located on the active site lid-loop and might work as a hinge for loop-flexibility. The idea was 
that the introduction of a sterically more hindered valine residue at this position might cause a drastic 
decrease in loop flexibility. Indeed, the variant G59V did not show measurable activity 
(kcat,G59V < 0.001 s-1). Inspection of the crystal structure suggests that in the closed conformation the 
propyl side chain of Val59 would clash with residues Asn63 and Lys66. Therefore, we constructed the 
variant G59A. Alanine is still less flexibility than glycine, though it is less sterically hindered than valine. 
Kinetic investigation of G59A showed a 150-fold decrease in kcat and catalytic efficiency in comparison 
to the wild type (Table 10). The KIE both on kcat and catalytic efficiency of that variant (KIE (kcat) = 2.1 ± 
0.1, KIE (kcat/KM) = 1.6 ± 0.2) showed that for G59A the decay of the enzyme:substrate complex is fast 
relative to the forward reaction. A possible explanation for the reduced kcat might be that the variant 
induces a distortion of the closed enzyme:substrate complex. However, as shown above, even the slow 
Y54F variant do not render substrate binding reversible. It appears more likely that the G59A variant 
destabilizes the closed loop conformation which allows reversible substrate binding, represented by 
the KIE on catalytic efficiency of G59A.  
 
3.4.3 Impact of the N63C Variant 
In order to further investigate destabilization of the closed form of the active site loop, we constructed 
the variant N63C. Asn63 is part of the loop, however this residue is about 9 Å distance apart from the 




active site (Figure 50). Asn63 forms a hydrogen bond to the side chain of Arg367 from chain C. 
Additionally Asn63 is connected to the backbone carbonyls of Arg367 and Ile377 from chain C via a 
crystallographic water (Figure 52). Arg367 interacts with Asp65 and Trp62, these two residues are 
located on the active site loop. Among ergothionase Asn63 is conserved, however not in MIO-
dependent ammonia-lyases (Figure 51).  
 
Figure 52. Close up view on the interactions of Asn63 and Arg367 in the crystal structure of TdETL (PDB: 6S7Q). The active 
site loop is colored in dark blue. Asn63, Asp65 and Trp62 are part of the loop. Figure 50 gives an overview of the position of 
Asn63 within the loop.  
 
Michaelis-Menten kinetics of N63C showed that kcat is reduced 350-fold in comparison to the wild type 
(Table 11). The dramatic effect of that variant seems surprising because Asn63 is not part of the active 
site of TdETL. Whereas, the great impact on catalysis of the N63C variant suggests that Asn63 might 
play a crucial role in stabilizing the closed conformation of the active site loop. 
Table 11. Observed kinetic parameters of TdETL WT and TdETL N63C at pH 7.5 and pH 9 using ergothioneine as substrate. 
   kcat [s-1]  KM [µM] kcat/KM [M-1s -1] 
pH 7.5 WT  64 ± 3 45 ± 4 1.4 x 106 
 N63C  0.18 ± 0.01 16 ± 3 1.2 x 104 
     
pH 9 WT 28 ± 2 25 ± 5 1.1 x 106 
 N63C  1.4 ± 0.1 25 ± 3 5.4 x 104  
 




In order to investigate this proposition, we determined the substrate KIE of the N63C variant. The 
observed KIE on both kcat (KIE = 2.4 ± 0.1) and on kcat/KM (KIE = 2.8 ± 0.1) at pH 7.5 shows that substrate 
binding is reversible and only C-H cleavage is rate-limiting (Table 12).  
Table 12. Observed substrate kinetic isotope effects (KIE) of TdETL N63C at pH 7.5 and pH 9 using ergothioneine as substrate. 
 KIE (kcat) KIE (kcat/ KM) 
N63C    pH 7.5 2.4 ± 0.1 2.8 ± 0.1 
N63C    pH 9 1.8 ± 0.1 1.3 ± 0.1 
 
A possible explanation is that the N63C variant destabilizes the closed loop conformation. As previously 
mentioned, Asn63 hydrogen bonds to Arg367. This hydrogen bond might stabilize the closed 
conformation of the active site loop. Since the thiol side chain of cysteine of N63C is a weak hydrogen 
bond acceptor, the stability of the closed loop conformation is reduced in the variant. Collectively, 
these results suggest that the N63C variant might allow reversible substrate binding through an open 
conformation of the active site loop.  
Additionally, the substrate KIE of the N63C variant at pH 9 was only significant on kcat (KIE = 1.8 ± 0.1) 
but not on kcat/KM (KIE = 1.3 ± 0.1) (Table 12). This finding can be rationalized because at pH 9, the 
introduced cysteine is mostly present in its thiolate form which forms a salt bridge to Arg367. This salt 
bridge stabilizes a closed loop conformation, similar as observed for the wild type enzyme (Figure 53). 
The influence on activity of the N63C variant at pH 9 also resembles more to the wild type and reduced 
kcat only 20-fold in contrast to the 350-fold activity reduction observed at pH 7.5 (Table 11).  
 
Figure 53. Interaction between Asn63 and Arg367 in the wild type enzyme (left) and the influence of the variant N63C on the 
interaction with Arg367 at pH 9 (middle) and pH 7.5 (right). The schematic active site loop is depicted in blue. 
 
We further investigated the solvent KSIE of N63C at pH 7.5 (KSIE (kcat) = 1.1 ± 0.1; KSIE (kcat/KM) = 1.4 ± 


























trimethylamine, however interpretation of solvent isotope effects needed to be handled with care. 
The solvent KIE of the N63C variant could be off-set due to the isotope effect on the pKa of the thiol 
because D2O might lower the pKa of the thiol. 
In conclusion, the G59A variant and the N63C variant at pH 7.5 enabled reversible substrate binding 
due to destabilization of the closed loop-conformation. However, we have to consider that these 
results were based on kinetic data and molecular dynamics simulations may be necessary to predict 
the behavior of the loop domain in detail. Furthermore, a crystal structure of the N63C variant would 
be interesting for studying the orientation and possible interactions of the cysteine residue. 
 
3.5 Occurrence of Ergothionase 
Based on the presented characterization of TdETL, we identified four residues, which are crucial for 
the degradation of ergothioneine and ergothioneine sulfonic acid (Tyr54, Lys64, Lys384, Glu412). We 
ran a UniProt database search and found around 300 homologue proteins with strict conservation of 
these four residues. These proteins are encoded by proteobacteria (185), firmicutes (77), synergistetes 
(19), and miscellaneous species from other phyla (Table 16). This group includes many species of 
gastrointestinal bacteria, such as Blautia spp., Campylobacter spp., Clostridium spp., Escherichia spp., 
Paenibacillus spp., and Peptoniphilus spp. The occurrence of ergothionase in the gastrointestinal 
system shows that ergothioneine degradation in the gut is widely distributed. This finding is in 
particular interesting because ergothioneine is recognized as an important micronutrient for humans 
that protects against inflammatory, cardiovascular or infective disease, cancer and 
neurodegeneration.[116] Whereas, ergothionase-mediated degradation of ergothioneine leads to the 
emergence of trimethylamine and the corresponding oxidative degradation product trimethylamine 
N-oxide. These degradative products are associated with atherosclerosis and severe cardiovascular 
diseases.[153–155] Our finding of ergothioneine degradation in the gut microbiome therefore questions 
the medical benefit of ergothioneine uptake.  
 
3.6 Identification of a New Ergothioneine Sulfonic Acid Lyase 
Beside the described ergothionase, we also worked on a related lyase from Martelella endophytica 
(MeLyase). MeLyase and TdETL share over 45% sequence similarity and the catalytic important 
residues Tyr54, Lys384 and Glu412 (counting based on TdETL) are conserved. Therefore, we suggest 
that both enzymes run the elimination reaction through a similar mechanism.  




However, investigation on substrate specificity showed only barely turnover of ergothioneine (Table 
13). The main substrate of MeLyase is ergothioneine sulfonic acid (kcat = 12 s-1, kcat/KM = 3.2 x 104 M-1s-
1) (Figure 54). The second best found substrate was S-methyl ergothioneine. All other tested 
compounds show negligible slow turnover by MeLyase (Table 13).  
Table 13. Observed activity of MeLyase on different substrates in HEPES buffer at pH 7.5 using 2 mM substrate. 
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Figure 54. Catalyzed reaction of ergothioneine sulfonic acid lyase. 
 
A sequence alignment of MeLyase and ergothionases revealed that His84 (TdETL counting) is not 
present in MeLyase (Figure 55). Instead, MeLyase has an arginine on this position (Arg87, MeLyase 
counting). Histidine ammonia-lyases have a conserved histidine residue, which is suggested to be 
involved in zinc-dependent binding and orienting of the imidazole moiety of the substrate.[142] 
Mutation of this histidine to leucine in PpHAL caused a complete loss in activity. In tyrosine ammonia-
lyases a His-Leu dyad at the equivalent position is important for substrate specificity.[56] The mutation 
of histidine to phenylalanine in RsTAL shifted TAL activity towards PAL activity.  
 
Figure 55. Abbreviated sequence alignment of the ergothionases TdETL and BpETL and ergothioneine sulfonic acid lyase of 
Martelella endophytica (MeLyase). The catalytic important residues for ergothionase activity are highlighted in turquoise, the 
conserved Arg residue for class-3 lyase activity is highlighted in orange. Counting based on TdETL. 
For TdETL, His84 works as a hydrogen bond donor to Nτ of the imidazole moiety of the substrate (Figure 
40). Hence, His84 participates in the stabilization of the crucial zwitterionic charge separation within 
the substrate during catalysis. Due to the cationic Arg87 in MeLyase, ergothioneine cannot bind in the 
        54    84    384    412 
TdETL  ...KPVYGLNR...LLNSHCLGV...GTIQKTFTM...GTIEDHAS... 
BpETL  ...QQIYGLTV...LIHAHSGSV...GAMEKPPTA...GGIEDIAT... 
MeLyase ...KPVYGLTT...VPQARAVGV...ATVQKTVSA...DGVEDHAS... 




cationic imidazolium state. Since the zwitterionic side chain of ergothioneine is crucial for catalysis, 
MeLyase is barely active on ergothioneine. Whereas, the anionic head group of ergothioneine sulfonic 
acid can bind to Arg87, and thus allows turnover.  
A UniProt database search suggested around 170 homologue lyases that possess a conserved arginine 
residue, in addition to the important catalytic residues, Tyr54, Lys384, Glu412 (counting based on 
TdETL). Interestingly around 75% of these lyases belong to a family of rhizobia bacteria (Table 17). 
Rhizobia are aerobic, diazotrophic gram-negative bacteria that live symbiotically in roots nodules of 
plants, where they are responsible for N2 fixation.[156]  
In contrast, ergothionase mainly occurred in gut bacteria as outlined above (section 3.5). The different 
environment of the bacteria producing ergothionase or ergothioneine sulfonic acid lyases underlines 
that both lyases occur in a different type of bacteria. Ergothioneine sulfonic acid is an important 
metabolite of ergothioneine that emerges upon non-enzymatic oxidation of ergothioneine. We 
suggest that bacteria diverged to use ergothioneine sulfonic acid because of its availability in an 









This chapter outlined the key principles in the mechanism of ergothionase. Ergothionase catalyzes the 
first degradation step of ergothioneine, namely the elimination of the trimethylamine group, resulting 
in the formation of unsaturated thiourocanic acid. In the first part of this chapter, we outlined the acid-
base dependent mechanism: the enzyme possesses a conserved tyrosine residue as base to abstract 
the β-proton of the substrate and a conserved glutamate and lysine residue to protonate the leaving 
group trimethylamine. In the second part of this chapter, we examined the substrate activation 
strategy of TdETL. The enzyme stabilizes the polarized form of ergothioneine as thiolate and 
imidazolium. The cationic imidazolium in vicinity to the β-position increases the acidity of the β-proton 
of the substrate which facilitates β-C-H-bond cleavage. Additionally, TdETL activates the leaving group 
through desolvation by binding the trimethylammonium group in an apolar pocket. The third part of 
the chapter focused on the loop, covering the active site of the enzyme. The absence of a KIE on kcat/KM 
suggests partially irreversible substrate binding. Replacement of a glycine residue within the loop by a 
more rigid alanine residue renders substrate binding reversible due to destabilization of the closed 
loop conformation. Furthermore, replacement of an asparagine with a cysteine residue within the loop 
enabled pH-dependent opening and closing of the active site loop. The finding that ergothionase is 
mainly produced by gut bacteria suggests that bacterial ergothioneine degradation should be 
considered while determining the availability and distribution of dietary ergothioneine in human 
tissues. Additionally, we identified a related new lyase that is responsible for ergothioneine sulfonic 









Recombinant Protein Production and Purification. The synthetic genes of tdetl wild type and variants 
were purchased from BioCat GmbH encoded on a pET28 plasmid. The gene of bpetl was already 
recloned without its leader sequence in a pET28 plasmid equipped with C-terminal His-tag in a previous 
work in our lab.  
For gene expression, the plasmids were transformed into CaCl2 competent E.coli BL21(DE3). In case of 
bpetl, the plasmid was transformed into CaCl2 competent E.coli BL21(DE3) coexpressing molecular 
chaperones. Cells were grown at 37 °C in LB-medium supplemented with kanamycin (50 µg/mL), 
chloramphenicol (34 µg/mL) and in case of bpetl additionally ampicillin (100 µg/mL). As soon as optical 
density reached OD600 0.6, isopropyl-β-D-thiogalactopyranosid (0.1 mM) was added. The cultures were 
incubated for either 4 h at 37 °C or 16 h at 18 °C. Cells were harvested by centrifugation (20 min, 
15000 x g) and the pellet was stored at -20 °C.  
Frozen cell-pellet was lysed by sonication (Sonifier 250, Branson) in lysis buffer (300 mM NaCl, 50 mM 
Na2HPO4 pH 8). Cell debris was removed by centrifugation (1 h, 80000 x g). The soluble protein was 
purified by Ni2+ NTA affinity chromatography (Qiagen). Proteins were washed using increasing 
concentrations of imidazole (10 mM, 20 mM) in lysis buffer, afterwards purified protein was eluted by 
lysis buffer supplemented with 250 mM imidazole. The protein was dialyzed into Tris-HCl (50 mM, 
pH 8) and NaCl (50 mM). Protein concentration was determined by UV at 280 nm (Nanodrop2000, 
Thermo Scientific) using the calculated extinction coefficient.[157] Protein homogeneity was assessed 
by SDS-PAGE. 
 
   
Figure 56. SDS-PAGE of the purified proteins TdETL WT, Y54F, K64M, E412Q (left gel, lane 2-5), K384M (middle gel, lane 2), 





































In order to confirm the sequence of TdETL WT, the protein was digested using 0.8 mg/mL TdETL WT 
was incubated with 0.08 mg/mL Chymotrypsin in Tris-HCl (50 mM, pH 8) for 16 h. The digested 
fragments were analysed by UPLC-HR-ESI-MS (Bruker, maXis II ESI-TOF). 
Table 14. Chymotryptic fragments of TdETL WT.  
Fragment Expected mass [m/z] Observed mass [m/z] 
NNRQVKISDDAEERVKKARQIL 2610.4434 2610.4673 
REDVNAVRGIKGQIKAAEM 2085.1233 2085.1432 
NTTDDNPCIIIDEHSSF 1920.8280 1920.8413 
GVKPYHPDEQVRAIL 1721.9333 1721.9868 
NEDRNISRDIETM 1592.7333 1592.7028 
GSSHHHHHHSSGL 1416.6264 1416.612 
AGTIEDHASNLPL 1337.6695 1337.6463 
RSSIGEGDITTL 1248.6430 1248.6201 
SIVSCNAQGEAM 1209.5238 1209.5173 
TPQDVKTIAF 1119.6044 1119.6113 
RCAHSVNGTM 1075.4771 1075.4811 
TGHTGISAEL 985.4949 985.4771 
GIHPRIPM 920.5134 920.5142 
DPDPERAL 912.4421 912.4428 
IGEEDVSF 895.4043 895.3879 
IREVLPF 873.5192 873.5035 
GEGTKKAY 853.4414 853.4546 
HAAQAIDL 838.4417 838.4263 
AAEGKPVY 834.4356 834.4198 
DTQNRGL 803.4006 803.392 
GTIQKTF 794.4407 794.4312 
VPRGSHM 783.3930 783.373 
NKDKEF 780.3886 780.3749 
IIGIEAM 746.4117 746.3974 
KEIEDL 746.3930 746.3974 
IKSKKL 716.5029 716.5086 
NGVVQSL 716.3937 716.3959 




RGNKKL 715.4573 715.4628 
NRGVGW 688.3525 688.3573 
SKTSCY 688.2970 688.3031 
DNIRY 680.3362 680.3368 
NSKKAM 678.3603 678.3639 
VREQL 644.3726 644.3678 
AIGVEM 619.3119 619.2999 
ANPSSM 606.2552 606.2601 
GPKDGL 586.3195 586.3116 
NSHCL 573.2449 573.2353 
NGEIM 563.2494 563.2379 
EITSL 562.3082 562.2969 
KPAKL 556.3817 556.3706 
CREF 554.2391 554.2474 
VSANF 537.2667 537.2561 
ADPSF 536.2351 536.2312 
SHIGL 526.2983 526.2877 
EDVY 525.2191 525.2288 
DEDF 525.1827 525.1904 
EKAGL 517.2980 517.2957 
TAIVL 516.3391 516.3286 
NRNL 516.2889 516.2878 




Figure 57. SDS-PAGE analysis of the purified protein B.pseudomallei ETL (lane 2). Lane 1 shows the protein standard (Precision 
Plus Protein Standard, Bio-Rad). 































The mass of the purified protein BpETL was determined on a Bruker maXis II ESI-TOF coupled to 
Shimadzu Nexera-X2 equipped with a Phenomex C4 column (Jupiter, 300A, 50 x 2 mm, 5 Microns). 
MWobs = 56236 Da  
MWexp (BpETL WT) = 56206 Da  
MWexp (BpETL A189T) = 56236 Da  
The observed mass difference to the initial expected mass of BpETL WT was 30 Da. Renewed 
sequencing of bpetl revealed the mutation A189T. Considering the mutation the observed mass is 
correct. As Ala189 is not conserved in ergothionases we assume the mutation does not affect activity. 
 
 
Figure 58. SDS-PAGE analysis of the purified protein S.jonesii ETL (lane 2 and lane 3). Lane 1 shows the protein standard 
(Precision Plus Protein Standard, Bio-Rad). 
 




































Figure 59. SDS-PAGE analysis of the purified protein MeLyase (lane 2). Lane 1 shows the protein standard (Precision Plus 
Protein Standard, Bio-Rad). 
 










Reagents. Ergothioneine, desmethyl-ergothioneine, S-methyl ergothioneine and trimethylhistidine 
were synthesized by David Lim.  
Ergothioneine sulfonic acid and desmethyl-ergothioneine sulfonic acid were obtained from 
Tetrahedron (http://www.tetrahedron.fr). 
Deuterated N--trimethylhistidine (D5, 98%; 15N3, 98%; ReseaChem GmbH) was converted to 
deuterated ergothioneine by using the enzyme EanB.(Burn et al., 2017) For this purpose, 5 mM TMH 

























(100 mM, pH 8) and NaCl (100 mM). Both TMH and deuterated TMH were used as substrate and 
treated equally. Finally, EanB was denaturated by heat-shock and precipitated protein as well as 
precipitated sulfur was removed by centrifugation. The purity and concentration of both ergothioneine 
and deuterated ergothioneine was examined by ion-exchange chromatography (Figure 60). MS: m/z 
calc. for C9H16N3O2S [M]+ 230.10, found 230.15. m/z calc. for C9H12D415N3O2S [M]+ 237.12, found 237.15. 












 1 mM Ergothioneine
 1 mM  deut.-Ergothioneine
  
Figure 60. Ion-Exchange HPLC Chromatogram of 1 mM deuterated and 1 mM non-deuterated ergothioneine recorded at 
265 nm. 
 
Product Identification. The products formed during the elimination reaction were analyzed by ESI-MS 
(Bruker Esquire3000plus). 
Thiourocanic acid: [M+H]+calc .= 171.01, [M+H]+obs. = 171.02 
Sulfono urocanic acid: [M+H]+calc. = 219.00, [M+H]+obs. = 219.10 
S-methyl urocanic acid: [M+H]+calc. = 185.03, [M+H]+obs. = 185.10 








pH-Dependence of TdETL WT 












 = 1.7 ± 0.1 1/s
K
M






























 = 2.8 ± 0.1 1/s
K
M































 = 6.1 ± 0.1 1/s
K
M






























 = 13 ± 2 1/s
K
M
































 = 36 ± 2 1/s
K
M






























 = 56 ± 2 1/s
K
M



































 = 64 ± 2 1/s
K
M






























 = 61 ± 6 1/s
K
M

































 = 43 ± 2 1/s
K
M



















[Ergothioneine] (M)  









 = 28 ± 2 1/s
K
M



















[Ergothioneine] (M)  










 = 12 ± 1 1/s
K
M



















[Ergothioneine] (M)  
Figure 61. Michaelis-Menten Kinetics of TdETL WT at pH 4.5 – pH 9.5. A buffer solution containing 40 mM acetic acid, 40 mM 
boric acid and 40 mM phosphoric acid (BR-buffer) was adjusted with NaOH to the desired pH. Ergothioneine substrate 
concentration was in between 2 µM and 250 µM. Enzyme concentration was in between 0.01 µM and 0.2 µM. Formation of 
the product thiourocanic acid at 23 °C was monitored using the spectrophotometer (Variant Cary 300 UV-Vis 
spectrophotometer). ε311 nm (thiourocanic acid) = 22500 M-1cm-1. 
 
 




pH-Dependence of BpETL 















pKa1 = 5.3 ± 0.3 
pKa2  = 6.8 ± 0.3
 






















pKa1 = 5.9 ± 0.3 
pKa2  = 6.2 ± 0.3
 
Figure 62. pH-Dependent kcat and kcat/KM values of BpETL WT. pH dependent kinetic parameters were fitted to y = kHA/ 
(1+10(pKa1-pH) + 10(pH-pKa2)). 
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kcat = 3.4 ± 0.1 1/s
KM = 0.30 ± 0.05 mM

















kcat = 1.3 ± 0.1 1/s
KM = 0.33 ± 0.06 mM



















kcat = 0.17 ± 0.01 1/s
KM = 1.6 ± 0.3 mM
















kcat = 0.05 ± 0.003 1/s
KM = 3.5 ± 0.6 mM












Figure 63. Michaelis-Menten Kinetics of BpETL WT at pH 4.5 – pH 8. A buffer solution containing 40 mM acetic acid, 40 mM 
boric acid and 40 mM phosphoric acid (BR-buffer) was adjusted with NaOH to the desired pH. Ergothioneine substrate 
concentration was in between 0.1 mM and 20 mM. Enzyme concentration was in between 0. 1 µM and 1 µM. Formation of 
the product thiourocanic acid at 23 °C was monitored using the spectrophotometer (Variant Cary 300 UV-Vis 
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Figure 64. Michaelis-Menten Kinetics of TdETL WT, Y54F, K64M, E412Q, K384M at pH 7.5. Ergothioneine substrate 
concentration was in between 1 µM and 1000 µM. Enzyme concentration was 2 µM for Y54F, E412Q and K384M and 
0.2 µM for K64M. Formation of the product thiourocanic acid at 23 °C was monitored using the spectrophotometer (Variant 
Cary 300 UV-Vis spectrophotometer). ε311nm (thiourocanic acid) = 22500 M-1cm-1. 
  




pH-Dependence of TdETL K64M 







kcat = 0.018 ± 0.001 1/s
KM = 0.45 ± 0.01 µM


















kcat = 0.059 ± 0.002 1/s
KM = 0.67 ± 0.09 µM



















kcat = 0.11 ± 0.01 1/s
KM = 1.0 ± 0.1 µM




















kcat = 0.72 ± 0.03 1/s
KM = 4.8 ± 0.8 µM


















kcat = 1.1 ± 0.1 1/s
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kcat = 1.1 ± 0.1 1/s
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kcat = 0.80 ± 0.03 1/s
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kcat = 0.37 ± 0.01 1/s
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kcat = 0.24 ± 0.01 1/s
KM = 26 ± 2 µM












Figure 65. Michaelis-Menten Kinetics of TdETL K64M at pH 5.5 – pH 10.5. A buffer solution containing 40 mM acetic acid, 
40 mM boric acid and 40 mM phosphoric acid (BR-buffer) was adjusted with NaOH to the desired pH. Ergothioneine substrate 
concentration was in between 0.5 µM and 160 µM. Enzyme concentration was in between 0.2 µM and 0.5 µM. Formation of 
the product thiourocanic acid at 23 °C was monitored using the spectrophotometer (Variant Cary 300 UV-Vis 
spectrophotometer). ε311 nm (thiourocanic acid) = 22500 M-1cm-1. 
 
 
Substrate specificity. Substrate specificity was monitored in HEPES buffer at pH 7.5 using 2 mM of 
substrate by measuring the rate of product formation at 23 °C in a 1 cm quartz cuvette using a Variant 
Cary 300 UV-Vis spectrophotometer. If the activity was too low to determine Michaelis-Menten 
kinetics, enzyme concentration of 5 µM was used to follow turnover. ε311.(thiourocanic 
acid) = 22500 M-1cm-1; ε295.(urocanic acid, pH 7.5) = 38565 M-1cm-1, ε295.(sulfono thiourocanic 
acid) = 15890 M-1cm-1; ε295.(S-methyl thiourocanic acid) = 12170 M-1cm-1. 
 
















 = 17 ± 1 1/s
K
M






























 = 0.003 ± 0.001 1/s
K
M


















[Egt-Sulfonicacid] (M)  








 = 0.002 ± 0.001 1/s
K
M





























 = 0.005 ± 0.001 1/s
K
M
















[Egt-Sulfonicacid] (M)  
Figure 66. Michaelis-Menten Kinetics of TdETL WT (upper left), Y54F (upper right), E412Q (lower left), K384M (lower right). 
Ergothioneine sulfonic acid substrate concentration was in between 1 µM and 5000 µM. Enzyme concentration was 0.02 µM 
for WT and 4 µM for Y54F, E412Q and K384M. Formation of the product was monitored using the spectrophotometer (Variant 
Cary 300 UV-Vis spectrophotometer). ε295nm (sulfono thiourocanic acid) = 15890 M-1cm-1. 
 









kcat = 0.33 ± 0.01 1/s
KM = 110 ± 15 µM












Figure 67. Michaelis-Menten Kinetics of BpETL WT. Ergothioneine sulfonic acid substrate concentration was in between 
20 µM and 800 µM. Enzyme concentration was 1 µM. Formation of the product was monitored using the spectrophotometer 
(Variant Cary 300 UV-Vis spectrophotometer). ε295nm (sulfono thiourocanic acid) = 15890 M-1cm-1. 











Ki = 204 M
250 M DM-Ergo
kcat = 58 ± 2 1/s
KM = 100 ± 10 µM



















Ki = 256 M
500 M DM-Ergo
kcat = 86 ± 3 1/s
KM = 130 ± 10 µM



















Ki = 263 M
1000 uM DM-Ergo
kcat = 79 ± 5 1/s
KM = 220 ± 40 µM


















Ki = 270 M
1500 M DM-Ergo
kcat = 64 ± 4 1/s
KM = 300 ± 50 µM



















Ki = 250 M
2000 M DM-Ergo
kcat = 81 ± 3 1/s
KM = 400 ± 40 µM
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Figure 68. Michaelis-Menten Kinetics of TdETL WT in HEPES buffer at pH 7.5 using ergothioneine as substrate in the presence 
of 250 - 2000 µM desmethyl ergothioneine. Formation of the product was monitored using the spectrophotometer (Variant 
Cary 300 UV-Vis spectrophotometer). ε311.(thiourocanic acid) = 22500 M-1cm-1. Desmethyl-ergothioneine inhibits TdETL in a 
competitive model with ergothioneine. Obtained kinetic data were fit to  =
∗[]
(.) 
. Ki (desmethyl ergothioneine) = 
249 ± 23 µM. 
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Figure 69. Michaelis-Menten Kinetics of TdETL WT in HEPES buffer at pH 7.5 using ergothioneine (left figures) or deuterated 
ergothioneine (right figures) as substrate. Deuterated histidine (D5, 98%; 15N3, 98%; ReseaChem GmbH) was converted to 
deuterated N-α-trimethyl histidine according to the published protocol.[158] Deuterated N-α-trimethyl histidine was converted 
to deuterated ergothioneine using the enzyme EanB.[105] Substrate concentration was in between 5 µM and 300 µM. Enzyme 
concentration was 0.01 µM. Formation of the product was monitored using the spectrophotometer (Variant Cary 300 UV-Vis 
spectrophotometer). ε311.(thiourocanic acid, pH 7.5) = 22500 M-1cm-1.  
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Figure 70. Michaelis-Menten Kinetics of TdETL WT at pH 7.5 using HEPES buffer in H2O (left graph) or D2O (right graph). The 
pH of the buffer was adjusted to 7.5 for the reaction in H2O and to 7.10 for the reaction in D2O. Both buffers were lyophilized 
and dissolved in H2O or D2O, respectively. Ergothioneine substrate concentration was in between 5 µM and 500 µM. Enzyme 
concentration was 0.01 µM. Formation of the product thiourocanic acid at 23 °C was monitored using the spectrophotometer 
(Variant Cary 300 UV-Vis spectrophotometer). ε311.(thiourocanic acid) = 22500 M-1cm-1. KSIE (kcat) = 1.7 ± 0.1; KSIE (kcat/KM) = 
1.2 ± 0.1. 
 
 
Kinetic solvent isotope effect using deuterated ergothioneine as substrate. To determine the kinetic 
solvent isotope effect of TdETL WT using deuterated ergothioneine as substrate turnover at pH 7.5 in 
HEPES buffer in H2O or D2O was followed. The pH of the buffer was adjusted to 7.5 for the reaction in 
H2O and to 7.10 for the reaction in D2O. Both buffers were lyophilized and dissolved in H2O or D2O, 
respectively. 200 µM ergothioneine or deuterated ergothioneine were used as substrate. Deuterated 
histidine (D5, 98%; 15N3, 98%; ReseaChem GmbH) was converted to deuterated TMH according to the 
published protocol.[158] Deuterated TMH was converted to deuterated ergothioneine using the enzyme 
EanB.[105] The reaction rates were determined by following product formation at 23 °C using the 
spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). ε311.(thiourocanic 
acid) = 22500 M-1cm-1. The ratio 
   !2#
   $2#
  presents the kinetic solvent isotope effect. KSIE = 1.0 ± 0.2. 
 




















kcat = 70 ± 3 1/s
KM = 65 ± 6 µM




















kcat = 53 ± 3 1/s
KM = 51 ± 7 µM




Figure 71. Substrate isotope effect of TdETL WT at pH 7.5 in HEPES buffer in D2O using ergothioneine or deuterated 
ergothioneine as substrate. Deuterated histidine (D5, 98%; 15N3, 98%; ReseaChem GmbH) was converted to deuterated N-α-
trimethyl histidine according to the published protocol.[158] Deuterated N-α-trimethyl histidine was converted to deuterated 
ergothioneine using the enzyme EanB.[105] The pH of the buffer was adjusted to 7.10, lyophilized and dissolved in D2O (final 
pD 7.5). Formation of the product was monitored using the spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). 
ε311.(thiourocanic acid) = 22500 M-1cm-1. KIE (kcat) = 1.3 ± 0.2; KIE (kcat/KM) = 1.0 ± 0.3. 
 















kcat = 0.012 ± 0.001 1/s
KM = 63 ± 8 µM
kcat / KM = 197 M
-1s-1
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kcat = 0.009 ± 0.001 1/s
KM = 49 ± 6 µM




Figure 72. Michaelis-Menten Kinetics of TdETL Y54F at pH 7.5 using HEPES buffer in H2O (left graph) or D2O (right graph). The 
pH of the buffer was adjusted to 7.5 for the reaction in H2O and to 7.10 for the reaction in D2O. Both buffers were lyophilized 
and dissolved in H2O or D2O, respectively. Ergothioneine substrate concentration was in between 5 µM and 200 µM. Enzyme 
concentration was 2 µM. Formation of the product thiourocanic acid at 23 °C was monitored using the spectrophotometer 
(Variant Cary 300 UV-Vis spectrophotometer). ε311.(thiourocanic acid) = 22500 M-1cm-1. KSIE (kcat) = 1.3 ± 0.1; KSIE (kcat/KM) = 
1.0 ± 0.1. 









kcat = 0.074 ± 0.004 1/s
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kcat = 0.076 ± 0.004 1/s
KM = 380 ± 50 µM
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Figure 73. Michaelis-Menten Kinetics of TdETL E412Q at pH 7.5 using HEPES buffer in H2O (left graph) or D2O (right graph). 
The pH of the buffer was adjusted to 7.5 for the reaction in H2O and to 7.10 for the reaction in D2O. Both buffers were 
lyophilized and dissolved in H2O or D2O, respectively. Ergothioneine substrate concentration was in between 50 µM and 
2000 µM. Enzyme concentration was 2 µM. Formation of the product thiourocanic acid at 23 °C was monitored using the 
spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). ε311.(thiourocanic acid) = 22500 M-1cm-1. KSIE (kcat) = 1.0 ± 
0.1; KSIE (kcat/KM) = 0.8 ± 0.1. 
 















kcat = 0.006 ± 0.001 1/s
KM = 35 ± 4 µM
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Figure 74. Michaelis-Menten Kinetics of TdETL K384M at pH 7.5 using HEPES buffer in H2O (left graph) or D2O (right graph). 
The pH of the buffer was adjusted to 7.5 for the reaction in H2O and to 7.10 for the reaction in D2O. Both buffers were 
lyophilized and dissolved in H2O or D2O, respectively. Ergothioneine substrate concentration was in between 5 µM and 
200 µM. Enzyme concentration was 2 µM. Formation of the product thiourocanic acid at 23 °C was monitored using the 
spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). ε311.(thiourocanic acid) = 22500 M-1cm-1. KSIE (kcat) = 1.5 ± 
0.1; KSIE (kcat/KM) = 1.0 ± 0.1. 
 
 




Table 15. Summary of the observed KSIE effects of TdETL WT and variants in HEPES buffer at pH 7.5 using ergothioneine as 
substrate.  
 KSIE (kcat) KSIE (kcat/ KM) 
TdETL WT 1.7 ± 0.1 1.2 ± 0.1 
TdETL Y54F 1.3 ± 0.1 1.0 ± 0.1 
TdETL E412Q 1.0 ± 0.1 0.8 ± 0.1 
TdETL K384M 1.5 ± 0.1 1.0 ± 0.1 
 
 














kcat = 0.0091 ± 0.0004 1/s
KM = 42 ± 6 µM
kcat / KM = 210 M
-1s-1
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kcat = 0.0045 ± 0.0001 1/s
KM = 25 ± 1 µM




Figure 75. Michaelis-Menten Kinetics of TdETL Y54F in HEPES buffer at pH 7.5 using ergothioneine (left figures) or deuterated 
ergothioneine (right figures) as substrate. Deuterated histidine (D5, 98%; 15N3, 98%; ReseaChem GmbH) was converted to 
deuterated N-α-trimethyl histidine according to the published protocol.[158] Deuterated N-α-trimethyl histidine was converted 
to deuterated ergothioneine using the enzyme EanB.[105] Substrate concentration was in between 5 µM and 200 µM. Enzyme 
concentration was 2 µM. Formation of the product thiourocanic acid at 23 °C was monitored using the spectrophotometer 
(Variant Cary 300 UV-Vis spectrophotometer). ε311.(thiourocanic acid, pH 7.5) = 22500 M-1cm-1. KIE (kcat) = 2.0 ± 0.2; KIE 
(kcat/KM) = 1.2 ± 0.1. 
 


















kcat = 0.44 ± 0.01 1/s
KM = 34 ± 2 µM
kcat / KM = 1.3 x 10
4 M-1s-1
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kcat = 0.11 ± 0.01 1/s
KM = 27 ± 4 µM












Figure 76. Michaelis-Menten Kinetics of TdETL G59A and G61A at pH 7.5. Ergothioneine substrate concentration was in 
between 5 µM and 200 µM. Enzyme concentration was 0.1 µM for G59A and 1 µM for G61A. Formation of the product 
thiourocanic acid at 23 °C was monitored using the spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). ε311nm 
(thiourocanic acid) = 22500 M-1cm-1.  
 














kcat = 0.44 ± 0.01 1/s
KM = 34 ± 2 µM



















kcat = 0.21 ± 0.01 1/s
KM = 24 ± 3 µM
kcat / KM = 8.5 x 10
3 M-1s-1
 
Figure 77. Michaelis-Menten Kinetics of TdETL G59A in HEPES buffer at pH 7.5 using ergothioneine (left figures) or deuterated 
ergothioneine (right figures) as substrate. Deuterated histidine (D5, 98%; 15N3, 98%; ReseaChem GmbH) was converted to 
deuterated N-α-trimethyl histidine according to the published protocol.[158] Deuterated N-α-trimethyl histidine was converted 
to deuterated ergothioneine using the enzyme EanB.[105] Substrate concentration was in between 5 µM and 200 µM. Enzyme 
concentration was 0.1 µM. Formation of the product thiourocanic acid at 23 °C was monitored using the spectrophotometer 
(Variant Cary 300 UV-Vis spectrophotometer). ε311.(thiourocanic acid, pH 7.5) = 22500 M-1cm-1. KIE (kcat) = 2.1 ± 0.1; KIE 
(kcat/KM) = 1.6 ± 0.2. 
 











kcat = 0.18 ± 0.01 1/s
KM = 16 ± 3 µM

















kcat = 0.078 ± 0.003 1/s
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Figure 78. Michaelis-Menten Kinetics of TdETL N63C in HEPES buffer at pH 7.5 using ergothioneine (left figures) or deuterated 
ergothioneine (right figures) as substrate. Deuterated histidine (D5, 98%; 15N3, 98%; ReseaChem GmbH) was converted to 
deuterated N-α-trimethyl histidine according to the published protocol.[158] Deuterated N-α-trimethyl histidine was converted 
to deuterated ergothioneine using the enzyme EanB.[105] Substrate concentration was in between 5 µM and 100 µM. Enzyme 
concentration was 0.1 µM. Formation of the product thiourocanic acid at 23 °C was monitored using the spectrophotometer 
(Variant Cary 300 UV-Vis spectrophotometer). ε311.(thiourocanic acid, pH 7.5) = 22500 M-1cm-1. KIE (kcat) = 2.4 ± 0.1; KIE 
(kcat/KM) = 2.8 ± 0.1. 
 








kcat = 1.4 ± 0.1 1/s
KM = 25 ± 3 µM






















kcat = 0.74 ± 0.02 1/s
KM = 18 ± 2 µM
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Figure 79. Michaelis-Menten Kinetics of TdETL N63C in BR-buffer (described above) at pH 9 using ergothioneine (left figures) 
or deuterated ergothioneine (right figures) as substrate. Deuterated histidine (D5, 98%; 15N3, 98%; ReseaChem GmbH) was 
converted to deuterated N-α-trimethyl histidine according to the published protocol.[158] Deuterated N-α-trimethyl histidine 
was converted to deuterated ergothioneine using the enzyme EanB.[105] Substrate concentration was in between 5 µM and 
100 µM. Enzyme concentration was 0.1 µM. Formation of the product thiourocanic acid at 23 °C was monitored using the 
spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). ε311.(thiourocanic acid, pH 7.5) = 22500 M-1cm-1. KIE (kcat) 
= 1.8 ± 0.1; KIE (kcat/KM) = 1.3 ± 0.1. 









kcat = 0.16 ± 0.01 1/s
KM = 21 ± 4 µM
















kcat = 0.15 ± 0.01 1/s
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Figure 80. Michaelis-Menten Kinetics of TdETL N63C at pH 7.5 using HEPES buffer in H2O (left graph) or D2O (right graph). The 
pH of the buffer was adjusted to 7.5 for the reaction in H2O and to 7.10 for the reaction in D2O. Both buffers were lyophilized 
and dissolved in H2O or D2O, respectively. Ergothioneine substrate concentration was in between 5 µM and 100 µM. Enzyme 
concentration was 0.1 µM. Formation of the product thiourocanic acid at 23 °C was monitored using the spectrophotometer 
(Variant Cary 300 UV-Vis spectrophotometer). ε311.(thiourocanic acid) = 22500 M-1cm-1. KSIE (kcat) = 1.1 ± 0.1; KSIE (kcat/KM) = 
1.4 ± 0.1. 
 
 
Table 16. Phylum, organism and accession number of putative ergothionase homologs. Homologs were found by creating a 
Sequence Similarity Network based on the UniProt database using TdETL sequence as an input sequence.[159] Conservation of 
the catalytic important residues Tyr54, Lys64, Lys384 and Glu412 was used as a requirement for putative ergothionases. 
Phylum Organism Accession Number 
Acidobacteria Acidobacteria bacterium. A0A2V9QRG7 
Bacteroidetes Microscilla marina ATCC 23134. A1ZWV6 
candidate division NC10 candidate division NC10 bacterium 
RIFCSPLOWO2_02_FULL_66_22. 
A0A1F4PYG1 
candidate division NC10 candidate division NC10 bacterium 
RIFCSPLOWO2_12_FULL_66_18. 
A0A1F4QK64 
Chlamydiae Chlamydia trachomatis. A0A0E9GAP9 
Chlamydiae Chlamydia trachomatis. A0A0E9EV04 
Cyanobacteria Leptolyngbya sp. PCC 7375. K9F598 
Cyanobacteria Leptolyngbya sp. PCC 7376. K9Q1N5 
Firmicutes Acidaminobacter hydrogenoformans DSM 2784. A0A1G5S0B1 
Firmicutes Anaeromicrobium sediminis. A0A267MKA2 
Firmicutes Anaerosphaera aminiphila DSM 21120. A0A1M5RMG5 




Firmicutes Anaerovirgula multivorans. A0A239I834 
Firmicutes Bacillus sp. FJAT-26390. A0A1B8W885 
Firmicutes Bacillus sp. FJAT-26390. A0A1B8WBJ0 
Firmicutes Bacillus sp. FJAT-27264. A0A1B8WEI8 
Firmicutes Bacillus sp. FJAT-27264. A0A1B8WEW0 
Firmicutes Blautia producta. A0A2S4GLB0 
Firmicutes Blautia producta. A0A2S4GMW9 
Firmicutes Blautia sp. YL58. A0A1C7I7W8 
Firmicutes Blautia sp. YL58. A0A1C7ICE6 
Firmicutes Candidatus Carbobacillus altaicus. A0A2R6Y2G9 
Firmicutes Clostridia bacterium BRH_c25. A0A101WNZ4 
Firmicutes Clostridium aceticum. A0A0D8I7S1 
Firmicutes Clostridium ljungdahlii. A0A162J9E2 
Firmicutes Clostridium sp. 7_3_54FAA. G5FFL7 
Firmicutes Clostridium sp. 7_3_54FAA. G5FEN4 
Firmicutes Clostridium sp. HMb25. A0A2N0KBS0 
Firmicutes Clostridium sp. HMP27. A0A099RQF7 
Firmicutes Clostridium symbiosum  A0A174CFW7 
Firmicutes Clostridium symbiosum  A0A174H5D0 
Firmicutes Clostridium symbiosum ATCC 14940. U2DAB6 
Firmicutes Clostridium symbiosum ATCC 14940. U2BTG2 
Firmicutes Clostridium symbiosum WAL-14163. E7GKQ7 
Firmicutes Clostridium symbiosum WAL-14163. E7GIG0 
Firmicutes Clostridium termitidis CT1112. S0FKX7 
Firmicutes Clostridium ultunense Esp. A0A1M4PLN0 
Firmicutes Cohnella kolymensis. A0A0C2UIY0 
Firmicutes Dethiosulfatibacter aminovorans DSM 17477. A0A1M6AAG9 
Firmicutes Dethiosulfatibacter aminovorans DSM 17477. A0A1M6G2C4 
Firmicutes Enterococcus malodoratus ATCC 43197. R2QJZ3 
Firmicutes Enterococcus malodoratus. A0A2X1LPU2 
Firmicutes Eubacterium yurii subsp. margaretiae ATCC 
43715. 
E0QHA3 
Firmicutes Firmicutes bacterium ASF500. V2XW62 
Firmicutes Firmicutes bacterium ASF500. V2YC09 




Firmicutes Firmicutes bacterium CAG:129_59_24. A0A1Q6QC58 
Firmicutes Firmicutes bacterium CAG:129_59_24. A0A1Q6QCM7 
Firmicutes Geosporobacter ferrireducens. A0A1D8GCM4 
Firmicutes Geosporobacter subterraneus DSM 17957. A0A1M6I960 
Firmicutes Maledivibacter halophilus. A0A1T5KZP2 
Firmicutes Maledivibacter halophilus. A0A1T5M9E4 
Firmicutes Natronincola ferrireducens. A0A1G9HD03 
Firmicutes Paenibacillus borealis. A0A089MKG9 
Firmicutes Paenibacillus durus  A0A089HJ17 
Firmicutes Paenibacillus durus ATCC 35681. A0A0F7CGW2 
Firmicutes Paenibacillus ferrarius. A0A1V4HLC4 
Firmicutes Paenibacillus naphthalenovorans. A0A0U2WFR1 
Firmicutes Paenibacillus riograndensis SBR5. A0A0E4HBC3 
Firmicutes Paenibacillus sabinae T27. X4ZXH0 
Firmicutes Paenibacillus sophorae. A0A1H8VQP4 
Firmicutes Paenibacillus sp. 276b. A0A1H4BIT9 
Firmicutes Paenibacillus sp. A59. A0A0M9BLP7 
Firmicutes Paenibacillus sp. FSL A5-0031. A0A1R1A1N6 
Firmicutes Paenibacillus sp. JCM 10914. V9GAF1 
Firmicutes Paenibacillus sp. LK1. A0A2G7M2N4 
Firmicutes Paenibacillus sp. OV191. A0A2V4W4F3 
Firmicutes Paenibacillus sp. Root444D2. A0A0Q7JBM1 
Firmicutes Paenibacillus sp. Soil724D2. A0A0Q9K4T2 
Firmicutes Peptoanaerobacter stomatis J5UPN6 
Firmicutes Peptoanaerobacter stomatis V9HLH1 
Firmicutes Peptoanaerobacter stomatis G9XE22 
Firmicutes Peptoniphilus asaccharolyticus DSM 20463. A0A1W1V430 
Firmicutes Peptoniphilus grossensis. A0A1U7M2E5 
Firmicutes Peptoniphilus indolicus ATCC 29427. G4D1P9 
Firmicutes Peptoniphilus sp. oral taxon 386 str. F0131. D7N6A3 
Firmicutes Peptostreptococcaceae bacterium AS15. G9WXX7 
Firmicutes Peptostreptococcaceae bacterium AS15. J4K8R1 
Firmicutes Seinonella peptonophila. A0A1M5AZW6 
Firmicutes Sporolactobacillus laevolacticus DSM 442. V6IXX0 




Firmicutes Sporomusa malonica. A0A1W2C325 
Firmicutes Sporomusa sphaeroides DSM 2875. A0A1U7MIZ9 
Firmicutes Thermotalea metallivorans. A0A140L7C4 
Firmicutes Tindallia californiensis. A0A1H3MI16 
Firmicutes uncultured Clostridium sp. A0A1C5ZVS6 
Firmicutes uncultured Clostridium sp. A0A1C6DS28 
Firmicutes uncultured Sporomusa sp. A0A212LUU0 
Fusobacteria Fusobacterium naviforme. A0A2P8EQ63 
Fusobacteria Fusobacterium nucleatum subsp. animalis 
11_3_2. 
F7L375 
Fusobacteria Fusobacterium nucleatum subsp. animalis 
11_3_2. 
F7L438 
Proteobacteria Achromobacter insolitus. A0A167CPW9 
Proteobacteria Achromobacter insuavis AXX-A. F7SYB1 
Proteobacteria Achromobacter insuavis AXX-A. F7SXG1 
Proteobacteria Achromobacter insuavis AXX-A. A0A1R1JQB7 
Proteobacteria Achromobacter marplatensis. A0A225NCR7 
Proteobacteria Achromobacter piechaudii HLE. J4PBZ7 
Proteobacteria Achromobacter pulmonis. A0A2N8KQ02 
Proteobacteria Achromobacter sp. A0A0M7EBE7 
Proteobacteria Achromobacter sp. A0A0M7K465 
Proteobacteria Achromobacter sp. A0A0M7MF41 
Proteobacteria Achromobacter xylosoxidans  (strain A8) E3HLA6 
Proteobacteria Achromobacter xylosoxidans  (strain A8) E3HNF8 
Proteobacteria Agrobacterium fabrum. A0A2W5FBK6 
Proteobacteria Agrobacterium genomosp. 13 str. CFBP 6927. A0A1S7R922 
Proteobacteria Agrobacterium genomosp. 13 str. CFBP 6927. A0A1S7RBP2 
Proteobacteria Agrobacterium genomosp. 3 str. CFBP 6623. A0A1S7RRC6 
Proteobacteria Agrobacterium genomosp. 5 str. CFBP 6626. A0A1S7RTM1 
Proteobacteria Agrobacterium genomosp. 7 str. NCPPB 1641. A0A1S7U7I5 
Proteobacteria Agrobacterium radiobacter DSM 30147. W1KKH8 
Proteobacteria Agrobacterium sp. LY4. A0A0X7A063 
Proteobacteria Agrobacterium sp. SUL3. A0A0L6K5Q8 
Proteobacteria Agrobacterium tumefaciens F2. F7UDC5 




Proteobacteria Albidiferax sp. OV413. A0A1H0SZU2 
Proteobacteria Alcaligenes xylosoxydans xylosoxydans  A0A0X8P1Z2 
Proteobacteria Alcaligenes xylosoxydans xylosoxydans  A0A109XXI6 
Proteobacteria Alcaligenes xylosoxydans xylosoxydans  A0A2T5CSE9 
Proteobacteria Alcaligenes xylosoxydans xylosoxydans 
(Achromobacter xylosoxidans) 
A0A0M7FW64 
Proteobacteria Alcaligenes xylosoxydans xylosoxydans 
(Achromobacter xylosoxidans) 
A0A0D6INA3 
Proteobacteria Arcobacter canalis. A0A2G1CWD0 
Proteobacteria Arcobacter halophilus. A0A2N1J1J7 
Proteobacteria Arcobacter marinus. A0A1T5CRN4 
Proteobacteria Arcobacter marinus. A0A2G1DA93 
Proteobacteria Bordetella genomosp. 2. A0A261VFK0 
Proteobacteria Bordetella genomosp. 6. A0A261VXL6 
Proteobacteria Bordetella trematum. A0A157K554 
Proteobacteria Bordetella trematum. A0A2X1CQS6 
Proteobacteria Budvicia aquatica. A0A2C6DUF4 
Proteobacteria Burkholderia cepacia  A0A0J5XFB7 
Proteobacteria Burkholderia cepacia JBK9. A0A118RZD7 
Proteobacteria Burkholderia lata  A0A1D7ZNJ2 
Proteobacteria Burkholderia lata  (strain 383) A0A105L8S8 
Proteobacteria Burkholderia lata  (strain ATCC 17760) Q390I8 
Proteobacteria Burkholderia lata  (strain DSM 23089 ) A0A102EIG2 
Proteobacteria Burkholderia lata  (strain LMG 22485) A0A2A4CJ37 
Proteobacteria Burkholderia lata  (strain NCIMB9086) A0A0U4D2I0 
Proteobacteria Burkholderia lata  (strain R18194) A0A2A9L6A5 
Proteobacteria Burkholderia pseudomallei  A0A095GPC0 
Proteobacteria Burkholderia pseudomallei  (strain 1026b) A0A0H3HQ18 
Proteobacteria Burkholderia pseudomallei  (strain 1106a) A3NVD9 
Proteobacteria Burkholderia pseudomallei  (strain 1710b) Q3JS71 
Proteobacteria Burkholderia pseudomallei  (strain K96243) Q63UD0 
Proteobacteria Burkholderia pseudomallei 1710a. A0A0E1W8R9 
Proteobacteria Burkholderia pseudomallei 406e. A8EDJ4 
Proteobacteria Burkholderia pseudomallei 576. A0A0E1TYJ5 




Proteobacteria Burkholderia pseudomallei MSHR2543. A0A0F6GBL2 
Proteobacteria Burkholderia pseudomallei MSHR346. C4KLN0 
Proteobacteria Burkholderia pseudomallei MSHR4000. A0A0F6LB82 
Proteobacteria Burkholderia pseudomallei Pakistan 9. A0A0E1UJX7 
Proteobacteria Burkholderia pseudomallei S13. B1HJ69 
Proteobacteria Burkholderia puraquae. A0A084DNS9 
Proteobacteria Burkholderia pyrrocinia  A0A104NMV4 
Proteobacteria Burkholderia sp. D7. A0A2C9BBG5 
Proteobacteria Burkholderia sp. D7. A0A2C9BN69 
Proteobacteria Burkholderia sp. HME13. A0A1X1PNB3 
Proteobacteria Burkholderia sp. IDO3. A0A118HTM9 
Proteobacteria Burkholderia sp. JKS000303. K4PZA7 
Proteobacteria Burkholderia sp. KK1. A0A1B4PM34 
Proteobacteria Burkholderia sp. MSh2. A0A069B857 
Proteobacteria Burkholderia sp. PAMC 28687. A0A242N6D4 
Proteobacteria Burkholderia sp. RF2-non_BP3. A0A1P9XUU5 
Proteobacteria Burkholderia stabilis. A0A106PKF7 
Proteobacteria Burkholderia ubonensis. A0A103P858 
Proteobacteria Burkholderiales bacterium 1_1_47. D9Y3S2 
Proteobacteria Burkholderiales bacterium YL45. A0A1C7HL58 
Proteobacteria Caballeronia mineralivorans PML1 A0A0J1G0Q2 
Proteobacteria Caballeronia sordidicola. A0A242M5G6 
Proteobacteria Campylobacter blaseri. A0A2P8QZX2 
Proteobacteria Campylobacter fetus subsp. fetus  (strain 82-40) A0RMB1 
Proteobacteria Campylobacter fetus subsp. fetus. A0A0S4RNI9 
Proteobacteria Campylobacter fetus subsp. testudinum. A0A2S5J965 
Proteobacteria Campylobacter fetus subsp. venerealis 293. A0A2S0JAW0 
Proteobacteria Campylobacter fetus subsp. venerealis cfvi03. W0D8I6 
Proteobacteria Campylobacter geochelonis. A0A128EBH4 
Proteobacteria Campylobacter hyointestinalis subsp. 
hyointestinalis LMG 9260. 
A0A172SPB5 
Proteobacteria Campylobacter hyointestinalis subsp. 
hyointestinalis. 
A0A2X4P4V8 
Proteobacteria Campylobacter mucosalis. A0A071L8M5 




Proteobacteria Campylobacter pinnipediorum subsp. 
caledonicus. 
A0A1S6U835 
Proteobacteria Campylobacter pinnipediorum subsp. 
pinnipediorum. 
A0A1T2XPU7 
Proteobacteria Campylobacter rectus RM3267. B9CZV2 
Proteobacteria Campylobacter sp. FOBRC14. J4KTT0 
Proteobacteria Campylobacter subantarcticus LMG 24374. A0A0A8H9C0 
Proteobacteria Citrobacter freundii. A0A2T3RNW5 
Proteobacteria Citrobacter sp. 92. A0A2S4QF24 
Proteobacteria Citrobacter sp. 92. A0A212HFV8 
Proteobacteria Citrobacter sp. MGH106. A0A0J1PA51 
Proteobacteria Comamonas testosteroni  A0A096FCF7 
Proteobacteria Comamonas testosteroni  A0A096FDM7 
Proteobacteria Comamonas testosteroni  A0A1Y1JB67 
Proteobacteria Desulfovibrio bizertensis DSM 18034. A0A1T4VRQ5 
Proteobacteria Ensifer sojae CCBAU 05684. A0A249PKJ0 
Proteobacteria Enterobacteriaceae bacterium 9_2_54FAA. E5YH86 
Proteobacteria Enterobacteriaceae bacterium bta3-1. A0A0C5WBM2 
Proteobacteria Escherichia albertii B156. A0A1X3JQ66 
Proteobacteria Escherichia albertii KF1. W0AR86 
Proteobacteria Escherichia albertii. A0A2S6P482 
Proteobacteria Escherichia coli A0A210G163 
Proteobacteria Escherichia coli A0A2B7LL73 
Proteobacteria Escherichia coli A0A0A1A7N5 
Proteobacteria Escherichia coli A0A1D7PXJ9 
Proteobacteria Escherichia coli A0A1X0PKJ9 
Proteobacteria Escherichia coli O7:K1  (strain IAI39 / ExPEC) A0A0H3MF89 
Proteobacteria Escherichia coli O7:K1 str. CE10. A0A0E0V382 
Proteobacteria Escherichia coli. A0A1M2J2H7 
Proteobacteria Escherichia coli. A0A0K4JRR6 
Proteobacteria Escherichia coli. A0A2U2VEY5 
Proteobacteria Escherichia coli. A0A2W6P050 
Proteobacteria Escherichia sp. KTE159. S1MFV0 
Proteobacteria Escherichia sp. KTE52. S1CQE4 




Proteobacteria Escherichia sp. MOD1-EC5451. A0A2T3BIE5 
Proteobacteria Ferrimonas balearica  (strain DSM 9799 / CCM 
4581 / PAT) 
E1SV38 
Proteobacteria Ferrimonas sediminum. A0A1G8JY84 
Proteobacteria Gammaproteobacteria bacterium. A0A2G6ELY6 
Proteobacteria Gammaproteobacteria bacterium. A0A2G6LDZ9 
Proteobacteria Hafnia alvei ATCC 51873. G9Y7H0 
Proteobacteria Hafnia alvei. A0A1C6Z7N0 
Proteobacteria Hafnia paralvei. A0A2A2MDV2 
Proteobacteria Helicobacter sp. 11S03491-1. A0A268TFD6 
Proteobacteria Klebsiella oxytoca. A0A168VFH5 
Proteobacteria Legionella clemsonensis. A0A222P3S0 
Proteobacteria Legionella gratiana. A0A0W0UF88 
Proteobacteria Legionella maceachernii. A0A0W0WDX4 
Proteobacteria Leminorella grimontii ATCC 33999 = DSM 5078. A0A085HFJ0 
Proteobacteria Leminorella richardii. A0A2X4Y3V6 
Proteobacteria Morganella morganii  A0A2S1BA97 
Proteobacteria Morganella psychrotolerans. A0A1B8H210 
Proteobacteria Paraburkholderia sp. SOS3. A0A126YU72 
Proteobacteria Paraburkholderia sp. SOS3. A0A1L6HTZ5 
Proteobacteria Paracoccus denitrificans  (strain Pd 1222) A1B7U5 
Proteobacteria Paracoccus saliphilus. A0A1N7NBZ3 
Proteobacteria Parasutterella excrementihominis CAG:233. R5DY36 
Proteobacteria Parasutterella excrementihominis CAG:233. R5E7S4 
Proteobacteria Parasutterella excrementihominis YIT 11859. F3QJ16 
Proteobacteria Parasutterella excrementihominis YIT 11859. F3QK73 
Proteobacteria Polaromonas sp.  (strain JS666 / ATCC BAA-500) Q120I2 
Proteobacteria Polaromonas sp. OV174. A0A1I1LXE8 
Proteobacteria Polaromonas sp. YR568. A0A1I7KJA3 
Proteobacteria Proteobacteria bacterium CAG:139. R6A805 
Proteobacteria Proteobacteria bacterium CAG:139. R6A045 
Proteobacteria Providencia stuartii. A0A1S1HS62 
Proteobacteria Pseudomonas gingeri NCPPB 3146 = LMG 5327. A0A2K1FFU2 
Proteobacteria Pseudorhodoferax sp. Leaf274. A0A0S9MTX7 




Proteobacteria Ralstonia sp. MD27. A0A0J9E039 
Proteobacteria Raoultella terrigena  A0A1V2BU72 
Proteobacteria Rhizobium radiobacter  A0A024J059 
Proteobacteria Rhizobium sp. Root651. A0A0Q8FD29 
Proteobacteria Rhodoferax sp. YR267. A0A2U0YVW7 
Proteobacteria Serratia grimesii. A0A2H1LEX0 
Proteobacteria Serratia proteamaculans. A0A1W5DIY9 
Proteobacteria Serratia quinivorans. A0A2X2GG94 
Proteobacteria Serratia sp. LCN16. A0A0X2NZE9 
Proteobacteria Shewanella algae. A0A2T3H024 
Proteobacteria Shewanella benthica KT99. A9DB79 
Proteobacteria Shewanella bicestrii. A0A220UNI3 
Proteobacteria Shewanella chilikensis. A0A1S2TY49 
Proteobacteria Shewanella decolorationis S12. V1DE01 
Proteobacteria Shewanella halifaxensis  (strain HAW-EB4) B0TSP0 
Proteobacteria Shewanella loihica  (strain ATCC BAA-1088 / PV-
4) 
A3QF98 
Proteobacteria Shewanella oneidensis  (strain MR-1) Q8ECS5 
Proteobacteria Shewanella oneidensis. A0A2W5DPW1 
Proteobacteria Shewanella pealeana  (strain ATCC 700345 / 
ANG-SQ1) 
A8H7Z6 
Proteobacteria Shewanella putrefaciens  (strain ATCC BAA-453) A0A2V4W9E6 
Proteobacteria Shewanella putrefaciens  (strain CN-32) A4Y869 
Proteobacteria Shewanella sediminis  (strain HAW-EB3) A8FQ33 
Proteobacteria Shewanella sp.  (strain ANA-3) A0KVA5 
Proteobacteria Shewanella sp. cp20. A0A0C3LN95 
Proteobacteria Shewanella sp. FDAARGOS_354. A0A1Z4A7I0 
Proteobacteria Sinorhizobium meliloti  (strain BL225C) A0A0E0ULX2 
Proteobacteria Sinorhizobium meliloti  (strain SM11) F7XCM2 
Proteobacteria Stigmatella aurantiaca  (strain DW4/3-1) Q098W6 
Proteobacteria Stigmatella erecta. A0A1I0DHZ1 
Proteobacteria Sutterella sp. KLE1602. A0A139JRY8 
Proteobacteria Sutterella wadsworthensis 2_1_59BFAA. K1JY86 
Proteobacteria Tatlockia micdadei  A0A098GF27 




Proteobacteria Turicimonas muris. A0A227KGA2 
Proteobacteria Turicimonas muris. A0A227KSA1 
Spirochaetes Treponema denticola SP33. M2BPW8 
Spirochaetes Treponema phagedenis F0421. E7NQ07 
Spirochaetes Treponema phagedenis. A0A0B7GW92 
Synergistetes Acetomicrobium mobile  (strain ATCC BAA-54 / 
DSM 13181 / JCM 12221 /NGA) 
I4BXM9 
Synergistetes Aminomonas paucivorans DSM 12260. E3CYY6 
Synergistetes Cloacibacillus evryensis DSM 19522. A0A010YTQ8 
Synergistetes Cloacibacillus porcorum. A0A1B2I5L2 
Synergistetes Cloacibacillus sp. An23. A0A1Y4GEV9 
Synergistetes Cloacibacillus sp. An23. A0A1Y4GFU5 
Synergistetes Dethiosulfovibrio peptidovorans. A0A2G6M1E6 
Synergistetes Dethiosulfovibrio salsuginis. A0A1X7IZU0 
Synergistetes Synergistales bacterium 53_16. A0A117LMB5 
Synergistetes Synergistales bacterium 54_9. A0A101IRU6 
Synergistetes Synergistes jonesii. A0A073J785 
Synergistetes Synergistes sp. 3_1_syn1. G9PVB9 
Synergistetes Synergistes sp. 3_1_syn1. G9PXA9 
Synergistetes Synergistetes bacterium HGW-Synergistetes-1. A0A2N1QT95 
Synergistetes Thermanaerovibrio acidaminovorans  (strain 
ATCC 49978 / DSM 6589 /Su883) 
D1B828 
Synergistetes Thermanaerovibrio velox DSM 12556. H0UQM1 
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Figure 81. Michaelis-Menten Kinetics of Melyase. Substrate concentration of ergothioneine sulfonic acid was in between 
5 µM and 1000 µM. Enzyme concentration was 0.1 µM. Formation of the product was monitored using the 
spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). ε295 nm (sulfono urocanic acid) = 15890 M-1cm-1. 
 
 
Table 17. Phylum, Organism and Accession Number of putative ergothioneine sulfonic acid lyase homologs. Homologs were 
found by creating a Sequence Similarity Network based on the UniProt database using TdETL (accession number: 
WP_010693216) and Melyase sequence as an input sequence.[159] Conservation of the catalytic important residues Tyr57, 
Arg87 Lys387 and Glu415 (counting based on Melyase) was used as a requirement for putative ergothioneine sulfonic acid 
lyase. 
Phylum Organism Accession Number 
Actinobacteria Actinobacteria bacterium OK074. A0A0N0MKZ3 
Actinobacteria Prauserella muralis. A0A2V4AQF0 
Actinobacteria Streptomyces antibioticus. A0A101QGJ9 
Actinobacteria Streptomyces sp. A217. A0A2P8Q1V8 
Actinobacteria Streptomyces turgidiscabies Car8. L7F0I9 
Proteobacteria Acetobacter malorum. A0A149R7L7 
Proteobacteria Agrobacterium radiobacter  (strain K84 / ATCC BAA-
868) 
B9JID5 
Proteobacteria Agrobacterium rhizogenes NBRC 13257. A0A061MWB1 
Proteobacteria Agrobacterium rhizogenes. A0A071IL44 
Proteobacteria alpha proteobacterium BAL199. A8TQH4 
Proteobacteria Azospirillum lipoferum. A0A1X7QBK3 
Proteobacteria Azospirillum sp.  (strain B510) D3NYZ8 
Proteobacteria Azospirillum sp. TSH64. A0A2U1XFA2 




Proteobacteria Bosea lathyri. A0A1H6C5T1 
Proteobacteria Bosea lupini. A0A1H7TC09 
Proteobacteria Bosea sp. 1131. A0A2S4LY50 
Proteobacteria Bosea sp. 32-68-6. A0A258D5E3 
Proteobacteria Bosea sp. AAP35. A0A0N1BC31 
Proteobacteria Bosea sp. BIWAKO-01. A0A1E1V193 
Proteobacteria Bosea sp. LC85. A0A085EW28 
Proteobacteria Bosea sp. OK403. A0A1I3LXI4 
Proteobacteria Bosea sp. PAMC 26642. A0A126NXS9 
Proteobacteria Bosea sp. RAC05. A0A1B3NKD2 
Proteobacteria Bosea sp. Root483D1. A0A0Q9IUG3 
Proteobacteria Bosea vaviloviae. A0A0N0MC47 
Proteobacteria Bosea vaviloviae. A0A1D7TZ70 
Proteobacteria Brenneria sp. CFCC 11842. A0A2U1UCU2 
Proteobacteria Chelativorans sp.  (strain BNC1) Q11E25 
Proteobacteria Citrobacter koseri  A0A078LHJ6 
Proteobacteria Citrobacter koseri  A0A2X2VDX3 
Proteobacteria Citrobacter koseri  (strain ATCC BAA-895 / CDC 4225-
83 / SGSC4696) 
A8AKL9 
Proteobacteria Enterobacter sp. 10-1. A0A267RII3 
Proteobacteria Inquilinus limosus. A0A211ZTK6 
Proteobacteria Labrys okinawensis. A0A2S9Q4B1 
Proteobacteria Martelella endophytica. A0A0D5LLV5 
Proteobacteria Martelella mediterranea DSM 17316. A0A1U9Z848 
Proteobacteria Mesorhizobium amorphae CCNWGS0123. G6YBD2 
Proteobacteria Mesorhizobium amorphae. A0A2W4ZPB6 
Proteobacteria Mesorhizobium australicum  (strain HAMBI 3006 / 
LMG 24608 / WSM2073) 
L0KNI4 
Proteobacteria Mesorhizobium delmotii A0A2P9AXX8 
Proteobacteria Mesorhizobium helmanticense. A0A2T4IQA8 
Proteobacteria Mesorhizobium huakuii 7653R. A0A068D833 
Proteobacteria Mesorhizobium japonicum  (strain LMG 29417 / CECT 
9101 / MAFF 303099) 
Q98JY1 
Proteobacteria Mesorhizobium kowhaii. A0A2W7C9J0 




Proteobacteria Mesorhizobium mediterraneum. A0A271L823 
Proteobacteria Mesorhizobium opportunistum  (strain LMG 24607 / 
HAMBI 3007 / WSM2075) 
F7YDI3 
Proteobacteria Mesorhizobium plurifarium. A0A090DPU8 
Proteobacteria Mesorhizobium plurifarium. A0A090EV99 
Proteobacteria Mesorhizobium plurifarium. A0A090G9B6 
Proteobacteria Mesorhizobium plurifarium. A0A0K2VPB5 
Proteobacteria Mesorhizobium soli. A0A2P7RPK5 
Proteobacteria Mesorhizobium sp. 65-26. A0A1Q4AJQ3 
Proteobacteria Mesorhizobium sp. AA22. A0A1A5TAR8 
Proteobacteria Mesorhizobium sp. BSA136. A0A2A6FB12 
Proteobacteria Mesorhizobium sp. L103C105A0. X6KNW9 
Proteobacteria Mesorhizobium sp. L103C119B0. X6K8U6 
Proteobacteria Mesorhizobium sp. L103C120A0. V7HKF1 
Proteobacteria Mesorhizobium sp. L103C131B0. X6JI92 
Proteobacteria Mesorhizobium sp. L103C565B0. X6J8N5 
Proteobacteria Mesorhizobium sp. L2C054A000. X6IJV0 
Proteobacteria Mesorhizobium sp. L2C066B000. X6IBI6 
Proteobacteria Mesorhizobium sp. L2C067A000. X6HK44 
Proteobacteria Mesorhizobium sp. L2C084A000. X6GLB7 
Proteobacteria Mesorhizobium sp. L2C085B000. X6G5H3 
Proteobacteria Mesorhizobium sp. L2C089B000. V7H7S3 
Proteobacteria Mesorhizobium sp. LCM 4576. A0A1S1SGE3 
Proteobacteria Mesorhizobium sp. LNHC209A00. X6FGQ1 
Proteobacteria Mesorhizobium sp. LNHC220B00. X6E869 
Proteobacteria Mesorhizobium sp. LNHC221B00. X6DIU1 
Proteobacteria Mesorhizobium sp. LNHC229A00. X6F5F1 
Proteobacteria Mesorhizobium sp. LNHC232B00. X6CG07 
Proteobacteria Mesorhizobium sp. LNJC372A00. X6C9N2 
Proteobacteria Mesorhizobium sp. LNJC386A00. X6AY22 
Proteobacteria Mesorhizobium sp. LNJC391B00. A0A0E2P1G0 
Proteobacteria Mesorhizobium sp. LNJC394B00. V7G761 
Proteobacteria Mesorhizobium sp. LNJC395A00. X5ZPA2 
Proteobacteria Mesorhizobium sp. LNJC399B00. X5YP03 




Proteobacteria Mesorhizobium sp. LNJC405B00. X5Y750 
Proteobacteria Mesorhizobium sp. LSHC412B00. X5XFZ5 
Proteobacteria Mesorhizobium sp. LSHC414A00. A0A0E2NC56 
Proteobacteria Mesorhizobium sp. LSHC422A00. X5VM34 
Proteobacteria Mesorhizobium sp. LSHC426A00. X5UD94 
Proteobacteria Mesorhizobium sp. LSJC264A00. V7F6E4 
Proteobacteria Mesorhizobium sp. LSJC265A00. X5S1I0 
Proteobacteria Mesorhizobium sp. LSJC269B00. X5QPQ9 
Proteobacteria Mesorhizobium sp. LSJC277A00. X5PGA8 
Proteobacteria Mesorhizobium sp. LSJC285A00. X5QS57 
Proteobacteria Mesorhizobium sp. NFR06. A0A1I5G908 
Proteobacteria Mesorhizobium sp. ORS 3324. A0A090F2E9 
Proteobacteria Mesorhizobium sp. ORS 3359. A0A090GRZ5 
Proteobacteria Mesorhizobium sp. Root172. A0A0Q8KGY0 
Proteobacteria Mesorhizobium sp. SEMIA 3007. A0A1E2T2G2 
Proteobacteria Mesorhizobium sp. SOD10. A0A090EHA6 
Proteobacteria Mesorhizobium sp. STM 4661. M5FF31 
Proteobacteria Mesorhizobium sp. WSM3859. A0A2A3E142 
Proteobacteria Mesorhizobium sp. WSM3860. A0A2A3D7I2 
Proteobacteria Mesorhizobium sp. WSM3864. A0A2A3CSR2 
Proteobacteria Mesorhizobium sp. WSM3866. A0A2A3B5V7 
Proteobacteria Mesorhizobium sp. WSM3873. A0A1A5S1U6 
Proteobacteria Mesorhizobium sp. WSM3876. A0A2A3C641 
Proteobacteria Mesorhizobium sp. WSM4308. A0A2A3BTW1 
Proteobacteria Mesorhizobium sp. WSM4313. A0A2A3AMD6 
Proteobacteria Mesorhizobium sp. YR577. A0A1I7EFU9 
Proteobacteria Mesorhizobium temperatum. A0A271LPB7 
Proteobacteria Mesorhizobium wenxiniae. A0A271KGC9 
Proteobacteria Paracoccus aminophilus JCM 7686. S5XUM9 
Proteobacteria Phyllobacterium brassicacearum. A0A2P7BEM8 
Proteobacteria Phyllobacterium endophyticum. A0A2P7ANN3 
Proteobacteria Phyllobacterium myrsinacearum. A0A2S9JQA3 
Proteobacteria Phyllobacterium sophorae. A0A2P7B9V6 
Proteobacteria Phyllobacterium sp. OV277. A0A1H0UID8 




Proteobacteria Phyllobacterium sp. YR531. J3CFV9 
Proteobacteria Phyllobacterium zundukense. A0A2N9VTN8 
Proteobacteria Prosthecomicrobium hirschii. A0A0N8GFR1 
Proteobacteria Proteobacteria bacterium ST_bin15. A0A1W9KGW6 
Proteobacteria Pseudooceanicola sp. A0A2E2PAE0 
Proteobacteria Rhizobiales bacterium GAS113. A0A1H1EVZ7 
Proteobacteria Rhizobiales bacterium GAS188. A0A1H4VTU5 
Proteobacteria Rhizobiales bacterium GAS191. A0A1H4SBE6 
Proteobacteria Rhizobiales bacterium. A0A2W4T2N0 
Proteobacteria Rhizobium acidisoli. A0A0N1DQ59 
Proteobacteria Rhizobium etli 8C-3. A0A1L5PHN5 
Proteobacteria Rhizobium freirei PRF 81. N6V2P0 
Proteobacteria Rhizobium hainanense. A0A1C3VFC0 
Proteobacteria Rhizobium laguerreae. A0A1S9GZG6 
Proteobacteria Rhizobium leguminosarum bv. trifolii WSM1689. W0IM90 
Proteobacteria Rhizobium leguminosarum bv. trifolii WSM2012. J0VG82 
Proteobacteria Rhizobium leguminosarum bv. trifolii WSM2297. J0CHG4 
Proteobacteria Rhizobium leguminosarum bv. trifolii WSM597. I9XBR0 
Proteobacteria Rhizobium leguminosarum bv. trifolii. A0A1B8R9C6 
Proteobacteria Rhizobium leguminosarum bv. viciae  (strain 3841) Q1M368 
Proteobacteria Rhizobium leguminosarum bv. viciae  (strain 
WSM1455) 
J0US37 
Proteobacteria Rhizobium leguminosarum bv. viciae. A0A1Q8HLJ8 
Proteobacteria Rhizobium leguminosarum bv. viciae. A0A222U4U6 
Proteobacteria Rhizobium leguminosarum bv. viciae. A0A2L1CPB6 
Proteobacteria Rhizobium leguminosarum. A0A1B1CI88 
Proteobacteria Rhizobium leguminosarum. A0A2K9ZE12 
Proteobacteria Rhizobium loessense. A0A1G4QVR2 
Proteobacteria Rhizobium loti  A0A117N3J6 
Proteobacteria Rhizobium loti  A0A1A5HRE7 
Proteobacteria Rhizobium loti  A0A1A5QH25 
Proteobacteria Rhizobium loti  A0A1A5R4W2 
Proteobacteria Rhizobium loti  A0A1B4YGQ6 
Proteobacteria Rhizobium lusitanum. A0A1C3XE19 




Proteobacteria Rhizobium miluonense. A0A1C3VF14 
Proteobacteria Rhizobium multihospitium. A0A1C3TVG9 
Proteobacteria Rhizobium sp. 11515TR. A0A248WAG4 
Proteobacteria Rhizobium sp. 60-20. A0A1M3Q932 
Proteobacteria Rhizobium sp. AC27/96. A0A1B9S3G1 
Proteobacteria Rhizobium sp. AP16. J2CWP4 
Proteobacteria Rhizobium sp. CF142. J1TC54 
Proteobacteria Rhizobium sp. H4. A0A2A6R4T7 
Proteobacteria Rhizobium sp. L43. A0A2A6HSS8 
Proteobacteria Rhizobium sp. L9. A0A2A6KSI3 
Proteobacteria Rhizobium sp. NFR03. A0A1H9WZC8 
Proteobacteria Rhizobium sp. NFR07. A0A1I0VUJ4 
Proteobacteria Rhizobium sp. NXC14. A0A1W6Q3K8 
Proteobacteria Rhizobium sp. NXC24. A0A2L0W7N1 
Proteobacteria Rhizobium sp. P44RR-XXIV. A0A1V3G1K7 
Proteobacteria Rhizobium sp. SEMIA4064. A0A2T3GTY4 
Proteobacteria Rhizobium sp. WYCCWR10014. A0A198YF95 
Proteobacteria Rhizobium sp. YK2. A0A1E4Y2S8 
Proteobacteria Rhizobium tropici CIAT 899. L0LXF7 
Proteobacteria Rhizobium tubonense. A0A2W4C6N3 
Proteobacteria Rhizobium tumorigenes. A0A2W4DHA7 
Proteobacteria Rhodobacteraceae bacterium. A0A2E0RFB9 
Proteobacteria Rhodospirillaceae bacterium. A0A2E2CUY2 
Proteobacteria Rhodospirillaceae bacterium. A0A2E2DYB2 
Proteobacteria Rhodospirillales bacterium. A0A2D9I5I5 
Proteobacteria Roseovarius mucosus. A0A1V0RMQ0 
Proteobacteria Roseovarius sp. TM1035. A6E627 





4 TMH-Lyase  
The enzyme ergothionase, characterized in the previous chapter, is in particular interesting because it 
shares an overall high similarity with the aromatic amino acid lyases, although ergothionase does not 
form their catalytic important MIO-moiety. Beside ergothionase, we found another lyase that also did 
not possess the active site residues that build the basis for MIO-formation. Instead, the new lyase has 
a conserved tyrosine residue at the equivalent position (Figure 82).  
 
Figure 82. Abbreviated sequence alignment of the new class of lyase from Lihuaxuella thermophila (LtLyase), ergothionases 
TdETL and histidine ammonia-lyase from Pseudomonas putida (PpHAL). The amino acids forming the MIO-moiety in PpHAL 
are highlighted in pink, Tyr147 of the new lyase is highlighted in green.  
 
The overall high similarity of the new lyase to ergothionase and aromatic amino acid lyases indicates 
the close relation of these three lyases. However, the absence of the MIO-moiety and the conservation 
of the tyrosine residue in the active site suggests profound differences in the mechanism. The new 
lyase is not simply a homologue of ergothionase with a slightly different substrate specificity profile. 
The comparison of sequences, structures and catalytic behavior demonstrate that the two enzymes 
use different catalytic strategies and may have evolved through independent events. 
In the following chapter, we will identify the substrate of the new lyase, we will outline important 
catalytic residues and we will present a possible mechanism. Our results also shed light on the 
mechanism by which the MIO-moiety catalyzes the elimination reaction in aromatic amino acid 
ammonia-lyases. Based on the structural and mechanistic knowledge of this new class of lyase, 
ergothionase and histidine ammonia-lyase in the context with the aspartase/fumarase superfamily, 
we will also discuss the evolutionary history of these enzymes. 
 
4.1 Identification of a TMH-Lyase 
In order to identify the new lyase, we produced three homologue lyases deriving from 
Lihuaxuella thermophila (LtLyase), Halomonas desiderata (HdLyase) and Rhizobium oryzae (RoLyase) 
recombinantly in E. coli. All proteins were soluble and produced in yields up to 10 mg/L of culture. We 
demonstrated the activity of RoLyase and HdLyase (Figure 107, Figure 108). However, for our detailed 








kinetic investigations, we continued with LtLyase. The crystal structure of HdLyase was solved. LtLyase 
and HdLyase share 53% sequence similarity. 
The sequence of the new lyase revealed a profound difference in the active site compared to 
ergothionase and histidine lyase (Figure 82). Indeed, the slow turnover of ergothioneine (2.1 x 10-5 s-1) 
corroborated that the new lyase is no ergothionase. Therefore, our first goal was to identify the 
substrate of the new lyase. Investigation into the substrate specificity (described in detail in section 
4.3.1) revealed that the new class of lyase is responsible for the 1,2-elimination of TMH to yield trans-
urocanic acid and trimethylamine (Figure 83).  
 
Figure 83. Reaction catalyzed by TMH-lyase. TMH is degraded to trans-urocanic acid and trimethylamine. 
 
The kcat of LtLyase for TMH turnover to urocanic acid at pH 9 was kcat = 7.2 ± 0.2 s-1 (Table 18). The KM 
of LtLyase for its main substrate TMH seemed to be high (KM,TMH = 900 ± 80 µM) in regard to the low 
KM of TdETL for ergothioneine (KM,ergothioneine = 45 ± 4 µM). However, the reported KM (KM,His = 3900 µM) 
of the histidine ammonia-lyase from Pseudomonas putida (PpHAL) is even higher than the KM we 
observed for LtLyase.[142]  
Table 18. Kinetic parameters at the corresponding pH-optima of LtLyase (pH 9, TMH as substrate), TdETL (pH 7.5, 
ergothioneine as substrate), PpHAL (pH 9.3, histidine as substrate).[142] 
 kcat [s-1] KM [µM] kcat/KM [M-1s -1] 
LtLyase 7.2 ± 0.2  900 ± 80  7.9 x 103 
TdETL 64 ± 3 45 ± 4 1.4 x 106 
PpHAL[142] 86 ± 6 3900 ± 900 2.2 x 104 
 
The high KM of PpHAL might be advantageous to avoid histidine degradation at low histidine 
concentrations; the affinity of histidyl-tRNA-synthetase for histidine should exceed the affinity for 
histidine degradation in order to circumvent histidine wastage and to ensure proper protein 
synthesis.[89] The comparatively low KM of ergothionase can be a sign for an extremely optimized 





Furthermore, we showed that the reaction product urocanic acid is a competitive inhibitor of LtLyase 
(Ki, urocanic acid = 74 ± 13 µM) (data shown in the experimental section, Figure 111). Product inhibition 
might be essential to avoid accumulation of urocanic acid and to keep a homeostasis with TMH 
availability. Thus, product inhibition helps to regulate the activity of the lyase.  
 
4.2 Crystal Structure 
The TMH-lyase HdLyase was crystallized and the structure was solved by Florian Leisinger. The 
structure was co-crystallized with the product of the reaction, urocanic acid. Similar to ergothionase 
and MIO-dependent lyases, TMH-lyase is a homo-tetramer with a chain fold mainly consisting of α-
helices (Figure 84). The structure is part of the protein domain family lyase_aromatic pfam00221. The 
backbones of HdLyase and TdETL superimpose with an RMSD of 2.73 Å while sharing 31.5% sequence 
identity. The four identical active sites of HdLyase are lined by residues from three different subunits.  
Similar as shown for TdETL, the carboxylate side chain of the ligand approaches the side chains of 
Asn313 (3.3 Å) and Arg283 (3.3 Å) in HdLyase (Figure 84). The imidazole moiety of urocanic acid 
hydrogen bonds to His88 (Nτ, 2.8 Å) and Glu416 (Nπ, 2.8 Å). Glu416 in turn hydrogen bonds with 
Tyr388 (2.5 Å) and approaches Tyr147 (2.8 Å) which is a main difference in the active site architecture 
of HdLyase in contrast to TdETL.  
 
Figure 84. Crystal structure of the homo-tetramer of HdLyase (left). The black box indicates the active site of subunit A that 






In contrast to LtLyase and TdETL, PpHAL requires zinc for substrate binding and optimal activity.[160] It 
is suggested that in PpHAL, Zn2+ coordinates the imidazole ring of the substrate to the equivalents of 
His88 and Met384 during catalysis.[68] The crystal structure of HdLyase with urocanic acid in the active 
site and our studies on zinc-dependent activity of LtLyase (Table 23) gave evidence that TMH-lyases 
are not zinc-dependent. 
The crystal structure provides key information for the identification of important catalytic residues to 
understand the mechanism of TMH-lyase and provides the basis for insights into the phylogenetic 
origin. With the crystal structure of HdLyase at hand, we investigated the catalytic behavior of TMH-
lyase, which allowed us to outline parallels and differences of this enzyme and ergothionase. 
 
4.3 Kinetic Investigations of the Wild Type 
4.3.1 Substrate Specificity  
In order to closely analyze the reactivity of TMH-lyase and to understand the mechanism, we 
investigated the substrate specificity of LtLyase. Studies on substrate specificity can give insights into 
the distinctive feature of an enzymatic reaction. Following product formation by LtLyase using different 
compounds, we found that TMH turnover to give urocanic acid and trimethylamine is the favored 
reaction of LtLyase (1.7 ± 0.1 s-1 at pH 7.5). LtLyase-mediated turnover of DMH was 100-fold lower than 
turnover of the trimethylated variant (Table 19). However, the activity reduction of the desmethylated 
substrate derivative is clearly less dramatic than observed in ergothionase (5300-fold). Additionally, 
LtLyase shows turnover on S-methyl ergothioneine, whereas LtLyase was barely active on 
ergothioneine and ergothioneine sulfonic acid (Table 19).  
Table 19. Observed activity of LtLyase on different substrates in HEPES buffer at pH 7.5 using 2 mM substrate.  













1.7 ± 0.1     
x 100  
1.6 ± 0.1     
x 10-2  
7.0 ± 0.1     
x 10-2   
2.1 ± 0.1     
x 10-5    
4.0 ± 0.1     
x 10-4  
8.5 ± 0.1     
x 10-5 
1.2± 0.1      
x 10-3 
 
In a way, TMH-lyase is characterized by a substrate specificity profile that is complementary to that of 
ergothionase. In contrast to ergothioneine and ergothioneine sulfonic acid, TMH and S-methyl 





Both TMH and S-methyl ergothioneine possess similar chemical properties, since both compounds can 
stabilize a cationic charge on their imidazole moiety (Figure 85).  
 
Figure 85. Resonance structures of cationic TMH and S-methyl ergothioneine. 
 
The imidazolium appears to be crucial for the activity of the lyase while increasing acidity of the β-
proton of the substrate. Abstraction of the β-proton is a key step in LtLyase activity, similar to that 
shown for ergothionase and histidine ammonia-lyase.[161] The acidity of the β-proton in ergothionase 
is increased by the electron-withdrawing capacity of the imidazolium in the zwitterionic form of 
ergothioneine that binds in the active site. In TdETL, Lys384 is important for stabilizing the polarized 
form of the substrate. In the previous chapter, we showed that the mutant K384M possesses 
decreased activity towards ergothioneine and increased activity towards TMH. Indeed, comparison of 
the active sites of TdETL and LtLyase shows that the structural equivalent of Lys384 is Tyr388 in TMH-
lyases, which explains the differences in substrate specificity of both enzymes (Figure 86).  
   
Figure 86. Crystal structure of HdLyase in complex with urocanic acid (left) and TdETL in complex with desmethyl-
ergothioneine sulfonic acid (right, PDB: 6S7Q). The imidazole moiety of the ligands in both proteins are coordinated to 







The substrate specificity was assessed at pH 7.5. To gain a deeper understanding in the reactivity of 
LtLyase, we investigated the pH-dependence of the 1,2-elimination reaction. Studies on the pH-
dependence of an enzymatic reaction can give insights into the protonation states of the substrate or 
the catalytic residues of the enzyme that are required for activity. In the case of LtLyase, we analyzed 
pH-dependent Michaelis-Menten kinetics using TMH and DMH as substrates. The kcat for TMH-
turnover increased with increasing pH (Figure 87). In contrast to ergothionase, the pH-dependence of 
kcat was not bell-shaped which is a major difference of both enzymes. Maximal catalytic efficiency was 
observed at pH 9 and decreased at higher pH values. The pH-dependent measurements of LtLyase with 
DMH also showed a similar pattern (data shown in the experimental section, Figure 114).  




















pKa1 = 6.8 ± 0.2














Figure 87. Summary of the observed pH-dependent kinetic parameters of LtLyase WT using TMH as substrate. Obtained 
kcat/KM values were fitted to y = kHA/ (1+10(pKa1-pH) + 10(pH-pKa2)) (right figure).  
 
The reduced catalytic efficiency at high pH suggests that the formation of the enzyme:substrate 
complex requires a proton. Indeed, the crystal structure suggests a hydrogen bonding network 
between His88, Glu416, Tyr147, Tyr388 and the substrate (Figure 84). At higher pH, less protons are 
available and formation of the enzyme:substrate complex is reduced, presented by a decrease in 
catalytic efficiency at higher pH. However, once the substrate is bound to the enzyme, catalysis occurs. 
Therefore, we do not see a reduced kcat at higher pH.  
 
4.3.3 Substrate and Solvent Isotope Effects 
In order to determine the substrate isotope effect (KIE) of LtLyase, we measured Michaelis-Menten 
kinetics using deuterated TMH as substrate and calculated the ratio of catalytic parameters observed 





= 2.2 ± 0.2), indicating that the cleavage of the β-C-H bond of the substrate is the rate-limiting step of 
the reaction. Similar as observed for TdETL, the KIE on kcat/KM was negligible (KIE (kcat/KM) = 1.4 ± 0.2), 
suggesting that substrate binding is partially irreversible (section 3.4.1).  
We also investigated in the solvent isotope effect (KSIE) of LtLyase, however solvent isotope effects 
are difficult to interpret because exchange of the solvent causes multiple changes in the reaction 
system and not only a specific variation like the substrate isotope effect. The observation of a KSIE on 
kcat (KSIE (kcat) = 2.3 ± 0.2) and on catalytic efficiency (KSIE (kcat/KM) = 1.8 ± 0.1) indicates that proton 
transfer occurs during a rate-limiting step. We suggest that protonation of the leaving group 
trimethylamine is reflected by the KSIE which might indicate an E2 elimination. Additionally, we 
measured a KIE in D2O (KIED2O = 1.6 ± 0.1) and a KSIE with deuterated substrate (KSIEdeut.-TMH = 1.5 ± 
0.2), both double deuterated effects were reduced (Table 20).  
Table 20. Observed substrate kinetic isotope effects (KIE) and kinetic solvent isotope effect (KSIE) at pH 7.5 of LtLyase. 
 KIE (kcat) KSIE (kcat) 
H2O  2.2 ± 0.2 --- 
D2O 1.6 ± 0.1 --- 
Ergothioneine --- 2.3 ± 0.2 
Deut.-Ergothioneine --- 1.5 ± 0.2 
 
In the case of TdETL, the KIE and KSIE of the double deuterated experiments vanish, suggesting a 
sequential order acid-base catalysis for TdETL. For LtLyase, the reduced double deuterated effects also 
suggest a sequential order acid-base catalysis for LtLyase-mediated TMH-degradation, in which a base 
is responsible for the abstraction of the β-proton of the substrate and an acid is responsible for 
protonation of the leaving group. 
 
4.4 Important Catalytic Residues of TMH-Lyase Compared to Ergothionase and Histidine 
Ammonia-Lyase 
Studies of the crystal structure of proteins and site-directed mutagenesis are valuable tools in order to 
identify the important catalytic residues of an enzyme. In the case of TMH-lyase, it is also helpful to 
compare the active site to the related previously described TdETL and the well-known enzyme PpHAL.  
All the three lyases LtLyase, TdETL and PpHAL catalyze a 1,2-elimination of the amine or trimethylamine 





conserved active site tyrosine (Tyr54 in TdETL) that cleaves the C-H bond of the substrate.[68,142] The 
equivalent residue in LtLyase is Tyr58. Mutation of this residue to phenylalanine caused a 105-times 
decrease in kcat, which shows that this tyrosine residue is indeed crucial for activity (Table 21).  
Table 21. Observed kinetic parameters at pH 9 of LtLyase WT and variants using TMH as substrate. 
 kcat [s-1]  KM [µM] kcat/KM [M-1s -1] 
LtLyase WT 7.2 ± 0.2 900 ± 80 7.9 x 103 
LtLyase Y58F 6.6 x 10-5 ± 7 x 10-6 700 ± 200 9.0 x 10-2 
LtLyase Y147F 9.3 x 10-2 ± 1 x 10-3 700 ± 100 1.4 x 102 
LtLyase E416Q 3.4 x 10-3 ± 3 x 10-4 1600 ± 300 2.1 x 100 
 
The crystal structure of HdLyase with urocanic acid shows proximity between the oxygen atom of Tyr58 
and the β-position of the product (2.7 Å) which gave evidence that Tyr58 is the catalytic base (Figure 
88). Considering the catalytic base, we found high similarities among the three classes of lyases, 
whereas other catalytic residues have distinct differences as will be outlined in the following. 
 
Figure 88. Crystal structure of HdLyase in complex with urocanic acid (colored in wheat). Tyr58 is positioned as catalytic base 
(colored in green). 
 
In the active site of LtLyase, a tyrosine residue (Tyr147) is located at the equivalent position of the MIO-
moiety in PpHAL (Figure 89). The ergothionase TdETL has a glutamate residue (Glu143) at that position; 
however, this glutamate points away from the active site and we suggest that this residue is not 
involved in catalysis. The phenol of Tyr147 in LtLyase is located in hydrogen bonding distance to the 






Figure 89. Superimposed structure of HdLyase (green), TdETL (blue, PDB: 6S7Q) and PpHAL (orange, PDB: 1B8F). Glu416 
(counting based on HdLyase) is structurally highly conserved, whereas Tyr147 (HdLyase) is located on the position of MIO in 
PpHAL and Glu143 in TdETL.  
 
 
Figure 90. Crystal structure of HdLyase in complex with urocanic acid (colored in wheat). Glu416 hydrogen bonds with Nπ of 
urocanic acid and Tyr388 and Tyr147. 
 
The variant Y147F caused an 80-fold reduction in kcat (Table 21). We further investigated the pH-
dependence of Y147F (Figure 91). Similar to the wild type, kcat was found to increase with pH, whereas 









































Figure 91. Summary of the observed pH-dependent kinetic parameters of LtLyase Y147F using TMH as substrate. Details are 
shown in the experimental section (Figure 118). 
 
One possible function of Tyr147 would be that this residue is involved in protonation of the leaving 
group trimethylamine (Figure 93). Usually, the pKa of a tyrosine residue is around 10; however, the 
hydrogen bonding network of Tyr147 with Glu416 influences the pKa which might allow protonation 
of the trimethylamine group which has a pKa of 9-10. 
Due to the hydrogen bonding distance between Tyr147 and Glu416 (2.8 Å), we propose that Glu416 
assists in stabilizing the acid proton as a hydrogen bond acceptor (Figure 90, Figure 93). The crystal 
structure also revealed hydrogen bonding distance (2.8 Å) between Glu416 and Nπ of the substrate. 
The variant E416Q reduced kcat and catalytic efficiency by over three orders of magnitude (Table 21). 
The pH-dependence of that variant showed an increase in kcat with increase in pH similar as observed 
for the wild type enzyme and variant Y147F (Figure 92).  






































Figure 92. Summary of the observed pH-dependent kinetic parameters of LtLyase E416Q. Details are shown in the 





Glutamine substitution of the equivalent glutamate in TdETL (Glu412) caused a similar decrease in kcat 
and catalytic efficiency. In TdETL, Glu412 is important for binding the N-H group of the substrate and 
for transferring the proton from Lys384 to the leaving group trimethylamine. The equivalent variant 
E414Q in PpHAL also caused a similar reduction in kcat and catalytic efficiency.[142] Computational 
investigations of the PpHAL reaction showed hydrogen bonding distance between Glu414 and Nπ of 
the substrate,[68] similar as we found for TdETL and LtLyase. Whereas in PpHAL, the hydrogen bonding 
network of the glutamate residue is not known to be required for proton transfer or catalytic acid 
stabilization. During formation of the MIO-moiety, the hydrogen bonding network of Glu414 in PpHAL 
facilitates hydroxyl elimination.[162] 
 
Figure 93. Mechanistic proposal of TMH degradation within the active site of TMH-lyase. 
 
4.4.1 Implications on the Mechanism of MIO-dependent Enzymes 
In aromatic amino acid lyases, such as PpHAL, the MIO-moiety is formed posttranslational from the 
tripeptide Ala142-Ser143-Gly144.[57] Proper formation of the MIO-moiety is crucial for catalysis of 
PpHAL.[142] Sequence alignment of LtLyase and PpHAL revealed a deletion of three amino acids and the 
conservation of Tyr147 in LtLyase at the position of the Ala-Ser-Gly tripeptide in PpHAL (Figure 82). 
Structural alignment of PpHAL (PDB: 1B8F) and HdLyase indicates that the MIO-moiety in PpHAL is 
exactly at the position of Tyr147 in HdLyase (Figure 94). As shown above, we suggest that Tyr147 






Figure 94. Superimposed structure of HdLyase (green) and PpHAL (orange, PDB:1B8F). The ligand urocanic acid of the HdLyase 
structure is colored in wheat. Counting based on HdLyase.  
 
The contribution of Tyr147 to catalysis in LtLyase highlights an interesting analogy to MIO-dependent 
enzymes. The phenol ring of Tyr147 might support the 1,2-elimination in a similar way as the 
enol/enolate function of the MIO-moiety in aromatic amino acid lyases. So far, the literature suggests 
that the -amino group of the substrate is activated as leaving group upon covalently attachment to 
the MIO-moiety.[56,67,149,163] However, it is not precisely clear whether monoalkylation would activate a 
primary amine as a leaving group. In most accounts on the mechanism of MIO-dependent enzymes, 
the cofactor is drawn in the deprotonated enolate form. The dominant protonation state of this moiety 
has not yet been established.  
Based on our finding of tyrosine as catalytic acid in TMH-lyases, we suggest that the MIO-moiety might 
also have a similar function. The MIO-oxygen might be proton-activated leading to an enol 
intermediate (Figure 95). The enol might then be responsible for leaving group protonation, similar as 
we have proposed for the catalytic acid tyrosine in TMH-lyase. The hydrogen transfer to MIO might be 






Figure 95. Proposed mechanism of the MIO-dependent deamination of histidine under formation of an enol intermediate. 
 
We found that in PpHAL (PDB: 1B8F), Asn195 points towards the oxygen of MIO (Figure 94). Maybe 
this Asn195 is important to aid stabilization of the MIO-enol form during catalysis. This hypothesis 
might explain the reported drastic reduction in activity of the N195A variant.[142] TMH-lyases have 
either a serine or asparagine residue at that position. In the structure of HdLyase, the oxygen of Tyr147 
does not point in the same direction as the oxygen of MIO which might explain why the corresponding 
Asn195 is not fully conserved in TMH-lyases.  
From an evolutionary point of view, we would propose that TMH-lyases first used a common active 
site tyrosine residue as a catalytic acid to protonate the leaving group trimethylamine. Later 
emergence of the MIO-moiety in histidine ammonia-lyases mimics both a catalytic acid and a higher 
substituted amino group to catalyze the reaction in an overall similar fashion as TMH-lyases. Thus, we 
suggest that MIO-dependent lyases might have evolved from TMH-lyases.  
 
4.5 Important Residues for MIO-Formation in Histidine Ammonia-Lyase 
Considering MIO-formation in PpHAL, it was postulated that, beside the crucial tripeptide Als142-
Ser143-Gly144, also Asp145, Asn195, Tyr280 and Phe329 serve important functions (Figure 
96).[68,142,162,164] 
 
Figure 96. Sequence alignment of PpHAL, TdETL, LtLyase and HdLyase. The residues important for MIO-formation are 
highlighted in purple. The Cys-motif in LtLyase is highlighted in yellow. Counting based on PpHAL. 
 
    142      195    280     329 
PpHAL  ...SVGASGDL...LLNG...DPYS...GGNFH... 







In PpHAL, Asp145 is the bordering residue in MIO-formation and is strongly fixed in a hydrogen bonding 
network.[162] The crystal structure of PpHAL_D145A (PDB: 1GK3) gave evidence that MIO formation is 
defective in the absence of Asp145. Even if ergothionase does not form the MIO-moiety, the 
corresponding Asp145 is conserved in TdETL. Whereas, LtLyase has a deletion of three residues at that 
position.  
It is proposed that Asn195 in PpHAL activates N-Gly144 as nucleophile for MIO-formation.[164] A 
possible explanation for the observed lack in activity of the N195A variant[142] might be its inability to 
form MIO,[164] however evidence for this hypothesis is lacking. TdETL has a conserved serine at that 
position, whereas TMH-lyases have a serine or an asparagine residue. The fact that TMH-lyases have 
variations at that position show that this residue might not be crucial for their activity. 
Tyr280 serves as an acid-base catalyst during MIO-formation and is, together with Glu414, responsible 
for the exocyclic dehydration step.[164] LtLyase and TdETL both have a conserved leucine at that 
position.  
Another important residue for MIO-formation in PpHAL is Phe329. The variant F329A is still able to 
form MIO (PDB: 1EB4), whereas F329G failed to form MIO (PDB: 1GK2).[162] Therefore, C-β of Phe329 
is proposed to be an important counteracting anchor point for the MIO-forming cyclization step. Even 
if variant F329A possesses the MIO-moiety, the activity of this variant remained low (0.04% activity of 
the wild type).[165] For TdETL, we showed that the equivalent Phe327 packs the aromatic plane against 
the N-α-methyl groups of the substrate.[133]  
LtLyase does not have a conserved aromatic residue. Instead, a cysteine residue (Cys331) is located at 
that position (Figure 96). There is also a second cysteine (Cys329) in close proximity, separated by an 
asparagine residue. These cysteine residues are not conserved throughout TMH-lyases; the crystallized 
HdLyase has an Ala329-Asn330-Pro331 motif at the same position. The structure revealed that this 
tripeptide is located on a loop-region in the protein close to the active site. In order to determine the 
function of the two cysteine residues in LtLyase, we constructed a double-mutant C329G_C331P. This 
variant leads to a more than two times increase in kcat (Table 22).  
Table 22. Observed kinetic parameters at pH 9 of LtLyase WT and C329G_C331P using TMH as substrate 
 kcat [s-1]  KM [µM] kcat/KM [M-1s -1] 
LtLyase WT 7.2 ± 0.2 900 ± 80 7.9 x 103 






We suggest that the two cysteine residues might have a regulatory function as the Cys-Asn-Cys motif 
forms disulfide bonds in high probability. Since other representatives of TMH-lyase class do not have 
the Cys-Asn-Cys motif, we suggest that the disulfide bond is not advantageous for turnover. In the 
variant C329G_C331P disulfide bond formation is no longer possible what might explain the increase 
in activity. 
We attempted to build a MIO-moiety in ergothionase by site-directed mutagenesis that introduced 
the described important residues into TdETL (described in detail in the experimental section, Figure 
123). However, we were not able to insert a MIO-moiety, most likely because such major changes in 
the active site of a protein leads to the problem of proper folding.  
 
4.6 Phylogenetic Development  
In the previous section, we showed distinct differences between the related lyases ergothionase, TMH-
lyase and HAL. However, the overall functional and structural similarity of these three lyases suggest a 
common ancestor. In order to evaluate which lyase evolved first and constituted the basis for their 
development, we compared these lyases to aspartase. Aspartase catalyzes the elimination of the 
amino group of aspartate to yield fumarate (section 1.1.1). Aspartase belongs to the 
aspartase/fumarase superfamily that participate in the citric acid cycle. The affiliation of fumarase in 
the ubiquitous citric acid cycle gives evidence that the enzymes of the aspartase/fumarase superfamily 
represent the ancestor for the development of ergothionase, TMH-lyase and HAL. 
The overall structure of aspartase, ergothionase, TMH-lyase and HAL are largerly conserved: all 
proteins are basically α-helical homo-tetramers.[13,133] The active site of these proteins is separated 
from the protein surface and contains residues from three different subunits. In contrast to the 
structural similarities, the mechanism of these proteins shows distinct differences. For aspartase, the 
carboxylate groups of the substrate stabilize the carbanion intermediate throughout the E1cb 
mechanism.[13] The need of an acid-catalyst that protonates the leaving group is not fully elucidated 
yet.[18] For HAL, the α-amino group of the substrate forms a covalent bond with the electrophilic carbon 
of the MIO-moiety, which is suggested to activate the amino group as leaving group.[63,65] Leaving group 
activation is also important for catalysis of ergothionase. In ergothionase, the leaving group abilities 
are increased through forcing the quaternary ammonium group in a nonpolar pocket. Additionally, the 
substrate ergothioneine is bound in a polarized form which increases acidity of the β-proton; substrate 
assistance was also shown for aspartase via the electron sink of the carboxylate groups. Accordingly, 





activation of MIO-dependent HAL. This finding could be interpreted as a hint that ergothionase 
presents the phylogenetic transition of ancestral aspartase and MIO-dependent enzymes. 
In order to further evaluate the phylogenetic development, we looked at the overall sequence 
similarity of aspartase to the three lyases (ergothionase, TMH-lyases, HAL). Because the degree of 
sequence identity sometimes reflects more the evolutionary distance between the species than 
differences in the protein,[148] we compared the aspartase sequence of the same organism to the 
corresponding lyase. Comparison of LtLyase to LtAspartase (WP_089965319) gave 16.0% sequence 
similarity, PpHAL to PpAspartase (WP_029380744) showed 19.6% similarity, while the sequence of 
TdETL and TdAspartase (WP_002679739) shared 31.0% similarity. This finding shows that ergothionase 
is overall more similar to the ancestor aspartase which suggests that ergothionase might be older than 
TMH-lyase and HAL.  
To further reconstruct the evolutionary history of these enzymes, we built a phylogenetic tree. A 
phylogenetic tree represents hypotheses about the evolutionary relationships among a group of 
enzymes.[166] We built an unrooted phylogenetic tree based on the protein sequences of ergothionase, 
TMH-lyase, MIO-dependent HAL and aspartase (Figure 97). To construct the phylogenetic tree, we 
selected the specific ergothionase and TMH-lyase characterized throughout this work (TdETL, BpETL, 
SjETL, LtLyase, HdLyase, RoLyase). Furthermore, we selected the MIO-dependent PpHAL because of 
the known crystal structure (PDB: 1B8F). Additionally, we added the MIO-dependent HAL deriving from 
the same organisms as ergothionase and TMH-lyase (T. denticola and L. thermophila). We proceeded 
similar while selecting the sequences of aspartase: known crystal structure of Bacillus sp. aspartase 
(PDB: 3R6V) and aspartase of T. denticola and L. thermophila. In the resulting phylogenetic tree, the 
branch of ergothionases (blue) is the closest to the branch of aspartase (grey), whereas the MIO-
dependent HAL (orange) are located on the opposite branch of aspartases (Figure 97). This pattern of 
branching in the phylogenetic tree suggests that ergothionases have evolved from aspartases; later 
TMH-lyases (green) diverged and the MIO-dependent lyases are a comparative new class of enzymes. 
Thus, the emergence of MIO probably constituted a new innovation. In contrast, the deletion of three 
amino acids in the active site of TMH-lyase might show that MIO got lost over time, which would claim 






Figure 97. Phylogenetic tree of aspartases (highlighted in grey; from T. denticola, P. putida, Bacillus sp., L. thermophila), 
ergothionases (highlighted in blue; from B. pseudomallei, S. jonesii, T. denticola), TMH-lyases (highlighted in green; from 
R. oryzae, H. desiderata, L. thermophila), MIO-dependent HAL (highlighted in orange, from P. putida, L. thermophila, 
T. denticola).  
 
Additionally, we dissected the active site architecture of Bacillus sp. (PDB: 3R6V). Similar to TdETL, 
HdLyase and PpHAL, the active site of aspartase is covered by a highly flexible conserved loop.[13] This 
loop is important for substrate binding and catalysis. A serine residue, located on the loop, works as 
catalytic base in aspartase. In the case of ergothionase, TMH-lyase, and HAL, a tyrosine residue which 
is also located on the loop region is the catalytic base. Aspartase possesses a lysine residue that is 
important for stabilization of the carboxylate of the substrate.[13] Recently, it has been suggested that 
the equivalent lysine residue in E. coli fumarase is important for lowering the pKa of the catalytic 
base.[14] Oxyanion stabilization of the catalytic base by a lysine residue (Lys64, TdETL counting) is also 
a conserved feature of ergothionase as described in section 3.2.4. Neither HAL or TMH-lyase have a 
lysine residue with a similar function. The functional conservation of the lysine residue only throughout 
ergothionases and the aspartase/fumarase superfamily can be interpreted as a hint for a closer 
relation between these two enzymes.  
Based on these findings, we suggest that ergothionase has probably evolved prior TMH-lyase and HAL. 
This finding seems surprising since HAL presents the first step of the universally conserved histidine 
degradation pathway hut. If ergothioneine degradation is older than the hut-system, this would pre-
date ergothioneine emergence prior to histidine. However, histidine is needed for ergothioneine 





histidine degradation but rather the improved replacement for an alternative histidine degradation 
pathway. Perhaps, HAL is not native to the histidine degradation pathway but is recruited from another 
family of lyases and has adapted to allow histidine degradation. It was found that the hut-operon in 
Pseudomonas is accompanied by a gene hutH1 which is similar to the gene coding for HAL.[167] 
However, the protein encoded in hutH1 does not form the MIO-moiety but resembles a TMH-lyase. 
The function of hutH1 within the hut-system is not clarified yet.[89] The finding of a second lyase 







4.7 Influence of Fluorine-Containing Substrates on Lyase Activity 
An interesting and major difference between LtLyase and TdETL is their reactivity with the fluorine-
incorporated substrate derivatives fluor-TMH (F-TMH) or fluor-ergothioneine (F-ergothioneine). F-
ergothioneine was an accepted substrate for TdETL (kcat/KM, F-ergothioneine = 5.5 x 105 M-1 s-1); the catalytic 
efficiency is within the same range as observed when ergothioneine is used as a substrate (kcat/KM, 
ergothioneine = 1.4 x 106 M-1 s-1). Apparently, the replacement of one hydrogen atom with fluorine in the 
substrate does not interfere with TdETL activity (Figure 124).  
In contrast, turnover of F-TMH by LtLyase was barely detectable (<0.001 s-1). In order to investigate if 
LtLyase was not able to bind F-TMH or whether it simply failed to turnover F-TMH, we examined 
whether F-TMH could inhibit LtLyase catalyzed turnover of TMH. First, we assessed the inhibitory 
activity under the assumption that F-TMH is a reversibly competitive inhibitor. Therefore, Michaelis-
Menten kinetics of LtLyase inhibition by F-TMH were run by measuring the apparent KM,TMH in the 
presence of different concentrations (0.3 µM; 0.4 µM; 0.5 µM) of F-TMH (Figure 98). From these data, 
Ki was calculated using the equation  =
∗[]
(.) 
.[147] The very low value of Ki (Ki, F-TMH = 0.09 µM) 
raised suspicions whether inhibition by F-TMH is reversible. 
 
Figure 98. Lineweaver-Burk plot of the data used to examine LtLyase inhibition by F-THM. Turnover of TMH was followed in 
the presence of 0.3 µM (blue); 0.4 µM (turquoise); 0.5 µM (pink) F-THM.  
 
In order to determine if inhibition of LtLyase by F-TMH is reversible, we investigated a time-dependent 
inhibition of LtLyase by pre-incubation of the enzyme (0.2 µM) with F-TMH (0.3 µM). After pre-
incubation, TMH (1 mM) was added to start the reaction (Figure 99). Only for the first data point 
(t = 0 min) the reaction was started by the addition of LtLyase to examine the turnover of TMH in the 
presence of F-TMH (1.10 ± 0.07 s-1). Incubation of LtLyase (0.2 µM) with F-TMH (0.3 µM) for 1 min 
reduced the catalytic activity to less than 2% (1.6 x 10-2 ± 1 x 10-3 s-1). Most interestingly, the activity 





a single unconfirmed experiment). Incubation of the enzyme in the absence of F-TMH, did not reduce 
activity to the same extent (Figure 99, black squares). From these observations we learned that F-TMH 
inhibits LtLyase in a fast and almost stoichiometric reaction that leads to long lasting (if not irreversible) 
inhibition.  






















Figure 99. Observed activity of LtLyase WT (0.2 µM) on TMH (1 mM) at pH 7.5 after incubation (0, 1, 5, 10, 15, 20, 45 min) in 
the absence (black) and presence of 0.3 µM F-TMH (red). The error bars present the standard deviation of the three 
independent measurements. F-TMH caused 98.6% reduction of activity within the first minute.  
 
The inhibitory behavior of F-TMH is characteristic for covalent inhibition. One possibility is that F-TMH 
could transfer its fluoromethyl group to a nucleophilic active site residue (Figure 100). In order to 
identify possible alkylation sites, we examined F-TMH treated and trypsin digested LtLyase by high-
resolution ESI-MS; however, we only found the masses of unmodified peptides. This negative result 
does not necessarily rule out the possibility that active site residues are fluoromethylated because this 
modification may not be stable under the conditions used for tryptic digest and ESI-measurements.  
  
Figure 100. Reaction scheme of a possible enzyme modification by F-TMH. 
 
As a second approach to identify a possible alkylation site, we surmised that if the enzyme is inhibited 
by alkylation of a specific active site residue, then the residual activity of the corresponding mutant 





candidate. This residue could make direct contact to the fluoromethyl group if F-TMH bound to the 
active site in a similar orientation as urocanic acid (Figure 84). The phenol function of this residue 
would provide a viable nucleophile. Incidentally, this idea would also explain why TdETL is not 
inhibited: ergothionases do not contain a structurally equivalent tyrosine residue. 
Contrary to our expectation, we found that the variant Y147F was also inhibited by F-TMH, although 
the observed activity reduction of Y147F was 10-fold instead of 100-fold for the wild type enzyme. 
Within the first minute, LtLyase Y147F (0.5 µM) lost 90.5% activity in the presence of F-TMH (0.3 µM) 
(t=0 min: 0.018 ± 0.006 s-1; t=1 min: 0.0017 ± 0.0002 s-1) (Figure 101, red dots). One explanation for the 
reduced inhibition of Y147F in contrast to the wild type might be the reduced ratio between enzyme 
and F-TMH. Nevertheless, the observed activity reduction of the variant Y147F shows that Tyr147 is at 
least not the only modified residue. Other possible modification targets might be Tyr388, Ser197, 
Cys68 or Cys412. Further mutational studies on these residues might help to identify another target of 
modification. 




















Figure 101. Observed activity of LtLyase_Y147F (0.5 µM) on TMH (1 mM) at pH 7.5 after incubation (0, 1, 5, 10, 15, 20 min) in 
the absence (black) and presence of 0.3 µM F-TMH (red). The error bars present the standard deviation of the three 
independent measurements. F-TMH caused 90.5% reduction of activity within the first minute. 
 
In order to detect any possible fluorine transfer from F-TMH to LtLyase, we recorded 19F-NMR spectra 
of F-TMH (1 mM) and of F-TMH (1 mM) in the presence of LtLyase (100 µM) (Figure 102). F-TMH shows 
a signal at -194.5 ppm. However, the sample that included F-TMH and LtLyase did not show a new 19F-
signal deriving from a fluoromethyl-modification on the enzyme. The new signal at -123.7 ppm in the 
sample of F-TMH and LtLyase derived from inorganic fluoride, the chemical shift was identical to the 
NaF control (spectra shown in the experimental section, Figure 127). The absence of a signal from a 





might be possible that we cannot detect transferred flourine on the large tetrameric enzyme (224 kDa) 
by NMR. However, the inorganic fluoride signal (-123.7 ppm) derived only in the presence of LtLyase. 
A possible explanation for the emergence of fluoride is that LtLyase, independent from any 
modification, at a very slow rate (<0.001 s-1) degrades F-TMH to urocanic acid and fluor-
trimethylamine. The leaving group, fluoro-trimethylamine, might then decompose to fluoride, 
dimethylamine and formaldehyde. 
 
Figure 102. 19F-NMR of F-TMH (1 mM, black) and F-TMH (1 mM) in the presence of LtLyase (100 µM, red). The signal at -76.55 
ppm shows the reference trifluoracetic acid. The signal at -194.5 ppm shows F-TMH. The signal at -123.7 ppm in the reaction 
derives from inorganic F-. 
 
The difference in reactivity of LtLyase and TdETL against the fluorine-incorporated substrates is an 
interesting finding that underlines the differences in the active site architecture or reaction mechanism 
of these two related enzymes. However, at this point in time, the exact mechanism of the irreversible 
inhibition of LtLyase still remains unclear. Since the mercaptoimidazole side chain of ergothioneine 
and the imidazole side chain of TMH are electronically isolated from the leaving group, we do not think 
that differences in the intrinsic reactivity could explain the different rates of enzyme-catalyzed 
turnover. It is more likely that the observed differences are related to the different catalytic strategies 
of the two enzymes. A test of this hypothesis might be to examine the rate of F-TMH degradation by 
TdETL or by TdETLK384M, which has appreciable activity for TMH. We would expect that at least 







In this chapter, we characterized a new enzyme that is responsible for TMH degradation. With 
assistance of the crystal structure of a TMH-lyase and based on site-directed mutageneses, we 
proposed an acid-base dependent mechanism. Similar to the previously presented ergothionase and 
the well-known HAL, a tyrosine residue acts as catalytic base and abstracts the β-proton of the 
substrate. Whereas a catalytic acid tyrosine residue is unique to TMH-lyase. This tyrosine residue is 
located on the equivalent position to the catalytic important MIO-moiety in HAL. Based on the overall 
relation of TMH-lyase and HAL, we suggest that the MIO-moiety in HAL might not only function as 
electron sink but also as the catalytic acid.  
Furthermore, analysis of the phylogeny of ergothionase, TMH-lyase and HAL in relation to the ancestral 
aspartase/fumarase superfamily suggests ergothionase as the oldest representative among TMH-lyase 
and HAL. If ergothionase is older than the MIO-dependent HAL, the presence of an alternative and 
currently unknown histidine degradation pathway seems likely. 
TMH-lyase was strongly inhibited by the compound F-TMH. The fast and long-lasting inhibitory 
behavior of F-TMH suggests a covalent modification on the enzyme. In contrast, ergothionase 
demonstrated turnover on F-ergothioneine. The different reactivity towards the fluorine-incorporated 









Protein Production. The synthetic genes of ltlyase wild type and variants, hdlyase, rolyase and tdetl 
variants were purchased from BioCat GmbH encoded on a pET28 plasmid. Proteins were produced as 
described in section 3.8. Protein concentration was determined by UV at 280 nm (Nanodrop2000, 
Thermo Scientific) using the calculated extinction coefficient.[157] Protein homogeneity was assessed 
by SDS-PAGE (Figure 103, Figure 104, Figure 105). 
 
                  
Figure 103. SDS-PAGE analysis of the purified protein LtLyase wild type (left gel, lane 2), E416Q (right gel, lane 2), 
C329G_C331P (right gel, lane 3), Y58F (right gel, lane 4), Y147F (right gel, lane 5). Lane 1 in both gels shows the protein 
standard (Precision Plus Protein Standard, Bio-Rad). 
 































Figure 104. SDS-PAGE analysis of the purified protein H.desiderata Lyase (lane 2). Lane 1 shows the protein standard 
(Precision Plus Protein Standard, Bio-Rad). 
 











Figure 105. SDS-PAGE analysis of the purified protein R.oryzae Lyase (lane 2). Lane 1 shows the protein standard (Precision 
Plus Protein Standard, Bio-Rad). 
 

















































   
Figure 106. SDS-PAGE analysis of the purified protein TdETL variant 1 - 3 (left gel, lane 2 - 4), TdETL variant 4 -5 (right gel, lane 
2 - 3). Lane 1 in both gels shows the protein standard (Precision Plus Protein Standard, Bio-Rad). 
TdETL variant-1       x144S 
TdETL variant-2 E143T x144S 
TdETL variant-3 E143A x144S 
TdETL variant-4 E143A_x144S_S195N 
TdETL variant-5 E143A_x144S_S195N_L278Y 
 
 
Reagents. The same reagents as described in section 3.8 were used. Ortho-hydroxy-benzyl-histidine 
was synthesized by David Lim. F-TMH was synthesized by Carsten Bauer. F-ergothioneine was enzyme 
based produced using F-TMH as starting material following the protocol described in the reagents 
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[DMH] (M)  
Figure 107. Michaelis-Menten Kinetics of HdLyase in HEPES buffer at pH 7.5 using TMH (left figure) or DMH (right figure) as 
substrate. Substrate concentration was in between 100 µM and 8000 µM. Enzyme concentration was in between 0.5 µM and 
1 µM. Formation of the product urocanic acid at 23 °C was monitored using the spectrophotometer (Variant Cary 300 UV-Vis 
spectrophotometer). ε295.(urocanic acid, pH 7.5) = 38565 M-1cm-1.  
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[DMH] (M)  
Figure 108. Michaelis-Menten Kinetics of R. oryzae Lyase in HEPES buffer at pH 7.5 using TMH (left figure) or DMH (right 
figure) as substrate. Substrate concentration was in between 25 µM and 6000 µM. Enzyme concentration was in between 
0.02 µM and 0.5 µM. Formation of the product urocanic acid at 23 °C was monitored using the spectrophotometer (Variant 








Figure 109. 1H-NMR of trans-urocanic acid. 1 mM TMH was incubated for 16 h with 0.2 µM LtLyase in phosphate buffer at 
pH 7.5. The spectra was recorded on a Bruker Ascend™ 500 (500 MHz) spectrometer. The coupling constants of  J(3) = 15 Hz 
and J(4) = 15 Hz gave evidence for the trans-product. 
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Figure 110. Michaelis-Menten Kinetics of LtLyase WT in HEPES buffer at pH 7.5 using TMH as substrate in the presence of 0, 
20, 40, 60 µM additional urocanic acid. Product formation at 23 °C was monitored using the spectrophotometer (Variant Cary 
300 UV-Vis spectrophotometer). ε295.(urocanic acid, pH 7.5) = 38565 M-1cm-1. Urocanic acid inhibits LtLyase in a competitive 
model with TMH. Obtained kinetic data were fit to  =
∗[]
(.) 
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Figure 111. Lineweaver-Burk plot of the data used to examine LtLyase inhibition by urocanic acid (UA). LtLyase activity was 
monitored in the presence of 0, 20, 40, 60 µM additional urocanic acid. Michaelis-Menten plots are shown in Figure 110. 
 
Table 23. Activity of LtLyase using TMH (2000 µM or 200 µM) as substrate in the presence of ZnCl2 (0 – 50 µM) in phosphate 
buffer at pH 7.5. Formation of the product was monitored using the spectrophotometer (Variant Cary 300 UV-Vis 
spectrophotometer). 
 vobs [s-1]  
2000 µM TMH 
vobs [s-1]  
200 µM TMH 
0 µM ZnCl2 2.30 ± 0.04 0.73 ± 0.06 
1 µM ZnCl2 1.54 ± 0.25 0.84 ± 0.05 
10 µM ZnCl2 1.40 ± 0.16 0.95 ± 0.11 
25 µM ZnCl2 1.55 ± 0.20 0.76 ± 0.04 
50 µM ZnCl2 1.90 ± 0.28 0.74 ± 0.08 
 
 
Substrate specificity. Substrate specificity was monitored in HEPES buffer at pH 7.5 using 2 mM of 
substrate by measuring the rate of product formation at 23 °C in a 1 cm quartz cuvette using a Variant 
Cary 300 UV-Vis spectrophotometer. If the activity was too low to determine Michaelis-Menten 
kinetics, enzyme concentration of 5 µM was used to follow turnover. ε311.(thiourocanic 
acid) = 22500 M-1cm-1; ε295.(urocanic acid, pH 7.5) = 38565 M-1cm-1, ε295.(sulfono thiourocanic 
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Figure 112. Michaelis-Menten Kinetics of LtLyase WT at pH 6 – pH 11. A buffer solution containing 40 mM acetic acid, 40 mM 
boric acid and 40 mM phosphoric acid (BR-buffer) was adjusted with NaOH to the desired pH. TMH substrate concentration 
was in between 10 µM and 10000 µM. Enzyme concentration was in between 0.1 µM and 0.3 µM. Formation of the product 
urocanic acid at 23 °C was monitored using the spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). ε295 nm 
(urocanic acid, pH 6) = 26470 M-1cm-1; ε295 nm (urocanic acid, pH 7) = 38680 M-1cm-1; ε295 nm (urocanic acid, pH 8) = 38450 M-
1cm-1; ε295 nm (urocanic acid, pH 9) = 41680 M-1cm-1; ε295 nm (urocanic acid, pH 10) = 42480 M-1cm-1; ε295 nm (urocanic acid, 
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Figure 113. Michaelis-Menten Kinetics of LtLyase WT at pH 7 – pH 11. A buffer solution containing 40 mM acetic acid, 40 mM 
boric acid and 40 mM phosphoric acid (BR-buffer) was adjusted with NaOH to the desired pH. DMH substrate concentration 
was in between 25 µM and 20000 µM. Enzyme concentration was 1 µM. Formation of the product urocanic acid at 23 °C was 
monitored using the spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). ε295 nm (urocanic acid, 
pH 6) = 26470 M-1cm-1; ε295 nm (urocanic acid, pH 7) = 38680 M-1cm-1; ε295 nm (urocanic acid, pH 8) = 38450 M-1cm-1; ε295 nm 








































Figure 114. Summary of the observed pH-dependent kinetic parameters of LtLyase WT using DMH as substrate (Kinetic data 
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Figure 115. Michaelis-Menten Kinetics of LtLyase WT in HEPES buffer at pH 7.5 using TMH (left figures) or deuterated N-α-
trimethyl histidine (deut.-TMH, right figures) as substrate. Deuterated histidine (D5, 98%; 15N3, 98%; ReseaChem GmbH) was 
converted to deuterated N-α-trimethyl histidine according to the published protocol.[158] TMH Substrate concentration was 
in between 25 µM and 800 µM. Enzyme concentration was 0.1 µM. Formation of the product urocanic acid at 23 °C was 
monitored using the spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). ε295.(urocanic acid, 
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Figure 116. Michaelis-Menten Kinetics of LtLyase WT at pH 7.5 using HEPES buffer in H2O (left graph) or D2O (right graph). 
The pH of the buffer was adjusted to 7.5 for the reaction in H2O and to 7.10 for the reaction in D2O. Both buffers were 
lyophilized and dissolved in H2O or D2O, respectively. TMH substrate concentration was in between 25 µM and 800 µM. 
Enzyme concentration was 0.1 µM. Formation of the product urocanic acid at 23 °C was monitored using the 
spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). ε295.(urocanic acid, pH 7.5) = 38565 M-1cm-1. KSIE (kcat) = 
2.3 ± 0.2; KSIE (kcat/KM) = 1.8 ± 0.1. 
 
 
Substrate kinetic isotope effect in D2O. To determine the substrate kinetic isotope effect in D2O 
turnover of LtLyase WT at pH 7.5 in HEPES buffer in D2O using TMH or deuterated TMH as substrate 
was followed. Substrate concentration was 1 mM. Deuterated histidine (D5, 98%; 15N3, 98%; 
ReseaChem GmbH) was converted to deuterated TMH according to the published protocol.[158] The pH 
of the buffer was adjusted to 7.10, lyophilized and dissolved in D2O (final pD 7.5). The reaction rates 
were determined by following product formation at 23 °C using the spectrophotometer (Variant Cary 
300 UV-Vis spectrophotometer). ε295.(urocanic acid, pH 7.5) = 38565 M-1cm-1. The ratio 
 (%&!)
 ('(.  %&!)
  
presents the substrate isotope effect. KIE (in D2O) = 1.6 ± 0.1. 
 
Kinetic solvent isotope effect using deuterated TMH as substrate. To determine the kinetic solvent 
isotope effect of LtLyase WT using deuterated TMH as substrate turnover at pH 7.5 in HEPES buffer in 
H2O or D2O was followed.  The pH of the buffer was adjusted to 7.5 for the reaction in H2O and to 7.10 
for the reaction in D2O. Both buffers were lyophilized and dissolved in H2O or D2O, respectively. 1 mM 
deuterated TMH was used as substrate. Deuterated histidine (D5, 98%; 15N3, 98%; ReseaChem GmbH) 
was converted to deuterated TMH according to the published protocol.[158] The reaction rates were 





UV-Vis spectrophotometer). ε295.(urocanic acid, pH 7.5) = 38565 M-1cm-1. The ratio 
   !2#
   $2#
  presents 
the kinetic solvent isotope effect. KSIE (deut. TMH) = 1.5 ± 0.2. 
 
 





kcat = 6.6 x 10
-5 ± 7 x 10-6 1/s
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Figure 117. Michaelis-Menten Kinetics of LtLyase Y58F in BR-Buffer at pH 9. TMH substrate concentration was in between 
400 µM and 4000 µM. Enzyme concentration was 3 µM. Formation of the product urocanic acid at 23 °C was monitored 
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Figure 118. Michaelis-Menten Kinetics of LtLyase Y147F at pH 7 – pH 11. A buffer solution containing 40 mM acetic acid, 
40 mM boric acid and 40 mM phosphoric acid (BR-buffer) was adjusted with NaOH to the desired pH. TMH substrate 
concentration was in between 25 µM and 8000 µM. Enzyme concentration was 0.5 µM. Formation of the product urocanic 
acid at 23 °C was monitored using the spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). ε295 nm (urocanic 
acid, pH 7) = 38680 M-1cm-1; ε295 nm (urocanic acid, pH 8) = 38450 M-1cm-1; ε295 nm (urocanic acid, pH 9) = 41680 M-1cm-1; ε295 nm 
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Figure 119. Michaelis-Menten Kinetics of LtLyase E416Q at pH 7 – pH 11. A buffer solution containing 40 mM acetic acid, 
40 mM boric acid and 40 mM phosphoric acid (BR-buffer) was adjusted with NaOH to the desired pH. TMH substrate 
concentration was in between 25 µM and 10000 µM. Enzyme concentration was in between 0.5 µM – 1 µM. Formation of 
the product urocanic acid at 23 °C was monitored using the spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). 
ε295 nm (urocanic acid, pH 7) = 38680 M-1cm-1; ε295 nm (urocanic acid, pH 8) = 38450 M-1cm-1; ε295 nm (urocanic acid, 






Ortho-Hydroxy Benzyl Histidine as MIO-Mimetic. In order to test if the elimination reaction catalyzed 
by an ortho-hydroxy group as acid is possible from a chemical perspective, the compound ortho-
hydroxy benzyl histidine was synthesized by David Lim. The idea was that incubation of this compound 
might lead to formation of urocanic acid, which would then show that the enol of MIO could indeed 
function as catalytic acid for the elimination reaction. However, due to solubility problems at neutral 
pH, we had to run this experiment at pH 9 which then caused degradation to histidine (Figure 120, 
Figure 121).  
 
 
Figure 120. 1H-NMR of o-hydroxy-benzyl-histidine (top: 8.8 – 6.4 ppm; bottom: 4.3 – 2.9 ppm). The compound (1 mM) was 









Figure 121. 1H-NMR of histidine at pH 9 (light blue) and the degradation product of o-hydroxy-benzyl-histidine after 15 days 
incubation at 60 °C at pH 9 (top: 8.9 – 6.4 ppm; bottom: 4.4 – 2.8 ppm). We suggest that o-hydroxy-benzyl-histidine 
decomposed to histidine.  
 
 





kcat = 17 ± 1 1/s
KM = 1400 ± 200 µM












Figure 122. Michaelis-Menten Kinetics of LtLyase C329G_C331P in BR-Buffer at pH 9. TMH substrate concentration was in 
between 100 µM and 5000 µM. Enzyme concentration was in between 0.2 µM. Formation of the product urocanic acid at 
23 °C was monitored using the spectrophotometer (Variant Cary 300 UV-Vis spectrophotometer). ε295 nm (urocanic acid, 







TdETL Variants to Simulate MIO-Formation. Formation of the Mio-moiety should give absorbance at 
308 nm.(Röther et al., Angew. Chem. Int. Ed Engl. 39, 2462–2464 (2000) Therefore, the UV-spectra of 
variant 1 – 5 and the wild type were recorded. The corresponding difference-spectra are shown in 
Figure 123. MIO-Formation includes two times elimination of H2O. Therefore, successful MIO-
formation causes a mass decrease of 32 Da. In order to investigate if the TdETL variants are able to 
form MIO, a chymotryptic digest was run. Subsequently, the resulting peptides were analyzed by 
UHPLC-MS (Agilent 1290 Infinity system coupled to Agilent 6130 quadrupol-MS). We did not detect a 
loss in mass of 32 Da (Table 24).  
TdETL variant-1       x144S 
TdETL variant-2 E143T x144S 
TdETL variant-3 E143A x144S 
TdETL variant-4 E143A_x144S_S195N 
TdETL variant-5 E143A_x144S_S195N_L278Y 
 





















Figure 123. Difference UV-spectra of the TdETL variants measured against TdETL WT. Protein concentration was 0.6 mg/mL. 
The maxima at around 250 nm and 290 nm are a result of unproper protein folding. Formation of a MIO-moiety should 
increase absorbance at 308 nm.  
Table 24. Overview of the calculated and observed masses of the chymotryptic peptide fragment of TdETL WT and variants. 




m/z calc (without 
modification) 
m/z calc (after MIO-
formation) 
m/z obs 
TdETL WT RSSIGEGDITTL 1248.6 -- 1249 
TdETL variant_1 RSSIGESGDITTL 1335.7 1303.7 1336 
TdETL variant_2 RSSIGTSGDITTL 1307.7 1275.7 1308 





TdETL variant_4 RSSIGASGDITTL 1277.7 1245.7 1278 
TdETL variant_5 RSSIGASGDITTL 1277.7 1245.7 1278 
 
 








kcat = 6.1 ± 0.3 1/s
KM = 11 ± 1 µM
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Figure 124. Michaelis-Menten kinetics of TdETL using F-ergothioneine as substrate in HEPES buffer (50 mM, pH 7.5). 
Formation of the product thiourocanic acid was monitored Variant Cary 300 UV-Vis spectrophotometer). ε311 nm (thio urocanic 
acid) = 22500 M-1cm-1 
 
 












 25uM Thermo + 1mM F-TMH
 1mM F-TMH
 
Figure 125. Ion-Exchange HPLC chromatogram of 1 mM F-TMH (black) and 1 mM F-TMH incubated in the presence of 25 µM 
LtLyase (red) 24h. The signal at 7.45 min shows F-TMH. The signal at 4.28 min shows Urocanic acid. Calculated turnover 
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Figure 126. Michaelis-Menten kinetic of LtLyase WT in HEPES buffer at pH 7.5 using TMH as substrate in the presence of 0.3, 
0.4, 0.5 µM F-TMH. Product formation at 23 °C was monitored using the spectrophotometer (Variant Cary 300 UV-Vis 




TMH) = 0.09 µM. 
 
Time-dependent inhibition. To determine time dependent inhibition 0.2 µM LtLyasewild type or 0.5 µM 
LtLyaseY147F were incubated in the presence of 0.3 µM F-TMH in HEPES buffer (50 mM, pH 7.5). After 
t = 1, 5, 10, 15, 20, 45 min 1 mM TMH was added to start the reaction. For the first time point, t = 0 min, 
1 mM TMH was added prior addition of the enzyme. The same experiment was run in the absence of 
F-TMH. Product formation was followed at 23 °C in a 1 cm quartz cuvette using a Variant Cary 300 UV-
Vis spectrophotometer. ε295.(urocanic acid, pH 7.5) = 38565 M-1cm-1. 
 
Tryptic digest. 60 µM LtLyase was incubated for 5 min in the presence of 30 µM F-TMH in HEPES buffer 
(50 mM, pH 7.5). Subsequently, the protein was digested by 2 µM trypsin for 16 h. The digested 





19F-NMR. 1 mM F-TMH was incubated in the presence of 100 µM LtLyase in phosphate buffer (50 mM, 
pH 7.5). In addition, 1 mM F-TMH was incubated in the same buffer without enzyme. As a control to 
determine the chemical shift of fluoride, NaF (50 µM) was analyzed (Figure 127). Each NMR sample 
contained an insert glass tube containing trifluoracetic acid (1 mM) as reference (-76.5 ppm). NMR 
spectra were obtained on a Bruker Ascend™ 500 (500 MHz) spectrometer. 
 
Figure 127. 19F-NMR of NaF (-123.7 ppm) using trifluoracetic acid (-76.5 ppm) as reference. 
 




5 Examination of EgtD Regulation 
The S-adenosyl methionine (SAM)-dependent methyltransferase EgtD (EC 2.1.1.44) catalyzes the 
formation of TMH from histidine and represents the first enzyme in the biosynthetic pathway for 
ergothioneine production (section 1.4.1).[121] EgtD possesses both a Rossmann-fold domain that is 
typical for SAM-dependent methyltransferases and a substrate binding domain that is unique to 
EgtD.[168] The binding site for histidine and SAM is located in the cleft between both domains. EgtD can 
be classified as part of the methyltransf_33 protein family.[169]  
As typical for SAM-dependent methyltransferases, EgtD proceeds methylation via a classic SN2 
reaction.[168] Kinetic and structural investigations provide evidence for an ordered sequential binding 
mechanism in which EgtD binds the substrate histidine first, followed by SAM binding. After one 
methylation has occurred, both the methylated substrate and S-adenosyl homocysteine (SAH) leave 
the binding site prior to re-binding of the mono-methylated substrate and SAM to run the subsequent 
methylation reaction, which is again followed by unbinding and renewed binding to proceed the third 
and final methylation.[170]  
A remarkable processivity of EgtD reactivity was found: one equivalent of both SAM and histidine 
produces less than 1% of mono-methylated histidine, 13 ± 9% of di-methylated histidine but 88 ± 4% 
of TMH.[169] Kinetic investigations revealed that this processivity does not originate from an increased 
kcat for the methylated histidine derivatives, rather an increased affinity of EgtD for the methylated 
variants. Detailed inspection of the crystal structure further corroborated this finding: the N-α-amino 
moiety of histidine hydrogen bonds to two active site residues (Gly161 and Asn166). In contrast, DMH 
only hydrogen bonds to Asn166; however, this single hydrogen bond becomes shorter and stronger, 
resulting in a 100-fold stronger binding of DMH in comparison to histidine.[170] In order to 
accommodate the growing size of substrate upon successive methylations, the active site of EgtD 
expands through the repositioning of Gly161 and Asn166. Interestingly, TMH is found to be a good 
ligand (Ki = 39 ± 6 µM), despite not forming any hydrogen bonds from the N-α-amino moiety; however, 
two methyl groups of TMH have attractive interactions with the carbonyl moieties of Gly161 and 
Asn166. The strong binding of TMH results in distinct product feedback inhibition of EgtD.[170]  
The efficient and irreversible trimethylation in addition to product inhibition, which derives from 
specific evolutionary optimization, is important to circumvent wastage of intracellular histidine, as any 
methylated histidine leads to ergothioneine production. Ergothioneine biosynthesis produces an 
inherent energy cost for mycobacteria. In addition to histidine and three equivalents of SAM, cysteine, 
glutamate, ATP and pyridoxalphosphate is required.[121] For this reason, regulation of the first enzyme 




of this biosynthesis pathway, EgtD, is important to regulate the whole ergothioneine biosynthetic 
pathway. The Ki,TMH= 39 ± 6 µM of EgtD is similar to the KM,TMH= 43 ± 12 µM of EgtB,[171] the next enzyme 
of the ergothioneine biosynthetic pathway.[170] This helps to avoid accumulation of TMH, and thus 
adjusts the supply of TMH to ergothioneine biosynthesis which might be of significant value for 
regulation. 
In 2015, Richard-Greenblatt et al. postulated that EgtD activity in Mycobacterium tuberculosis is under 
phosphorylation control.[172] Reversible post-translational phosphorylation is a dominant form of 
protein regulation.[173] Phosphorylation introduces a negative charge on the targeted amino acid and 
introduces the capacity to form a hydrogen network, both of which can strongly affect the overall 
activity of a protein.[174] Beside controlling protein activity, phosphorylation also affects protein 
localization and can induces changes in the secondary, tertiary or quaternary structure. In their 
publication, Richard-Greenblatt et al. claim that introduction of a phosphate on the EgtD active site 
residue Thr213 hidners interaction between the enzyme and substrate, and thus inhibits EgtD 
activity.[172] They proposed that the kinase PknD is responsible for this phosphorylation event. In the 
following chapter we reexamine the possible phosphorylation of EgtD from M. tuberculosis (TbEgtD). 
The goal is to investigate the influence of PknD on TbEgtD activity, to analyze PknD activity in vitro, and 
thus determine if the proposed phosphorylation on TbEgtD occurs. 
 
5.1 Importance of Residue Thr213 
Richard-Greenblatt et al. reported that the active site residue Thr213 of TbEgtD is target for a 
phosphorylation reaction.[172] Therefore, we were curious to investigate the localization and function 
of this residue. The previously published crystal structure of EgtD from Mycobacterium smegmatis 
(SmEgtD) in complex with DMH and SAH (PDB: 4PIO) provided a thorough structural description of 
SmEgtD active site residues.[169] In SmEgtD, Thr213 is located on a α-helix in the active site that forms 
part of the pocket in which the imidazole ring of the substrate binds (Figure 128).[169] Nτ of the 
imidazole ring hydrogen bonds to a water molecule that anchors to Thr213 and Ala205. While Nπ of 
the imidazole ring shares a proton with the side chain of Glu282. Glu282 was stated to be highly 
important for substrate binding, with the KM, His for the E282A mutation increases 200-fold. The 
hydrogen bond of Thr213 to the active site water is reported to be essential for the substrate specificity 
of EgtD as tyrosine and phenylalanine cannot hydrogen bond to Thr213 and are therefore rejected as 
substrates.[169] As SmEgtD shares >70% sequence identity with TbEgtD we can assume that both 
proteins adopt a similar structure. Therefore, we hypothesized that Thr213 may also be important for 
catalysis in TbEgtD and expect a decrease in activity of the T213A variant. 





Figure 128. Crystal structure of SmEgtD in complex with DMH and SAH (PDB: 4PIO). Overall structure (left) and close up view 
of the active site (right). Nπ of DMH hydrogen bonds with Glu282; Nτ hydrogen bonds via a water molecule to Thr213 and 
Ala205. 
 
Indeed, our investigation into TbEgtD T213A revealed a 300-fold decrease in activity (3.7 x 10-5 s-1) 
towards the wild type (1.2 x 10-2 s-1), underlining the importance of Thr213 for catalysis (Table 25). We 
further examined the variant T213E, however, the mutation to glutamate resulted in an unstable 
protein. Based on these data, we can conclude that Thr213 is essential for TbEgtD activity. Any changes 
at this position, such as phosphorylation, would impact enzyme activity. However, we have to consider 
that Thr213 is located on an α-helix within the EgtD structure, approximately 8 Å away from the protein 
surface, making this threonine residue an unlikely kinase substrate. Large scale conformational 
changes would be required to make Thr213 accessible to the kinase. 
Table 25. Observed activity of TbEgtD WT and T213A using histidine as substrate. The reaction conditions are described in 
the experimental section. 
 Rate [s-1] 
TbEgtD WT 1.2 x 10-2  
TbEgtD T213A 3.7 x 10-5  
 
We further tested the activity of the T213A variant with 1-methyl histidine (Figure 129) as substrate. 
Thereby, we observed an 8-fold increase in activity (3.0 x 10-4 ± 5 x 10-5 s-1) in comparison to the 
histidine substrate, likely due to an improved binding affinity between the small hydrophobic Ala-
moiety and the methylated imidazole moiety of 1-methyl histidine. 





Figure 129. Structure of 1-methyl histidine. 
 
5.2 Peptide Phosphorylation 
While the importance of Thr213 for EgtD catalysis has been confirmed, its amenability for 
phosphorylation requires investigation. The kinase PknD is postulated to be responsible for EgtD 
phosphorylation in M. tuberculosis.[172] PknD is among 10 other kinases part of the group of Ser/Thr 
protein kinases (STPK) that produce stable phosphor-esters that require a phosphatase to be 
reversed.[175] STPKs are involved in many cellular processes like regulation of development, stress 
response and pathogenicity.[176]  
In order to analyze PknD activity in vitro, we first investigated its ability for peptide phosphorylation. 
Therefore, we synthesized a peptide (peptide A, Abz- GRDDEATSAVELTEA), reported to be a good 
substrate for PknD.[177]. We decorated the peptide with a N-terminal amino benzoic acid (Abz) to 
enable UV-based detection. The subsequent phosphorylation assay showed 41 ± 4 % phosphorylated 
peptide A after 1 h incubation with PknD (Figure 130). Therefore, we concluded that PknD is an active 
enzyme that is able to transfer phosphor groups. Knowing that PknD is active under our experimental 
conditions, we set to explore our main question: Is PknD able to phosphorylate EgtD? To address this 
question, we constructed a peptide (peptide B, Abz- AYDDPGGVTAQFNR) with the EgtD sequence 
containing the postulated phosphorylation target Thr213. Utilizing the same assay as for peptide A, we 
observed 43 ± 2 % phosphorylation of peptide B (Figure 130). This study provides evidence that the 
Thr213 containing protein sequence of TbEgtD is a target for PknD. Next, we wanted to investigate if 
PknD-driven phosphorylation can occur on the native protein as well.  
 





Figure 130. HPLC-chromatograms of PknD-mediated peptide phosphorylation of peptide A (left) and peptide B (right). Both 
peptides possess the aminobenzoic acid precursor to show absorbance at 310 nm. The control reaction without PknD is 
shown in black. The reaction containing PknD is shown in grey. The reaction conditions are described in the experimental 
section. 
 
5.3 Examination on Protein Phosphorylation 
5.3.1 High-Resolution ESI-MS Analysis of Phosphorylation of Native TbEgtD 
Using high-resolution ESI-MS, we are able to determine the exact mass of native proteins. 
Phosphorylation of a protein residue results in a mass increase of 80 Da, and is therefore telling if 
phosphorylation has occurred or not. In order to explore the possible phosphorylation of TbEgtD, we 
incubated TbEgtD in the presence of PknD under the conditions which resulted in the successful 
phosphorylation of peptide A and peptide B (section 5.2). We ran the same experiment without PknD 
or without ATP as negative controls. Afterwards, the protein mixtures were analyzed using high-
resolution ESI-MS. In the phosphorylation experiment the mass of unmodified TbEgtD and TbEgtD with 
a mass increase of 178 Da, due to gluconylation of the N-terminal his-tag was found (Table 26).[178] 
Furthermore, we detected the mass of self-phosphorylated PknD (Table 26). However, we were not 
able to observe phosphorylation of TbEgtD. This finding suggests that PknD is not able to 
phosphorylate the native folded form of TbEgtD. To further support this finding, we ran a tryptic digest 





































Table 26. Overview of the calculated and observed masses of the native proteins in the protein phosphorylation assay. The 
reaction conditions are described in the experimental section.  
 
TbEgtD [Da] PknD [Da] 
Phosphorylated TbEgtD 
[Da] 
m/z calc.  m/z obs. m/z calc. m/z obs. m/z calc. m/z obs. 














TbEgtD + PknD  37436.2 37435.8 
37612.8*1 










TbEgtD + ATP 37436.2 37435.3 
37614.7*1 




*1 Gluconylated form of TbEgtD.[178] *2 Multiple self-phosphorylation of PknD. 
 
5.3.2 LC-MS Analysis of Tryptic Digests 
Based on the data achieved by high resolution MS, we suggest that native TbEgtD is not 
phosphorylated by PknD in vitro. In order to further confirm this finding experimentally, we incubated 
TbEgtD in the presence of PknD followed by trypsin digestion. Subsequently, we screened the resulting 
peptides for the phosphorylated variants by UPLC-MS. The advantage of this method was that we were 
able to analyze the tryptic digested peptides by both their mass and their chromatographic separation. 
The extracted ion chromatogram allowed us to plot signal intensity of a selected m/z value as a 
function of retention time. For this purpose, we selected (I) the mass of the unmodified tryptic digested 
TbEgtD fragment (1510 m/z) and (II) the mass of the phosphorylated TbEgtD fragment (1590 m/z) 




(Figure 131). In addition to the reaction mixture containing TbEgtD and PknD (blue), we also digested 
and analyzed controls containing only TbEgtD (red) or PknD (green). Analysis of this experiment 
required care because a tryptic fragment of PknD (residues 45 to 57; sequence: LISPQYSDNAVFR) 
resulted in the same mass (1510 m/z) as the Thr213 containing TbEgtD fragment of interest. 
Furthermore, the PknD-fragment contains a serine residue that is target of auto-phosphorylation. 
Accordingly, the resulting phosphorylated PknD-fragment would possess the same mass as a 
phosphorylated TbEgtD-fragment (1590 m/z). In the reaction mixture containing both TbEgtD and 
PknD, we observed a signal with 1590 m/z; however, the control reaction provides evidence that this 
signal derives from the phosphorylated PknD fragment. This indicates that Thr213 of TbEgtD is not 
phosphorylated by PknD in vitro. As mentioned above (section 5.1) Thr213 is not surface exposed 
which makes a phosphorylation of this residue unlikely. 
 
Figure 131. Extracted ion-chromatogram of the phosphorylation reaction of TbEgtD after trypsin digestion. The extracted ion 
chromatograms are shown for 1510 m/z (left, expected mass of the TbEgtD-derived fragment and the PknD derived 
fragment), for 1590 m/z (right, expected mass of the phosphorylated TbEgtD- and PknD-derived fragment). The reaction 
containing both TbEgtD and PknD is shown in blue, TbEgtD alone is shown in red, PknD alone is shown in green. The reaction 
conditions are described in the experimental section. 
 
In order to further validate this method for finding phosphorylated peptides, we ran a control reaction 
using peptide B as phosphorylation target (Figure 132). Peptide B is a synthetic tryptic fragment of 
TbEgtD that contains Thr213 with an ortho-amino benzoic acid at the N-terminus. From our previous 
experiment we can confidentially conclude that PknD is able to phosphorylate peptide B (section 5.2). 
Therefore, the extracted ion chromatogram also shows that the signal of the phosphorylated peptide 
B (1709 m/z) is derived only in presence of PknD. In order to screen for the tryptic PknD-fragment, 
which we observed in the previous study, we recorded the extracted ion chromatogram for the 




































































Surprisingly, we detected a signal for peptide B with the mass of 1510 m/z and the corresponding 
phosphorylated peptide B (1590 m/z). These signals derive from the reductive elimination of the N-
terminal amino benzoic acid (Abz) under ESI conditions (Figure 133) and therefore have the same 
retention time as their Abz-containing precursors. As expected, we further detected the signal of the 
PknD-fragment in both non-phosphorylated (1510 m/z) and phosphorylated (1590 m/z) form. In 
conclusion, this positive control showed that we are able to detect phosphorylation using this assay; 
confirming that we did not observe phosphorylation on TbEgtD. 
 
Figure 132. Extracted ion-chromatogram of the phosphorylation reaction of peptide B after trypsin digestion. The extracted 
ion chromatograms are shown for 1629 m/z (top left, expected mass of peptide B), 1709 m/z (top right, expected mass of 
phosphorylated peptide B), 1510 m/z (bottom left, expected mass of the PknD derived fragment and expected mass of 
peptide B after reductive elimination of the N-terminal amino benzoic acid, labeled as peptide B*), for 1590 m/z (bottom 
right, expected mass of the phosphorylated PknD fragment and expected mass of phosphorylated peptide B after reductive 
elimination of the N-terminal amino benzoic acid, labeled as phosphorylated peptide B*). The reaction containing both 

































































































































Figure 133. Reductive elimination of the N-terminal aminobenzoic acid under ESI conditions.  
 
5.4 Activity of EgtD in the Presence of PknD 
Previously, we showed that PknD does not phosphorylate TbEgtD; however, we were interested to 
examine if PknD influences TbEgtD activity. Therefore, we developed an in vitro assay where we 
studied methyltransferase activity with and without incubation for 1 h, both in the presence and in the 
absence of kinase. Firstly, TbEgtD activity with an excess of substrate was measured giving an observed 
rate of 1.2 x 10-2 ± 3 x 10-3 s-1, which is consistent with the published activity of TbEgtD (1.3 x 10-2 s-1) 
(Table 27).[172] Next, we incubated TbEgtD in the presence of PknD. After one hour of incubation we 
tested methyltransferase activity and observed a drastic decrease in TbEgtD activity (6.5 x 10-4 ± 1 x 10-
5 s-1). As a control, we ran the same experiment in the absence of PknD; however again, we observed 
the same diminished activity rate (8.4 x 10-4 ± 4 x 10-5 s-1). We deduced that after one hour of 
incubation TbEgtD loses activity; 95 ± 4 % activity loss in the presence of PknD, and 93 ± 1 % activity 
loss in the absence of PknD. This finding indicates that activity loss is independent of the presence of 
kinase and therefore not a result of any phosphorylation event. What remains is the observation of a 
general lack of stability of TbEgtD after one hour of incubation. 
Table 27. Observed activity of TbEgtD catalyzed formation of TMH. The reaction conditions are described in the experimental 
section. 
 Rate [s-1] 
published[172] 1.3 x 10-2 
TbEgtD  1.2 x 10-2 ± 3 x 10-3 
TbEgtD + 1 h incubation 8.4 x 10-4 ± 4 x 10-5 
TbEgtD + 1 h incubation + PknD 6.5 x 10-4 ± 7 x 10-5 
 
It was published previously that PknD (I) is part of the osmosensory pathway that enables adaption to 
osmotic stress,[179] (II) downregulates the malate dehydrogenase in the TCA cycle,[180] (III) influences 
cell division by phosphorylation of proteins that are key components of the bacterial chromosome 
segregation apparatus,[181] (IV) phosphorylates SAH-hydrolase, an enzyme that maintains cellular SAH 
concentration.[182] The later role might provide an alternative in which PknD-mediated phosphorylation 




may indirectly influence EgtD activity in M. tuberculosis in vivo. SAH-hydrolase catalyzes the NAD+ 
dependent degradation of SAH to adenosine and homocysteine. Reduction of SAH-hydrolase activity 
after phosphorylation would result in an increase in cellular SAH-concentration.[182] As SAH stabilizes 
the EgtD-TMH complex,[170] an increase in cellular SAH concentration would consequently 
downregulate ergothioneine biosynthesis. However, further experiments are required to confirm a 
possible SAH-hydrolase phosphorylation 
 
 
   





The presented data suggests that phosphorylation of EgtD by PknD does not occur in vitro. The 
observed loss in activity of EgtD is not related to the presence of PknD and a subsequent 
phosphorylation. Our control experiment in the absence of PknD rationalizes that any reduction in 
activity is due to the instability of EgtD. The kinase PknD was confirmed to be active and was able to 
phosphorylate a peptide sequence that originates from EgtD, however the tertiary fold of the EgtD 
structure prevents phosphorylation of its native folded form. Furthermore, we showed that Thr213, 
the postulated target for phosphorylation, is indeed an important residue for EgtD activity. However, 
we could not observe phosphorylation of Thr213 by analysis of native protein or peptide analysis after 
tryptic digest. Based on this data, we conclude that methyltransferase activity is in vitro not regulated 









Protein production. The pET28 plasmids containing genes coding for TbEgtD WT, TbEgtD T213A and 
PknD were kindly shared by Dr. Richard-Greenblatt and Av-Gay. Proteins were produced as described 
in section 3.8. The extinction coefficients 36565 M-1cm-1 for TbEgtD, 21890 M-1cm-1 for PknD were 
calculated to determine protein concentration by UV at 280 nm (Nanodrop2000, Thermo Scientific). 
Protein homogeneity was assessed by SDS-PAGE (Figure 134). The mass was confirmed by high 
resolution mass spectroscopy (micrOTOF ESI-TOF, Bruker).  
TbEgtD WT: m/z calc = 37436 Da,  m/z obs = 37436 Da 
TbEgtD T213A: m/z calc = 37406 Da,  m/z obs = 37406 Da 
PknD: m/z calc = 40124 Da,  m/z obs = 40770 Da; 40849 Da; 40930 Da; 41010 Da; 41090 Da; 41170 Da; 
41250 Da; 41330 Da (Δ x80 Da due to self-phosphorylation) 
 
Figure 134. SDS-PAGE of (A) TbEgtD WT (lane 2 shows the pellet fraction, lane 3 shows the purified protein), (B) TbEgtD T213A 
(lane 2 shows the pellet fraction, lane 3 shows the purified protein), (C) PknD (lane 2 shows the purified protein). 
 



















Methyltransferase Activity Assay. Methyltransferase activity was analyzed under the following 
conditions: TbEgtD WT or TbEgtD T213A (25 µM or 100 µM), histidine (4 mM) or 1-methyl histidine 
(4 mM), SAM (0.5 mM), adenine deaminase and adenosylhomocysteine nucleosidase (10 µM), DTT 
(2 mM), Tris-HCl (pH 7.6, 100 mM), MnCl2 (0.5 mM), NaCl (5 mM), Mg(OAc)2 (1 mM) were incubated 
at 37 °C. Aliquots of the reaction were quenched using 1% TFA and analyzed by cation exchange HPLC 
(Buffer A: 20 mM phosphoric acid pH 2; Buffer B: 20 mM phosphoric acid pH 2 with 1 M NaCl). 
Formation of the tri-methylated product was followed at 220 nm and the concentration was 
determined by using a calibration for the product peak area. The slope of the linear function of product 
formation against time was used to calculate enzyme activity (Figure 135, Figure 136).  
 
 
Figure 135. Product formation in the reaction of TbEgtD WT (left) and TbEgtD T213A (right). The rate of enzyme catalysis was 
calculated from the linear function of product formation against time. The observed activity was 0.012 ± 0.003 s-1 for TbEgtD 
WT and 3.7 x 10-5 s-1 for TbEgtD T213A.  
 









































Figure 136. Product formation in the reaction of TbEgtD T213A using 1-methyl histidine as substrate. The rate of enzyme 
catalysis was calculated by the linear function of product formation against time. The observed activity was 3.0 x 10-4 ± 5 x 10-
5 s-1. 
In order to determine influence of PknD, we incubated TbEgtD (25 µM), w/o and w/ PknD (25 µM), ATP 
(100 µM), MgSO4 (10 mM), MnCl2 (10 mM) in Tris-HCl (pH 7.4, 50 mM). After 1 h methyltransferase 
activity was analyzed as described above (Figure 137). 
 
Figure 137. Product formation in the reaction of TbEgtD WT after 1 h preincubation of TbEgtD WT in the absence of PknD 
(left), or in the presence of PknD (right). The rate of enzyme catalysis was calculated by the linear function of product 
formation against time. The observed activity was 8.4 x 10-4 ± 4 x 10-5 s-1 (left) and 6.5 x 10-4 ± 7 x 10-5 s-1 (right).  
 
Peptide Synthesis. Peptides (peptide A, published by Prisic to be a good substrate for PknD: ABZ-
GRDDEATSAVELTEA;[177] peptide B, tryptic digested part of TbEgtD: ABZ-AYDDPGGVTAQFNR) were 
synthesized using standard protocols for Fmoc solid phase peptide synthesis using the synthesis robot 
(Syro I, MultiSynTech). Peptides were cleaved from the rink amid resin (0.41 mmol/g) (Novabiochem), 
deprotected and washed using TFA: EDT: TIPS: DCM (94: 2.5: 2.5: 1) for 4 h. Ice-cold diethylether was 



































1 h preincubation w/o PknD














1 h preincubation w/ PknD




used for resuspension the peptides and afterwards removed by centrifugation. The pellet was dried 
using N2.  
Afterwards, the peptides were dissolved in acetonitrile: water (1:1) and purified by preparative HPLC 
(Buffer A: H2O, 1% acetonitrile, 0.1% TFA; Buffer B: acetonitrile, 0.085% TFA; Flowrate: 20 mL/min; 
column: 10 µm particles, 250x12, C18, Gemini Phenominics). After lyophilization the peptides were 
dissolved in acetonitrile: water (1:1) and analyzed by analytical RP-HPLC (Buffer A: Acetonitrile; 0.1% 
TFA; Buffer B: H2O, 1% Acetonitrile; 0.1% TFA) at 310 nm. The concentration was determined using a 
standard of free amino benzoic acid. The mass was determined by ESI-MS (Bruker Esquire3000plus). 
Peptide A: Mcalc. = 1681.7 Da; [M+H]+= 1683.1 
Peptide B: Mcalc = 1627.7 Da, [M+H]+= 1629.0 
 
Peptide Phosphorylation. Peptide phosphorylation was analyzed under the following conditions: 
peptide A or peptide B (25 µM), PknD (25 µM), ATP (100 µM), Buffer: Tris-HCl (pH 7.4, 50 mM); MgSO4 
(10 mM); MnCl2 (10 mM), incubated for 1 h at 30 °C. To quantify peptide phosphorylation, we used 
RP-HPLC at 310 nm (Buffer A: Acetonitrile; 0.1% TFA; Buffer B: H2O, 1% Acetonitrile; 0.1% TFA). The 
mass of the phosphorylated peptides was analyzed by UHPLC/MS on Agilent 1290 Infinity system with 
Zorbax Eclipse Plus C-18-column (2.1 x 50 mm; 1.8 µm) coupled to Agilent 6130 quadrupol-MS (Eluent 
A: water/ acetonitrile/ TFA (1000: 10: 1); Eluent B: acetonitrile/ water/ TFA (1000 : 10 : 1)).  
Phosphorylated peptide A: MWcalc = 1761.7 Da; [M+H]+ = 1763.0 
Phosphorylated peptide B: MWcalc = 1707.7 Da; [M+H]+ = 1709.0 
 
High-Resolution ESI-MS Analysis of Native Proteins. The following conditions were used to examine 
protein phosphorylation: TbEgtD WT (25-100 µM), PknD (2-100 µM), ATP (100 µM), Buffer: Tris-HCl 
(pH 7.4, 50 mM); MgSO4 (10 mM); MnCl2 (10 mM), incubated for 1-6 h. We run the same assay without 
ATP or PknD as negative controls. Protein mass was analyzed by LC/MS-TOF on Agilent 1100 Series 








LC-MS Analysis of Tryptic Digests. We incubated phosphorylation reactions containing one equivalent 
of TbEgtD and/or peptide B and PknD in the presence of ATP (100 µM), MgSO4 (10 mM); MnCl2 
(10 mM) for 1.5 h in Tris-HCl (pH 7.4, 50 mM). The phosphorylation reaction was heat-inactivated (98 
°C, 10 min) and subsequently digested with 4 µM trypsin for 1.5 h at 25 °C. These samples were heat 
inactivated and submitted to UHPLC/MS Agilent 1290 Infinity system with Zorbax Eclipse Plus C-18-
column (2.1 x 50 mm; 1.8 µm) coupled to Agilent 6130 quadrupol-MS (Eluent A: water/ acetonitrile/ 
TFA (1000: 10: 1); Eluent B: acetonitrile/ water/ TFA (1000 : 10 : 1)). The extracted ion chromatogram 
of the expected m/z values for the peptides of interest were analyzed (Table 28). 
 
Table 28. Overview of the observed m/z values in the analysis of tryptic digests. 
1510 m/z 
TbEgtD derived fragment 
PknD derived fragment 
Peptide B after reductive elimination of ABZ-precursor 
1590 m/z 
Phosphorylated PknD derived fragment 
Phosphorylated peptide B after reductive elimination of ABZ-precursor 
1629 m/z Peptide B 
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